CALIFORNIA CANCER REGISTRYccr.ca.gov/pdf/Reports/CCRPub2003.pdf · 6 california cancer registry publications, 2003 state of california, department of health services october 2003

O CO CO CO CO CTTTTTOOOOOBBBBBEEEEER 200R 200R 200R 200R 20033333

CALCALCALCALCALIFIFIFIFIFOOOOORRRRRNIANIANIANIANIA CAN CAN CAN CAN CANCECECECECER RER RER RER RER REGIGIGIGIGISSSSSTTTTTRRRRRYYYYYP UP UP UP UP UBBBBBLLLLLIIIIICCCCCAAAAATTTTTIIIIIOOOOONNNNNSSSSS

CCCCCALIFALIFALIFALIFALIFOOOOORRRRRNIANIANIANIANIA C C C C CANANANANANCERCERCERCERCER R R R R REEEEEGIGIGIGIGISSSSSTTTTTRRRRRYYYYY

PPPPPUUUUUBLIBLIBLIBLIBLICCCCCAAAAATTTTTIIIIIOOOOONNNNNSSSSS

OOOOOCTCTCTCTCTOOOOOBERBERBERBERBER 200 200 200 200 20033333

Gray DavisGovernor

State of California

Grantland JohnsonSecretaryCalifornia Health and HumanServices Agency

`

Diana M. Bonta, R.N., Dr.P.H.DirectorCalifornia Department ofHealth Services

This publication was prepared by:

The Cancer Surveillance SectionCancer Control BranchDivision of Chronic Disease and Injury ControlCalifornia Department of Health Services1700 Tribute Road, Suite 100Sacramento, CA 95815-4402(916) 779-0300http://www.dhs.cahwnet.gov/ps/cdic/cdicindex.htm

Information compiled by Debbie Fine, California Cancer Registry

Cover design by Maggie Burgos, California Cancer Registry

Copyright information:

All material in this report is in the public domain and may be reproduced or copied withoutpermission; citation as to source, however, is appreciated.

This and other California Cancer Registry publications are available on the World Wide Web athttp://www.dhs.cahwnet.gov/ps/cdic/cdicindex.htm.

33333CCCCCALIFALIFALIFALIFALIFOOOOORRRRRNIANIANIANIANIA C C C C CANANANANANCERCERCERCERCER R R R R REEEEEGIGIGIGIGISSSSSTTTTTRRRRRYYYYY P P P P PUUUUUBLIBLIBLIBLIBLICCCCCAAAAATTTTTIIIIIOOOOONNNNNSSSSS,,,,, 200 200 200 200 20033333

SSSSSTTTTTAAAAATTTTTEEEEE OOOOOFFFFF C C C C CALIFALIFALIFALIFALIFOOOOORRRRRNIANIANIANIANIA,,,,, D D D D DEPEPEPEPEPARARARARARTTTTTMENMENMENMENMENTTTTT OOOOOFFFFF H H H H HEEEEEALALALALALTTTTTHHHHH S S S S SERERERERERVIVIVIVIVICECECECECESSSSS OCTOBER 2003OCTOBER 2003OCTOBER 2003OCTOBER 2003OCTOBER 2003

California Cancer Registry Publications by Sites 5Bladder Cancer 6Brain Cancer 7Breast Cancer 9Cervical Cancer 17Childhood Cancer 18Colorectal Cancer 20Endometrium (Uterus) Cancer 22Esophagus Cancer 23Gallbladder Cancer 23Hodgkin’s Disease 23Kaposi’s Sarcoma 24Kidney Cancer 24Leukemia 25Liver Cancer 26Lung Cancer 27Melanoma 29Mesothelioma 30Multiple Myeloma 30Multiple Sites 30Non-Hodgkin’s Lymphoma 41Oral, Head, and Neck 42Ovarian Cancer 44Pancreas 45Prostate Cancer 46Sarcoma 48Stomach Cancer 48Testis 49Thyroid 50

Listings by Author 51A 52A-B 53B-C 56C-D 59D-F 61G 62G-H 64H-J 68K 69K-L 70L-M 72M-N 75N-P 76P-R 81R-S 83S-T 86T-W 87W-Y 91Y-Z 92

CCCCCONTENTSONTENTSONTENTSONTENTSONTENTS

44444 CCCCCALIFALIFALIFALIFALIFOOOOORRRRRNIANIANIANIANIA C C C C CANANANANANCERCERCERCERCER R R R R REEEEEGIGIGIGIGISSSSSTTTTTRRRRRYYYYY P P P P PUUUUUBLIBLIBLIBLIBLICCCCCAAAAATTTTTIIIIIOOOOONNNNNSSSSS,,,,, 200 200 200 200 20033333


CCCCCALIFALIFALIFALIFALIFOOOOORRRRRNIANIANIANIANIA C C C C CANANANANANCERCERCERCERCER R R R R REEEEEGIGIGIGIGISSSSSTTTTTRRRRRYYYYY

RRRRREEEEESESESESESEARARARARARCHCHCHCHCH BBBBBYYYYY S S S S SITITITITITEEEEESSSSS



BBBBBLLLLLADADADADADDDDDDEEEEERRRRR C C C C CANANANANANCECECECECERRRRR

Anton-Culver H, Lee-Feldstein A, Taylor TH. The association of bladder cancer risk with ethnicity, gender, andsmoking. Ann Epidemiol 1993;3:429-33.

Benton B, Henderson BE. Environmental exposure and bladder cancer in young males. J Natl Cancer Inst1973;51:269-70.

Castelao JE, Yuan JM, Gago-Dominguez M, Yu MC, Ross RK. Non-steroidal anti-inflammatory drugs and bladdercancer prevention. Br J Cancer 2000;82:1364-9.

Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Yu MC, Ross RK. Gender andsmoking-related bladder cancer risk. J Natl Cancer Inst 2001;4:538-45.

Chow WH, McLaughlin JK, Menck HR, Mack TM. Risk factors for extrahepatic bile duct cancers: Los AngelesCounty, California (USA). Cancer Causes Control 1994;5:267-72.

Gago-Dominguez M, Castelao JE, Yuan JM, Yu MC, Ross RK. Use of permanent hair dyes and bladder-cancer risk.Int J Cancer 2001;91:575-9.

Horn-Ross PL, Barnes S, Kirk M, Coward L, Parsonnet J, Hiatt RA. Urinary phytoestrogen levels in young womenfrom a multiethnic population. Cancer Epidemiol Biomarkers Prev 1997;6:339-45.

Ji H, Yu MC, Stillwell WG, Skipper PL, Ross RK, Henderson BE, Tannenbaum SR. Urinary excretion of 2-amino-3,8-dimethylimidazo-[4,5-f ]quinoxaline in white, black, and Asian men in Los Angeles County. Cancer EpidemiolBiomarkers Prev 1994;3:407-11.

Menck HR, Mack TM. Incidence of biliary tract cancer in Los Angeles. Natl Cancer Inst Monogr 1982;62:95-9.

Ross RK, Paganini-Hill A, Henderson BE. Epidemiology of bladder cancer. In: Skinner DG, ed. Urological Cancer:Grune & Stratton, Inc., 1983:113-33.

Ross RK, Paganini-Hill A, Henderson BE. Epidemiology of bladder cancer. In: Skinner DG, Liewskovsky G, eds.Diagnosis and Management of Genitourinary Cancer. Philadelphia: W.B. Saunders & Co., 1988:23-31.

Ross RK, Jones PA, Yu MC. Bladder cancer epidemiology and pathogenesis. Semin Oncol 1996;23:536-45.

Ross RK, Yuan JM, Yu MC. Recent progress in understanding the epidemiology and etiology of bladder cancer.In: Golematis BC, Dimopoulos KA, eds. Tumors of the Pelvis. New York: Wiley-Liss, Inc., In Press.

Spruck, CH, III, Rideout, WM, III, Olumi AF, Ohneseit PF, Yang AS, Tsai YC, Nichols PW, Horn T, Hermann GG, StevenK, et al. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Cancer Res1993;53:1162-6.

Weinberg DM, Ross RK, Mack TM, Paganini-Hill A, Henderson BE. Bladder cancer etiology. A different perspec-tive. Cancer 1983;51:675-80.

Yu MC, Ross RK. Epidemiology of bladder cancer. In: Petrovich Z, Baert L, Brady L, eds. Carcinoma of the Bladder:Innovations in Management. Berlin; Heidelberg: Springer-Verlag, 1998:1-13.

Yu MC, Skipper PL, Taghizadeh K, Tannenbaum SR, Chan KK, Henderson BE, Ross RK. Acetylator phenotype,aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in LosAngeles, California. J Natl Cancer Inst 1994;86:712-6.



BBBBBRRRRRAINAINAINAINAIN C C C C CANANANANANCECECECECERRRRR

Aldape K, Simmons ML, Davis RL, Miike R, Wiencke J, Barger G, Lee M, Chen P, Wrensch M. Discrepancies in diagnosesof neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study. Cancer 2000;88:2342-9.

Blowers L, Preston-Martin S, Mack WJ. Dietary and other lifestyle factors of women with brain gliomas in LosAngeles County (California, USA). Cancer Causes Control 1997;8:5-12.

Bunin G, Surawicz T, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology ofcraniopharygioma. Neurosurgical Focus 1997;3.

Carozza SE, Wrensch M, Miike R, Newman B, Olshan AF, Savitz DA, Yost M, Lee M. Occupation and adult gliomas.Am J Epidemiol 2000;152:838-46.

Chen P, Wiencke J, Aldape K, Kesler-Diaz A, Miike R, Kelsey K, Lee M, Liu J, Wrensch M. Association of an ERCC1polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev 2000;9:843-7.

Chen P, Wiencke JK, Conway K, Edmiston SN, Miike R, Wrensch M. Lack of association of rare alleles in the HRASvariable number of tandem repeats (VNTR) region with adult glioma. Neuro-oncol 2000;2:120-4.

Davis F, Preston-Martin S. Epidemiology — Incidence and survival in central nervous system neoplasia. In: BignerDD, ed. Russell and Rubenstein’s Pathology of Tumors of the Nervous System, 6th Edition. London: EdwardArnold Publishers, Ltd., In Press.

Goldhaber MK, Selby JV, Hiatt RA, Quesenberry CP. Exposure to barbiturates in utero and during childhood riskof intracranial and spinal cord tumors. Cancer Res 1990;50:4600-3.

Kelsey KT, Wrensch M, Zuo ZF, Miike R, Wiencke JK. A population-based case-control study of the CYP2D6 andGSTT1 polymorphisms and malignant brain tumors. Pharmacogenetics 1997;7:463-8.

Lee M, Wrensch M, Miike R. Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area(California, USA). Cancer Causes Control 1997;8:13-24.

Li Y, Millikan RC, Carozza S, Newman B, Liu E, Davis R, Miike R, Wrensch M. p53 mutations in malignant gliomas.Cancer Epidemiol Biomarkers Prev 1998;7:303-8.

Mack W, Preston-Martin S, Peters JM. Astrocytoma risk related to job exposure to electric and magnetic fields.Bioelectromagnetics 1991;12:57-66.

Preston-Martin S. A case-control study of brain tumors in men in Los Angeles County: investigaion of N-nitrosocompound exposures. IARC Sci Publ 1990;105:221-7.

Preston-Martin S. A case-control study of intracranial meningiomas in women. Am J Epidemiol 1978;108:233-4.

Preston-Martin S. Central Nervous Tumors, Epidemiology. In: Aminoff MJ, Daroff RB, eds. Encylopedia of theNeurological Sciences. San Diego: Academic Press, In Press.

Preston-Martin S. Combined modality therapy of central nervous system tumors-Chapter 1. Berlin ; New York:Springer, 2000.

Preston-Martin S. Descriptive epidemiology of primary tumors of the brain, cranial nerves and cranial meningesin Los Angeles County. Neuroepidemiology 1989;8:283-95.

Preston-Martin S. Descriptive epidemiology of primary tumors of the spinal cord and spinal meninges in LosAngeles County, 1972-1985. Neuroepidemiology 1990;9:106-11.

Preston-Martin S. Epidemiology, Chapter 1. In: Berger M, Wilson C, eds. The Gliomas. Cambridge, MA: W.B. SaundersCo., 1998:824.



BBBBBRRRRRAINAINAINAINAIN C C C C CANANANANANCECECECECERRRRR

Preston-Martin S. Epidemiology of primary CNS neoplasms. Neurol Clin 1996;14:273-90.

Preston-Martin S, Garabrant D. Occupational risks for meningiomas [letter]. J Occup Med 1988;30:14, 16, 18.

Preston-Martin S, Gurney JG, Pogoda JM, Holly EA, Mueller BA. Brain tumor risk in children in relation to use ofelectric blankets and water bed heaters. Results from the United States West Coast Childhood Brain TumorStudy. Am J Epidemiol 1996;143:1116-22.

Preston-Martin S, Henderson BE. Esthesioneuroblastoma [letter]. CA Cancer J Clin 1984;34:356.

Preston-Martin S, Henderson BE. N-nitroso compounds and human intracranial tumours. IARC Sci Publ1984;57:887-94.

Preston-Martin S, Henderson BE, Peters JM. Descriptive epidemiology of central nervous system neoplasms inLos Angeles County. Ann N Y Acad Sci 1982;381:202-8.

Preston-Martin S, Henderson BE, Yu MC. The epidemiology of intracranial meningiomas in Los Angeles County.Neuroepidemiology 1984;2:164-78.

Preston-Martin S, Mack W. Gliomas and meningiomas in men in Los Angeles County: investigation of exposuresto N-nitroso compounds. IARC Sci Publ 1991;105:197-203.

Preston-Martin S, Mack W. Neoplasms of the nervous system. In: Schottenfeld D, Fraumeni JF, Jr, eds. CancerEpidemiology and Prevention, 2nd Edition. New York: Oxford University Press, 1996:1231-81.

Preston-Martin S, Mack W, Henderson BE. Risk factors for gliomas and meningiomas in males in Los AngelesCounty. Cancer Res 1989;49:6137-43.

Preston-Martin S, Monroe K, Lee PJ, Bernstein L, Kelsey J, Henderson S, Forrester D, Henderson B. Spinal menin-giomas in women in Los Angeles County: investigation of an etiological hypothesis. Cancer EpidemiolBiomarkers Prev 1995;4:333-9.

Preston-Martin S, Thomas DC, Wright WE, Henderson BE. Noise trauma in the aetiology of acoustic neuromas inmen in Los Angeles County, 1978-1985. Br J Cancer 1989;59:783-6.

Preston-Martin S, Yu MC, Henderson BE, Roberts C. Risk factors for meningiomas in men in Los Angeles County.J Natl Cancer Inst 1983;70:863-6.

Wiencke JK, Wrensch MR, Miike R, Zuo Z, Kelsey KT. Population-based study of glutathione S-transferase mugene deletion in adult glioma cases and controls. Carcinogenesis 1997;18:1431-3.

Wrensch M, Bondy ML, Wiencke J, Yost M. Environmental risk factors for primary malignant brain tumors: areview. J Neurooncol 1993;17:47-64.

Wrensch M, Lee M, Miike R, Newman B, Barger G, Davis R, Wiencke J, Neuhaus J. Familial and personal medicalhistory of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol1997;145:581-93.

Wrensch M, Miike R, Lee M, Neuhaus J. Are prior head injuries or diagnostic X-rays associated with glioma inadults? The effects of control selection bias. Neuroepidemiology 2000;19:234-44.

Wrensch M, Weinberg A, Wiencke J, Masters H, Miike R, Barger G, Lee M. Does prior infection with varicella-zoster virus influence risk of adult glioma? Am J Epidemiol 1997;145:594-7.

Wrensch M, Yost M, Miike R, Lee G, Touchstone J. Adult glioma in relation to residential power frequency elec-tromagnetic field exposures in the San Francisco Bay area. Epidemiology 1999;10:523-7.



BBBBBREREREREREAAAAASSSSSTTTTT C C C C CANANANANANCECECECECERRRRR

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women withbreast cancer and 100,239 women without breast cancer from 54 epidemiological studies. CollaborativeGroup on Hormonal Factors in Breast Cancer. Lancet 1996;347:1713-27.

Anton-Culver H, Kurosaki T, Taylor TH, Gildea M, Brunner D, Bringman D. Validation of Family History of BreastCancer and Identification of the BRCA1 and Other Syndromes Using a Population-Based Cancer Registry.Genet Epidemiol 1996;13:193-205.

Astin JA, Anton-Culver H. Sense of control and adjustment to breast cancer: the importance of balancing con-trol coping styles. Beh Med 1999.

Barker DF, Almeida ER, Casey G, Fain PR, Liao SY, Masunaka I, Noble B, Kurosaki T, Anton-Culver H. BRCA1 R841W:a strong candidate for a common mutation with moderate phenotype. Genet Epidemiol 1996;13:595-604.

Bentley JR, Delfino RJ, Taylor TH, Howe S, Anton-Culver H. Differences in breast cancer stage at diagnosis be-tween non-Hispanic white and Hispanic populations, San Diego County 1988-1993. Br Cancer Res Treat1998;50:1-9.

Bernstein JL, Thompson WD, Risch N, Holford TR. Risk factors predicting the incidence of second primary breastcancer among women diagnosed with a first primary breast cancer. Am J Epidemiol 1992;136:925-36.

Bernstein JL, Thompson WD, Risch N, Holford TR. The genetic epidemiology of second primary breast cancer. AmJ Epidemiol 1992;136:937-48.

Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of malignant cystosarcoma phyllodes tumors ofthe breast. Cancer 1993;71:3020-4.

Bernstein L, Hanisch R, Sullivan-Halley J, Ross RK. Treatment with human chorionic gonadotropin and risk ofbreast cancer. Cancer Epidemiol Biomarkers Prev 1995;4:437-40.

Bernstein L, Henderson BE, Hanisch R, Sullivan-Halley J, Ross RK. Physical exercise and reduced risk of breastcancer in young women. J Natl Cancer Inst 1994;86:1403-8.

Bernstein L, Pike MC, Krailo M, Henderson BE. Update of the Los Angeles study of oral contraceptives andbreast cancer: 1981 and 1983. In: Mann R, ed. Oral Contraceptives and Breast Cancer. London: Parthenon Press inAssociation with The Royal Society of Medicine, 1990.

Bernstein L, Pike MC, Ross RK, Henderson BE. Age at menarche and estrogen concentrations of adult women.Cancer Causes Control 1991;2:221-5.

Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993;15:48-65.

Bernstein L, Ross RK, Pike MC, Casagrande JT, Henderson BE. Urinary estrogens and male-to-female breast cancerratios. Int J Cancer 1989;44:954-6.

Bernstein L, Yuan JM, Ross RK, Pike MC, Hanisch R, Lobo R, Stanczyk F, Gao YT, Henderson BE. Serum hormonelevels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from twobreast cancer case-control studies. Cancer Causes Control 1990;1:51-8.

Bloom JR, Grazier K, Hodge F, Hayes WA. Factors affecting the use of screening mammography among AfricanAmerican women. Cancer Epidemiol Biomarkers Prev 1991;1:75-82.

Boyer-Chammard A, Taylor TH, Anton-Culver H. Survival differences in breast cancer among racial/ethnic groups:a population-based study. Cancer Detection and Prev 1999;23:463-73.



Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L. Lifetime exercise activity and breast cancer risk among post-menopausal women. Br J Cancer 1999;80:1852-8.

Casagrande J, Gerkins V, Henderson BE, Mack T, Pike MC. Exogenous estrogens and breast cancer in womenwith natural menopause. J Natl Cancer Inst 1976;56:839-41.

Casagrande JT, Hanisch R, Pike MC, Ross RK, Brown JB, Henderson BE. A case-control study of male breast cancer.Cancer Res 1988;48:1326-30.

Coates RJ, Bransfield DD, Wesley M, Hankey B, Eley JW, Greenberg RS, Flanders D, Hunter CP, Edwards BK, FormanM, et al. Differences between black and white women with breast cancer in time from symptom recognitionto medical consultation. Black/White Cancer Survival Study Group. J Natl Cancer Inst 1992;84:938-50.

Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis: xenoestrogens aspreventable causes of breast cancer. Environ Health Perspect 1993;101:372-7.

Deapen D, Brody G. Re: Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice[letter; comment]. J Natl Cancer Inst 1995;87:315-6.

Deapen D, Hamilton A, Bernstein L, Brody GS. Breast cancer stage at diagnosis and survival among patients withprior breast implants. Plast Reconstr Surg 2000;105:535-40.

Deapen DM, Bernstein L, Brody GS. Are breast implants anticarcinogenic? A 14-year follow-up of the Los Ange-les Study. Plast Reconstr Surg 1997;99:1346-53.

Deapen DM, Brody GS. Augmentation mammaplasty and breast cancer: a 5-year update of the Los Angelesstudy. Plast Reconstr Surg 1992;89:660-5.

Delfino RJ, Sinha R, Smith C, West J, White E, Lin HJ, Liao SY, Gim JS, Ma HL, Butler J, Anton-Culver H. Breast cancer,heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype. Carcinogenesis 2000;21:607-15.

Delfino RJ, Smith C, West J, White E, Lin HJ, Liao SY, Butler J, Anton-Culver H. Breast cancer, cigarette smoking, andn-acetyltransferase2 genotype: a pre-incident case-control study. Pharmacogenetics 2000;21:101-9.

Demers PA, Thomas DB, Rosenblatt KA, Jimenez LM, McTiernan A, Stalsberg H, Stemhagen A, Thompson WD,Curnen MG, Satariano W, et al. Occupational exposure to electromagnetic fields and breast cancer in men.Am J Epidemiol 1991;134:340-7.

DiSaia PJ, Brewster WR, Ziogas A, Anton-Culver H. Breast cancer survival and hormone replacement therapy: acohort analysis. Am J Clin Oncol 2000;23:541-5.

DiSaia PJ, Grosen EA, Kurosaki T, Gildea M, Cowan B, Anton-Culver H. Hormone replacement therapy in breastcancer survivors: a cohort study. Am J Obstet Gynecol 1996;174:1494-8.

Dworsky R, Paganini-Hill A, Spicer D. Breast cancer screening and education in high risk women. Prog Clin BiolRes 1989;293:115-24.

Eley JW, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, Greenberg RS, Coates RJ, Correa P, Redmond CK, et al.Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White CancerSurvival Study. JAMA 1994;272:947-54.

Enger SM, Ross RK, Henderson B, Bernstein L. Breastfeeding history, pregnancy experience and risk of breastcancer. Br J Cancer 1997;76:118-23.





Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L. Body size, physical activity, and breast cancer hormonereceptor status: Results from two case-control studies. Cancer Epidemiol Biomarkers Prev 2000;9:681-7.

Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE. A polymorphism in the CYP17 gene increases therisk of breast cancer. Cancer Res 1997;57:1063-5.

Feigelson HS, McKean-Cowdin R, Coetzee GA, Stram DO, Kolonel LN, Henderson BE. Building a multigenic model ofbreast cancer susceptibility: CYP17 and HSD17B1 are two important candidates. Cancer Res 2001;61:785-9.

Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, Ponder BA, Anton-Culver H. Mutation analysisof BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 1997;60:313-9.

Glaser SL, Ambinder RF, DiGiuseppe JA, Horn-Ross PL, Hsu JL. Absence of Epstein-Barr virus EBER-1 transcripts inan epidemiologically diverse group of breast cancers. Int J Cancer 1998;75:555-8.

Goldstein AM, Haile RW, Hodge SE, Paganini-Hill A, Spence MA. Possible heterogeneity in the segregation pat-tern of breast cancer in families with bilateral breast cancer. Genet Epidemiol 1988;5:121-33.

Goldstein AM, Haile RW, Marazita ML, Paganini-Hill A. A genetic epidemiologic investigation of breast cancer infamilies with bilateral breast cancer. I. Segregation analysis. J Natl Cancer Inst 1987;78:911-8.

Goldstein AM, Haile RW, Spence MA, Sparkes RS, Paganini-Hill A. A genetic epidemiologic investigation of breastcancer in families with bilateral breast cancer. II. Linkage analysis. Clin Genet 1989;36:100-6.

Gong G, Whittemore AS, Grosser S. Censored survival data with misclassified covariates: A case study of breastcancer mortality. J Am Stat Assoc 1990;85:20-8.

Goodson WH, III, Moore DH, II, Ljung BM, Chew K, Mayall B, Smith HS, Waldman FM. The prognostic value of prolifera-tion indices: A study with in vivo bromodeoxyuridine and Ki-67. Br Cancer Res Treat 2000;59:113-23.

Gray GE, Henderson BE, Pike MC. Changing ratio of breast cancer incidence rates with age of black femalescompared with white females in the United States. J Natl Cancer Inst 1980;64:461-3.

Haile RW, Goldstein AM, Weeks DE, Sparkes RS, Paganini-Hill A. Genetic epidemiology of bilateral breast cancer:a linkage analysis using the affected-pedigree-member method. Genet Epidemiol 1990;7:47-55.

Haile RW, Witte JS, Ursin G, Siemiatycki J, Bertolli J, Douglas Thompson W, Paganini-Hill A. A case-control study ofreproductive variables, alcohol, and smoking in premenopausal bilateral breast cancer. Br Cancer Res Treat1996;37:49-56.

Henderson BE, Bernstein L. Etiology and pathogensis: endogenous and exogenous hormonal factors. In: Harris J,Lippman M, Morrow M, Hellman S, eds. Diseases of the Breast. Philadelphia: Lippincott-Raven Press, 1996:185-200.

Henderson BE, Bernstein L. The international variation in breast cancer rates: an epidemiological assessment. BrCancer Res Treat 1991;18 Suppl 1:S11-7.

Henderson BE, Pike MC, Bernstein L, Ross RK. Breast cancer. In: Schottenfeld D, Fraumeni JF, Jr, eds. CancerEpidemiology and Prevention, 2nd Edition. New York: Oxford University Press, 1996:1022-39.

Henderson BE, Pike MC, Ross RK. Epidemiology and risk factors. In: Bonadonna G, ed. Breast Disease. RecentAdvances in Diagnosis and Treatment. Chichester: John Wiley and Sons, Inc., 1983:15-33.



Henderson BE, Powell D, Rosario I, Keys C, Hanisch R, Young M, Casagrande J, Gerkins V, Pike MC. An epidemiologic studyof breast cancer. J Natl Cancer Inst 1974;53:609-14.

Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC. Do regular ovulatory cycles increase breast cancer risk?Cancer 1985;56:1206-8.

Henderson BE, Ross RK, Pike MC. Breast neoplasia. In: Mischell D, ed. The Menopause. Chicago: Yearbook MedicalPublishing, 1986:261-74.

Henderson BR, Gerkins V, Rosario I, Casagrande J, Pike MC. Elevated serum levels of estrogen and prolactin indaughters of patients with breast cancer. N Engl J Med 1975;293:790-5.

Hiatt RA. Alcohol consumption and breast cancer. Med Oncol Tumor Pharmacother 1990;7:143-51.

Hiatt RA, Klatsky A, Armstrong MA. Alcohol and breast cancer. Prev Med 1988;17:683-5.

Hiatt RA, Klatsky AL, Armstrong MA. Alcohol consumption and the risk of breast cancer in a prepaid health plan.Cancer Res 1988;48:2284-7.

Horn-Ross PL. Multiple primary cancers involving the breast. Epidemiol Rev 1993;15:169-76.

Horn-Ross PL. Phytoestrogens, body composition, and breast cancer. Cancer Causes Control 1995;6:567-73.

Hsu JL, Glaser SL, West DW. Racial/ethnic differences in breast cancer survival among San Francisco Bay Areawomen. J Natl Cancer Inst 1997;89:1311-2.

Hunter CP, Redmond CK, Chen VW, Austin DF, Greenberg RS, Correa P, Muss HB, Forman MR, Wesley MN, BlacklowRS, et al. Breast cancer: factors associated with stage at diagnosis in black and white women. Black/WhiteCancer Survival Study Group. J Natl Cancer Inst 1993;85:1129-37.

Ingles SA, Haile R, Henderson BE, Kolonel l, Coetzee GA. Association of vitamin D receptor genetic polymor-phism with breast cancer risk in African-American and Hispanic women. In: Norman A, Bouillon R, Thomasset M, eds.Vitamin D: Chemistry, Biology, and Clinical Applications of the Steroid Hormone. Riverside, CA: University of California,Printing and Reprographics, 1997:813-4.

Kampert JB, Whittemore AS, Paffenbarger RS, Jr. Combined Effect of Childbearing, Menstrual Events, and BodySize on Age-Specific Breast Cancer Risk. Am J Epidemiol 1988;128:962-79.

Kelsey JL, Horn-Ross PL. Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev1993;15:7-16.

Klonoff-Cohen H, Schaffroth L, Edelstein S, Molgaard C, Saltzstein SL. Breast Cancer Histology in Caucasians,African Americans, Hispanics, Asians, and Pacific Islanders. Ethnicity & Health 1998;3:189-98.

Krieger N. Social class and the black/white crossover in the age-specific incidence of breast cancer: a studylinking census-derived data to population-based registry records. Am J Epidemiol 1990;131:804-14.

Krieger N, Hiatt RA. Risk of breast cancer after benign breast diseases. Variation by histologic type, degree ofatypia, age at biopsy, and length of follow- up. Am J Epidemiol 1992;135:619-31.

Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D. Alternative therapies used by women with breast cancer infour ethnic populations. J Natl Cancer Inst 2000;92:42-7.





Lee-Feldstein A, Anton-Culver H, Feldstein PJ. Treatment differences and other prognostic factors related to breastcancer survival. Delivery systems and medical outcomes. JAMA 1994;271:1163-8.

Lee-Feldstein A, Feldstein PJ, Buchmueller T, Katterhagen G. Breast cancer outcomes among older women:HMO, fee-for-service, and delivery system comparisons. J Gen Intern Med 2001;16:189-99.

Lee-Feldstein A, Feldstein PJ, Buchmueller T, Katterhagen G. The relationship of HMOs, health insurance, anddelivery systems to breast cancer outcomes. Med Care 2000;38:705-18.

Lee M, Wrensch MR, Miike R, Petrakis N. The association of dietary fat with ability to obtain breast fluid. CancerEpidemiol Biomarkers Prev 1994;1:277-80.

Lee MM, Petrakis NL, Wrensch MR, King EB, Miike R, Sickles E. Association of abnormal nipple aspirate cytologyand mammographic pattern and density. Cancer Epidemiol Biomarkers Prev 1994;3:33-6.

Liu L, Deapen D, Bernstein L, Ross RK. Hormone levels in older women: a study of post-menopausal breastcancer patients and healthy population controls. Br J Cancer 1990;61:298-302.

Liu L, Deapen D, Bernstein L. Socioeconomic status and cancers of the female breast and reproductive organs:a comparison across racial/ethnic populations in Los Angeles County, California (United States). Cancer CausesControl 1998;9:369-80.

Longnecker MP, Bernstein L, Paganini-Hill A, Enger SM, Ross RK. Risk factors for in situ breast cancer. Cancer EpidemiolBiomarkers Prev 1996;5:961-5.

Longnecker MP, Paganini-Hill A, Ross RK. Lifetime alcohol consumption and breast cancer risk among post-menopausal women in Los Angeles. Cancer Epidemiol Biomarkers Prev 1995;4:721-5.

Longnecker MP, Paganini-Hill A, Ross RK. Risk of breast cancer in relation to lifetime alcohol consumption: Results fromLos Angeles. Am J Epidemiol 1995;141:853.

Menck HR, Mills PK. The influence of urbanization, age, ethnicity, and income on the early diagnosis of breastcarcinoma: opportunity for screening improvement. Cancer 2001;92:1299-304.

Mohle-Boetani JC, Grosser S, Whittemore AS, Malec M, Kampert JB, Paffenbarger RS, Jr. Body size, reproductivefactors, and breast cancer survival. Prev Med 1988;17:634-42.

Morgan JW, Gladson JE, Rau KS. Position Paper of the American Council on Science and Health on Risk Factors forBreast Cancer: Established, Speculated, and Unsupported. Breast J 1998;4:177-97.

Morgan JW, Sharma S, Lukachko A. The Breast Cancer Prevention Diet. A Position Paper from the AmericanCouncil on Science and Health 1998:1-17.

Morris CR, Cohen R, Schlag RD, Wright WE. Increasing Trends in the Use of Breast-Conserving Surgery in California.Am J Public Health 2000;90:281-4.

Morris CR, Wright WE. Breast Cancer in California. Sacramento, CA: California Dept. of Health Services, CancerSurveillance Section, 1996.

Morris CR, Wright WE, Schlag RD. The risk of developing breast cancer within the next five, ten, or 20 years of awoman’s life. Am J Prev Med 2001;20:214-8.



Ottman R, Pike MC, King M, Henderson BE. Practical guide for estimating risk for familial breast cancer. Lancet1983:556-8.

Ottman R, Pike MC, King M-C, Casagrande JT, Henderson BE. Familial breast cancer in a population-based series.Am J Epidemiol 1986;123:15-21.

Paganini-Hill A, Ross RK. Breast lumps and consultation delays [letter]. Lancet 1981;1:995.

Pathak DR, Whittemore AS. Combined effects of body size, parity, and menstrual events on breast cancer inci-dence in seven countries. Am J Epidemiol 1992;135:153-68.

Perkins CI, Allen ME, Wright WE, Takahashi E, Stoodt G, Cohen R. Breast Cancer in California: Stage at Diagnosisand Medi-Cal Status. Sacramento: California Dept. of Health Services, Cancer Surveillance Section, 2000.

Perkins CI, Kwong SL, Morris CR, Wright WE. Trends in female breast cancer mortality in California, 1973-1994. JRegistry Management 1996;23:164-7.

Perkins CI, Wright WE, Allen M, Samuels SJ, Romano PS. Breast cancer stage at diagnosis in relation to duration ofmedicaid enrollment. Med Care 2001;39:1224-33.

Petrakis NL, Lowenstein JM, Wiencke JK, Lee MM, Wrensch MR, King EB, Hilton JF, Miike R. Gross cystic diseasefluid protein in nipple aspirates of breast fluid of Asian and non-Asian women [published erratum appears inCancer Epidemiol Biomarkers Prev 1994 Jun;3(4):369]. Cancer Epidemiol Biomarkers Prev 1993;2:573-9.

Pike MC, Bernstein L, Peters RK. Re: “Dietary fat and postmenopausal breast cancer.” J Natl Cancer Inst1992;84:1666-7.

Pike MC, Henderson BE, Casagrande JT, Rosario I, Gray G. Oral contraceptive use and early abortion as riskfactors for breast cancer in young women. Br J Cancer 1981;43:72-6.

Pike MC, Henderson BE, Krailo M, Duke A, Roy S. Breast cancer and oral contraceptives: reply to critics. Lancet 1983:1414.

Pike MC, Ross RK. Breast cancer. Br Medical Bull 1984;40:351-4.

Pike MC, Ross RK. RESPONSE: re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogenplus progestin. J Natl Cancer Inst 2000;92:1951-2.

Plummer SJ, Anton-Culver H, Webster L, Noble B, Liao S, Kennedy A, Belinson J, Casey G. Detection of BRCA1mutations by the protein truncation test. Hum Mol Genet 1995;4:1989-91.

Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A, SlamonDJ, Phillips RN, Ross JS, Wolman SR, Flom KJ. HER-2/neu gene amplification characterized by fluorescence insitu hybridization: Poor prognosis in node-negative breast carcinomas. J Clin Oncol 1997;15:2894-904.

Reynolds P, Boyd PT, Blacklow RS, et al. The relationship between social ties and survival among black and whitebreast cancer patients. National Cancer Institute Black/White Cancer Survival Study Group. Cancer EpidemiolBiom Prev 1994;3:253-9.

Richardson B, Hulka B, David-Peck J, Hughes C, van den Berg BJ, Christianson R, Calvin J. Levels of maternal serumalpha-fetoprotein in pregnant women and subsequent breast cancer risk. Am J Epidemiol 1998;148:719-27.

Richardson JL, Langholz B, Bernstein L, Burciaga C, Danley K, Ross RK. Stage and delay in breast cancer diagnosis by race,socioeconomic status, age and year. Br J Cancer 1992;65:922-6.





Ross RK, Paganini-Hill A, Krailo MD, Gerkins VR, Henderson BE, Pike MC. Effects of reserpine on prolactin levels andincidence of breast cancer in postmenopausal women. Cancer Res 1984;44:3106-8.

Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: estro-gen versus estrogen plus progestin. J Natl Cancer Inst 2000;92:328-32.

Ross RK, Pike MC. RESPONSE: re: effect of hormone replacement therapy on breast cancer risk: estrogen versusestrogen plus progestin. J Natl Cancer Inst 2000;92:1100A-101.

Saltzstein SL. An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ:analysis of 11,436 cases from the California Cancer Registry. Anat Pathol 1996;1:193-203.

Saltzstein SL. Breast cancer is being detected earlier. San Diego Physician 1992;79:11.

Saltzstein SL. The association of ethnicity and the incidence of mammary carcinoma in situ in women: 11,436cases from the California Cancer Registry. Cancer Detect Prev 1997;21:361-9.

Snipes KP, Morris CR, Wright WE. Stage at diagnosis of female breast cancer in California, 1988-1992. J RegistryManagement 1996;23:158-63.

Stalsberg H, Thomas DB, Rosenblatt KA, Jimenez LM, McTiernan A, Stemhagen A, Thompson WD, Curnen MG,Satariano W, Austin DF, et al. Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men. Cancer Causes Control 1993;4:143-51.

Swanson GM, Ragheb NE, Lin CS, Hankey BF, Miller B, Horn-Ross P, White E, Liff JM, Harlan LC, McWhorter WP, et al.Breast cancer among black and white women in the 1980s. Changing patterns in the United States by race,age, and extent of disease [see comments]. Cancer 1993;72:788-98.

Ursin G, Aragaki CC, Paganini-Hill A, Siemiatycki J, Thompson WD, Haile RW. Oral contraceptives and premeno-pausal bilateral breast cancer: A case-control study. Epidemiology 1992;3:414-9.

Ursin G, Bernstein L, Pike MC. Breast cancer. Cancer Surv 1994;20:241-64.

Ursin G, Henderson BE, Haile RW, Pike MC, Zhou N, Diep A, Bernstein L. Does oral contraceptive use increase therisk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women? Cancer Res1997;57:3678-81.

Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC. A pilot study of urinary estrogenmetabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer. EnvironHealth Perspect 1997;105 Suppl 3:601-5.

Ursin G, Paganini-Hill A, Siemiatycki J, Thompson WD, Haile RW. Early adult body weight, body mass index, andpremenopausal bilateral breast cancer: data from a case-control study. Br Cancer Res Treat 1995;33:75-82.

Walker A. Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factorsin Breast Cancer. Contraception 1996;54:1S-106S.

Waldman FM, DeVries S, Chew KL, Moore DH, II, Kerlikowske K, Ljung BM. Chromosomal alterations in ductalcarcinomas in situ and their in situ recurrences. J Natl Cancer Inst 2000;92:313-20.

Waldman FM, Hwang ES, Etzell J, Eng C, DeVries S, Bennington J, Thor A. Genomic alterations in tubular breast carcinomas.Hum Pathol 2001;32:222-6.




Witte JS, Ursin G, Siemiatycki J, Thompson WD, Paganini-Hill A, Haile RW. Diet and premenopausal bilateral breastcancer: A case-control study. Br Cancer Res Treat 1997;42:243-51.

Wrensch M, Petrakis NL, King EB, Lee MM, Miike R. Breast cancer risk associated with abnormal cytology innipple aspirates of breast fluid and prior history of breast biopsy. Am J Epidemiol 1993;137:829-33.

Wrensch MR, Petrakis NL, King EB, Miike R, Mason L, Chew KL, Lee MM, Ernster VL, Hilton JF, Schweitzer R, et al.Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol1992;135:130-41.

Wrensch MR, Petrakis NL. Nipple aspirate cytology in high-risk breast cancer identification. Contemporary Oncology1994;4:37-45.

Wu AH, Bernstein L. Breast cancer among Asian Americans and Pacific Islanders. As Am Pac Island J Health1998;6:327-43.

Wu AH, Pike MC, Stram DO. Meta-analysis: Dietary fat intake, serum estrogen levels, and the risk of breastcancer. J Natl Cancer Inst 1999;91.

Wu AH, Ziegler RG, Horn-Ross PL, Nomura AM, West DW, Kolonel LN, Rosenthal JF, Hoover RN, Pike MC. Tofu andrisk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 1996;5:901-6.

Wu AH, Ziegler RG, Nomura AM, West DW, Kolonel LN, Horn-Ross PL, Hoover RN, Pike MC. Soy intake and risk ofbreast cancer in Asians and Asian Americans. Am J Clin Nutr 1998;68:1437S-43S.

Wu AH, Ziegler RG, Pike MC, Nomura AMY, West DW, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hoover RN. Menstrual andreproductive factors and risk of breast cancer in Asian-Americans. Br J Cancer 1996;73:680-6.

Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in Californiafor different race/ethnic groups. Cancer Causes Control 2001;12:703-11.

Ziegler RG, Hoover RN, Nomura AM, West DW, Wu AH, Pike MC, Lake AJ, Horn-Ross PL, Kolonel LN, Siiteri PK,Fraumeni JF, Jr. Relative weight, weight change, height, and breast cancer risk in Asian-American women. JNatl Cancer Inst 1996;88:650-60.

Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL,Rosenthal JF, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst1993;85:1819-27.



CCCCCERVICALERVICALERVICALERVICALERVICAL C C C C CANCERANCERANCERANCERANCER

Anton-Culver H, Bloss JD, Bringman D, Lee-Feldstein A, DiSaia P, Manetta A. Comparison of adenocarcinoma andsquamous cell carcinoma of the uterine cervix: a population-based epidemiologic study. Am J Obstet Gynecol1992;166:1507-14.

Boice JD, Jr, Engholm G, Kleinerman RA, Blettner M, Stovall M, Lisco H, Moloney WC, Austin DF, Bosch A, CookfairDL, et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res1988;116:3-55.

Brewster WR, DiSaia PJ, Monk BJ, Ziogas A, Yamada SK, Anton-Culver H. Young age as a prognostic factor in cervicalcancer: results of a population-based study. Am J Obstet Gynecol 1999.

Brewster WR, Monk BJ, Ziogas A, Anton-Culver H, Yamada SD, Berman ML. Intent-to-treat analysis of stage Ib andIIa cervical cancer in the United States: radiotherapy or surgery 1988-1995. Obstet Gynecol 2001;97:248-54.

Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, Wilczynski SP. Human papillomavirustype 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 1996;88:1361-8.

Burger RA, Monk BJ, Van Nostrand KM, Greep N, Anton-Culver H, Manetta A. Single-visit program for cervicalcancer prevention in a high-risk population. Obstet Gynecol 1995;86:491-8.

Holly EA, Cress RD, Ahn DK, Aston DA, Kristiansen JJ, Wu R, Felton JS. Detection of mutagens in cervical mucus insmokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 1993;2:223-8.

Howe SL, Delfino RJ, Taylor TH, Anton-Culver H. The risk of invasive cervical cancer among Hispanics: evidencefor targeted preventive interventions. Prev Med 1998;27:674-80.

Liu L, Deapen D, Bernstein L, Ross RK. Oral contraceptive use and adenocarcinoma of cervix [see comments].Lancet 1994;344:1390-4.

Peters RK, Chao A, Mack TM, Thomas D, Bernstein L, Henderson BE. Increased frequency of adenocarcinoma ofthe uterine cervix in young women in Los Angeles County. J Natl Cancer Inst 1985;76:423-8.

Peters RK, Thomas D, Hagan DG, Mack TM, Henderson BE. Risk factors for invasive cervical cancer among Latinasand non-Latinas in Los Angeles County. J Natl Cancer Inst 1986;77:1063-77.

Peters RK, Thomas D, Skultin G, Henderson BE. Invasive squamous cell carcinoma of the cervix after recentnegative cytologic test results—a distinct subgroup? Am J Obstet Gynecol 1988;158:926-35.

Peters RK, Henderson BE. Trends in cervical cancer rates in Norway [letter]. J Natl Cancer Inst 1988;80:288-9.

Peters RK, Bear MB, Thomas D. Barriers to screening for cancer of the cervix. Prev Med 1989;18:133-46.

Rosenthal DL, Acosta D, Peters RK. Computer-assisted rescreening of clinically important false negative cervicalsmears using the PAPNET Testing System. Acta Cytol 1996;40:120-6.

Ursin G, Pike MC, Preston-Martin S, d’Ablaing G, III, Peters RK. Sexual, reproductive, and other risk factors foradenocarcinoma of the cervix: results from a population-based case-control study (California, United States)[see comments]. Cancer Causes Control 1996;7:391-401.



CCCCCHILDHOODHILDHOODHILDHOODHILDHOODHILDHOOD C C C C CANCERANCERANCERANCERANCER

Bernstein L, Sullivan-Halley J, Krailo MD, Hammond GD. Trends in patterns of treatment of childhood cancer inLos Angeles County. Cancer 1993;71:3222-8.

Bowman JD, Sobel E, London SJ, Thomas DC, Garabrant DH, Pearce N, Peters JM. Electric and magnetic fieldexposures, chemical exposures in leukemia risk in “electrical” occupations: Electric Power Research Institute,1992:799-827.

Buckley JD, Sather H, Ruccione K, Rogers PC, Haas JE, Henderson BE, Hammond GD. A case-control study of riskfactors for hepatoblastoma. A report from the Childrens Cancer Study Group. Cancer 1989;64:1169-76.

Campleman SL, Schlag RD, Perkins CI, Glazer E, Kwong SL, Cress RD, Wright WE. Childhood Cancer in California1988-1994. Sacramento: California Dept. of Health Services, Cancer Surveillance Section, 1999.

Gold EB, Leviton A, Lopez R, Aschenbrener C, Austin DF. Parental smoking and risk of childhood brain tumors.Am J Epidemiol 1993;147:620-28.

Gurney JG, Mueller BA, Preston-Martin S, McDaniel AM, Holly EA, Pogoda JM, Davis RL. A study of pediatric braintumors and their association with epilepsy and anticonvulsant use. Neuroepidemiology 1997;16:248-55.

Gurney JG, Pogoda JM, Holly EA, Hecht SS, Preston-Martin S. Aspartame consumption in relation to childhoodbrain tumor risk: results from a case-control study [published erratum appears in J Natl Cancer Inst 1997 Oct1;89(19):1460]. J Natl Cancer Inst 1997;89:1072-4.

Gurney JG, Preston-Martin S, McDaniel AM, Mueller BA, Holly EA. Head injury as a risk factor for brain tumors inchildren: results from a multicenter case-control study. Epidemiology 1996;7:485-9.

Lowengart RA, Peters JM, Cicioni C, Buckley J, Bernstein L, Preston-Martin S, Rappaport E. Childhood leukemiaand parents’ occupational and home exposures. J Natl Cancer Inst 1987;79:39-46.

Maltzman TH, Mueller BA, Schroeder J, Rutledge JC, Patterson K, Preston-Martin S, Faustman EM. Ras oncogenemutations in childhood brain tumors. Cancer Epidemiol Biomarkers Prev 1997;6:239-43.

McKean-Cowdin R, Preston-Martin S, Pogoda JM, Holly EA, Mueller BA, Davis RL. Parental occupation and childhoodbrain tumors: astroglial and primitive neuroectodermal tumors. J Occup Environ Med 1998;40:332-40.

McKean-Cowdin R, Preston-Martin S, Pogoda JM, Mueller BA, Holly EA. Reliability of demographic, smoking andoccupational data provided by mothers vs. fathers in a childhood cancer study. Paediatr Perinat Epidemiol2000;14:257-62.

Mueller BA, Newton K, Holly EA, Preston-Martin S. Residential water source and the risk of childhood braintumors. Environ Health Perspect 2001;109:551-6.

Norman MA, Holly EA, Ahn DK, Preston-Martin S, Mueller BA, Bracci PM. Prenatal exposure to tobacco smoke andchildhood brain tumors: results from the United States West Coast childhood brain tumor study. CancerEpidemiol Biomarkers Prev 1996;5:127-33.

Norman MA, Holly EA, Preston-Martin S. Childhood brain tumors and exposure to tobacco smoke. CancerEpidemiol Biomarkers Prev 1996;5:85-91.

Peters FM, Preston-Martin S, Yu MC. Brain tumors in children and occupational exposure of parents. Science1981;213:235-7.



CCCCCHILDHOODHILDHOODHILDHOODHILDHOODHILDHOOD C C C C CANCERANCERANCERANCERANCER

Peters JM, Preston-Martin S. Childhood tumors and parental occupational exposures. Teratog Carcinog Mutagen1984;4:137-48.

Peters JM, Preston-Martin S, London SJ, Bowman JD, Buckley JD, Thomas DC. Processed meats and risk of child-hood leukemia (California, USA). Cancer Causes Control 1994;5:195-202.

Pogoda JM, Preston-Martin S. Pesticide exposure and development of brain tumors in children in Los AngelesCounty. Environ Health Perspect 1998;105:1214-20.

Preston-Martin S, Yu MC, Benton B, Henderson BE. N-Nitroso compounds and childhood brain tumors: a case-control study. Cancer Res 1982;42:5240-5.

Preston-Martin S, Navidi W, Thomas D, Lee PJ, Bowman J, Pogoda J. Los Angeles study of residential magneticfields and childhood brain tumors [see comments]. Am J Epidemiol 1996;143:105-19.

Preston-Martin S, Pogoda JM, Mueller BA, Holly EA, Lijinsky W, Davis RL. Maternal consumption of cured meatsand vitamins in relation to pediatric brain tumors. Cancer Epidemiol Biomarkers Prev 1996;5:599-605.

Preston-Martin S, Pogoda JM, Mueller BA, Lubin F, Modan B, Holly EA, Filippini G, Cordier S, Peris-Bonet R, Choi W,Little J, Arslan A. Results from an international case-control study of childhood brain tumors: the role ofprenatal vitamin supplementation. Environ Health Perspect 1998;106 Suppl 3:887-92.

Selvin S, Schulman J, Merrill DW. Distance and risk measures for the analysis of spatial data: a study of childhoodcancers. Soc Sci Med 1992;34:769-77.

Theuer CP, Kurosaki T, Taylor TH, Anton-Culver H. Unique features of gastric carcinoma in the young: a population-based analysis. Cancer 1998;83:25-33.



CCCCCOOOOOLLLLLOOOOORERERERERECCCCCTTTTTALALALALAL C C C C CANANANANANCECECECECERRRRR

Anthone G, Brophy M, Fals J, Vukasin P, Ortega A, Ross RK, Beart RW. Does designated surgical interest improvethe surgical management of colorectal cancer? Dis Colon Rectum In Press.

Anton-Culver H. Smoking and other risk factors associated with the stage and age of diagnosis of colon andrectum cancers. Cancer Detect Prev 1991;15:345-50.

Armstrong BG, Whittemore AS, Howe GR. Analysis of case-control data with covariate measurement error:application to diet and colon cancer. Stat Med 1989;8:1151-63; 1165-6.

Bernstein L, Wu HT. Colon and rectal cancer among Asian Americans and Pacific Islanders. Asian Am Pac Island JHealth In Press.

Blake C, Tsao JL, Wu A, Shibata D. Stepwise deletions of polyA sequences in mismatch repair-deficient colorectalcancers. Am J Pathol 2001;158:1867-70.

Blanco D, Ross RK, Paganini-Hill A, Henderson BE. Cholecystectomy and colonic cancer. Dis Colon Rectum1984;27:290-2.

Chu KC, Tarone RE, Chow WH, Hankey BF, Ries LA. Temporal patterns in colorectal cancer incidence, survival, andmortality from 1950 through 1990 [see comments]. J Natl Cancer Inst 1994;86:997-1006.

Courtney JG, Longnecker MP, Peters RK. Psychosocial aspects of work and the risk of colon cancer. Epidemiology1996;7:175-81.

Cress RD, Davidson-Sawyer K. Cancer of the colon and rectum in California: Anatomic site and stage at diagnosisby gender and race/ethnicity. J Registry Management 1997;24:120-24.

Cress RD, Morris CR, Wolfe BM. Cancer of the colon and rectum in California: trends in incidence by race/ethnicity,stage, and subsite. Prev Med 2000;31:447-53.

Friedman GD. Cancer of the large bowel after cholecystectomy. Biomed Pharmacother 1988;42:369-72.

Friedman GD, Fireman BH. Appendectomy, appendicitis, and large bowel cancer. Cancer Res 1990;50:7549-51.

Garabrant DH, Peters JM, Bernstein L, Mack T. Job activity and colon cancer risk. Am J Epidemiol 1984;119:1005-14.

Garabrant DH, Peters RK, Homa DM. Asbestos and colon cancer: lack of association in a large case-control study.Am J Epidemiol 1992;135:843-53.

Holly EA, Whittemore AS, Aston DA, Ahn DK, Nickoloff BJ, Kristiansen JJ. Anal cancer incidence: genital warts, analfissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst 1989;81:1726-31.

Howe GR, Aronson KJ, Benito E, Castelleto R, Cornee J, Duffy S, Gallagher RP, Iscovich JM, Deng-ao J, Kaaks R, KuneGA, Kune S, Lee HP, Lee M, Miller AB, Peters RK, Potter JD, Riboli E, Slattery ML, Trichopoulos D, Tuyns A, Tzonou A,Watson LF, Whittemore AS, Shu Z, et al. The relationship between dietary fat intake and risk of colorectal cancer:evidence from the combined analysis of 13 case-control studies. Cancer Causes Control 1997;8:215-28.

Howe GR, Peters RK. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: Evidencefrom the combined analysis of 13 case-control studies. J Natl Cancer Inst 1992;84:1887-95.

Inciardi JF, Lee JG, Stijnen T. Incidence trends for colorectal cancer in California: implications for current screeningpractices [In Process Citation]. Am J Med 2000;109:277-81.




Klatsky AL, Armstrong MA, Friedman GD, Hiatt RA. The relations of alcoholic beverage use to colon and rectal cancer. AmJ Epidemiol 1988;128:1007-15.

Kolodner R, Tytell J, Schmeits J, Kane M, Gupta R, Wahlber S, Fox E, Garber J, Syngal S, Peel D, Ziogas A, Anton-Culver H, Li F. Germ-line msh6 mutations in colorectal cancer families. Cancer Research 1999;59:5068-74.

Paganini-Hill A. Aspirin and colorectal cancer: the Leisure World cohort revisited. Prev Med 1995;24:113-5.

Peel DJ, Ziogas A, Fox EA, Gildea M, Laham B, Clements E, Kolodner RD, Anton-Culver H. Characterization ofhereditary nonpolyposis colorectal cancer families from a population-based series of cases. J Natl Cancer Inst2000;92:1517-22.

Peters RK, Garabrant DH, Yu MC, Mack TM. A case-control study of occupational and dietary factors in colorectalcancer in young men by subsite. Cancer Res 1989;49:5459-68.

Peters RK, Mack T, Garabrant DH, Homa DM, Pike MC. Calcium and colon cancer in Los Angeles County. In: Lipkin M,Newmark HL, Kelloff G, eds. Calcium, Vitamin D and Prevention of Colon Cancer. Boston: CRC Press, 1991:113-20.

Peters RK, Mack TM. Patterns of anal carcinoma by gender and marital status in Los Angeles County. Br J Cancer1983;48:629-36.

Peters RK, Mack TM, Bernstein L. Parallels in the epidemiology of selected anogenital carcinomas. J Natl CancerInst 1984;72:609-15.

Peters RK, Pike MC, Chang WW, Mack TM. Reproductive factors and colon cancers. Br J Cancer 1990;61:741-8.

Peters RK, Pike MC, Garabrant D, Mack TM. Diet and colon cancer in Los Angeles County, California. CancerCauses Control 1992;3:457-73.

Saltzstein SL, Behling C, Savides T. The relation of age, race and gender to the subsite location of colorectalcarcinoma. Cancer 1998;82.

Schroen AT, Cress RD. Use of surgical procedures and adjuvant therapy in rectal cancer treatment: a population-based study. Ann Surg 2001;234:641-51.

Selby JV. Explaining recent declines in colorectal cancer incidence: was it the sigmoidoscope? [In ProcessCitation]. Am J Med 2000;109:332-4.

Selby JV, Friedman GD, Collen MF. Sigmoidoscopy and mortality from colorectal cancer: the Kaiser PermanenteMultiphasic Evaluation Study. J Clin Epidemiol 1988;41:427-34.

Simons AJ, Ker R, Groshen S, Gee C, Anthone GJ, Ortega AE, Vukasin P, Ross RK, Beart RW, Jr. Variations intreatment of rectal cancer: the influence of hospital type and caseload. Dis Colon Rectum 1997;40:641-6.

Simpson CL, Garabrandt DH, Fryzek J, Homa DM, Peters RK. Wood dust exposure and colon cancer. J OccupEnviron Health In Press.

Slattery ML, Benson J, Curtin K, Ma KN, Schaeffer D, Potter JD. Carotenoids and colon cancer. Am J Clin Nutr2000;71:575-82.

Slattery ML, Potter JD, Ma KN, Caan BJ, Leppert M, Samowitz W. Western diet, family history of colorectal cancer,NAT2, GSTM-1 and risk of colon cancer. Cancer Causes Control 2000;11:1-8.



Theuer CP, Wagner JL, Taylor TH, Brewster WR, Tran D, McLaren CE, Anton-Culver H. Racial and ethnic colorectalcancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology2001;120:848-56.

Whittemore AS. Colorectal cancer incidence among Chinese in North America and the People’s Republic ofChina: variation with sex, age and anatomical site. Int J Epidemiol 1989;18:563-8.

Whittemore AS, Wu-Williams AH, Lee M, Zheng S, Gallagher RP, Jiao DA, Zhou L, Wang XH, Chen K, Jung D, et al.Diet, physical activity, and colorectal cancer among Chinese in North America and China. J Natl Cancer Inst1990;82:915-26.

Whittemore AS, Zheng S, Wu A, Wu ML, Fingar T, Jiao DA, Ling CD, Bao JL, Henderson BE, Paffenbarger RS, Jr.Colorectal cancer in Chinese and Chinese-Americans. Natl Cancer Inst Monogr 1985;69:43-6.

Wu AH, Henderson BE. Alcohol and tobacco use: risk factors for colorectal adenoma and carcinoma? [editorial;comment]. J Natl Cancer Inst 1995;87:239-40.

Wu-Williams AH, Lee M, Whittemore AS, Gallagher RP, Jiao DA, Zheng S, Zhou L, Wang XH, Chen K, Jung D, et al.Reproductive factors and colorectal cancer risk among Chinese females. Cancer Res 1991;51:2307-11.

Yost K, Schlag RD. Colorectal Cancer in California, 2001. Sacramento: California Department of Health Services,Cancer Surveillance Section, February, 2002.

EEEEENDOMETRIUMNDOMETRIUMNDOMETRIUMNDOMETRIUMNDOMETRIUM (U (U (U (U (UTERUSTERUSTERUSTERUSTERUS) C) C) C) C) CANCERANCERANCERANCERANCER


Buckley` J. Choriocarcinoma. In: Schottenfeld D, Fraumeni JF, Jr, eds. Cancer Epidemiology and Prevention, 2nd Edition.New York: Oxford University Press, 1996:1130-41.

Buckley JD, Henderson BE, Morrow CP, Hammond CB, Kohorn EI, Austin DF. Case-control study of gestationalchoriocarcinoma. Cancer Res 1988;48:1004-10.

Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN. Association of soy and fiber consumption withthe risk of endometrial cancer. Am J Epidemiol 1997;146:294-306.

Henderson BE, Casagrande JT, Pike MC, Mack T, Rosario I, Duke A. The epidemiology of endometrial cancer inyoung women. Br J Cancer 1983;47:749-56.

Pike MC, Peters RK, Cozen W, Probst-Hensch NM, Felix JC, Wan PC, Mack TM. Estrogen-progestin replacementtherapy and endometrial cancer. J Natl Cancer Inst 1997;89:1110-6.

Plaxe SC, Saltzstein SL. Impact of ethnicity on the incidence of high-risk endometrial carcinoma. Gynecol Oncol1997;65:8-12.



EEEEESOPHAGUSSOPHAGUSSOPHAGUSSOPHAGUSSOPHAGUS C C C C CANCERANCERANCERANCERANCER

GGGGGALALALALALLLLLLBBBBBLLLLLADADADADADDDDDDEEEEERRRRR C C C C CANANANANANCECECECECERRRRR

Bernstein L. The incidence of adenocarcinoma of the esophagus is currently increasing and accounts for 50 percentof esophageal carcinomas in some series. In: Guili R, Tytgat TNJ, DeMeester TR, Galmiche JP, eds. The EsophagealMucosa. Amsterdam: Elsevier, 1994:1059-65.

Yu MC, Garabrant DH, Peters JM, Mack TM. Tobacco, alcohol, diet, occupation, and carcinoma of the esophagus.Cancer Res 1988;48:3843-8.

Mack TM, Menck H. Epidemiology of cancer of the gallbladder and extra hepatic biliary passages. In: Correa P, HaenxzelW, eds. Epidemiology of cancer of the gallbladder and extra hepatic biliary passages. Boston: Nijhoff, 1982.

Boivin JF, Hutchison GB, Zauber AG, Bernstein L, Davis FG, Michel RP, Zanke B, Tan CT, Fuller LM, Mauch P, et al.Incidence of second cancers in patients treated for Hodgkin’s disease [see comments]. J Natl Cancer Inst1995;87:732-41.

Clarke CA, Glaser SL, Dorfman RF, Mann R, DiGiuseppe JA, Prehn AW, Ambinder RF. Epstein-Barr virus and survivalafter Hodgkin disease in a population-based series of women. Cancer 2001;91:1579-87.

Cozen W, Katz J, Mack TM. Risk patterns of Hodgkin’s disease in Los Angeles vary by cell type. Cancer EpidemiolBiomarkers Prev 1992;1:261-8.

Dworsky RL, Henderson BE. Hodgkin’s disease clustering in families and communities. Cancer Res 1974;34:1161-3.

Glaser SL. Spatial clustering of Hodgkin’s disease in the San Francisco Bay area. Am J Epidemiol 1990;132:S167-77.

Glaser SL, Swartz WG. Time trends in Hodgkin’s disease incidence. The role of diagnostic accuracy. Cancer1990;66:2196-204.

Glaser SL. Hodgkin’s disease in black populations: a review of the epidemiologic literature. Semin Oncol1990;17:643-59.

Glaser SL. Black-white differences in Hodgkin’s disease incidence in the United States by age, sex, histologysubtype and time. Int J Epidemiol 1991;20:68-75.

Glaser SL. Reproductive factors in Hodgkin’s disease in women: a review. Am J Epidemiol 1994;139:237-46.

Glaser SL, Jarrett RF. The epidemiology of Hodgkin’s disease. Baillieres Clin Haematol 1996;9:401-16.

Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, Pallesen G, Gulley ML, et al. Epstein-Barr Virus-Associated Hodgkin’s Disease: Epidemiologic Characteristics in International Data. Int J Cancer 1997;70:375-82.

Glaser SL, Dorfman RF, Clarke CA. Expert review of the diagnosis and histologic classification of Hodgkin diseasein a population-based cancer registry: interobserver reliability and impact on incidence and survival rates.Cancer 2001;92:218-24.

HHHHHOOOOODDDDDGKGKGKGKGKINININININ’’’’’SSSSS D D D D DIIIIISSSSSEEEEEAAAAASSSSSEEEEE



KKKKKAPAPAPAPAPOOOOOSSSSSIIIII’’’’’SSSSS S S S S SARARARARARCCCCCOOOOOMAMAMAMAMA

KKKKKIDNEYIDNEYIDNEYIDNEYIDNEY C C C C CANCERANCERANCERANCERANCER

Henderson BE, Dworsky R, Menck H, Alena B, Henle W, Henle G, Terasaki P, Newell GR, Rawlings W, KinnearBK. Case-control study of Hodgkin’s disease. II. Herpesvirus group antibody titers and HL-A type. J NatlCancer Inst 1973;51:1443-7.

Henderson BE, Dworsky R, Pike MC, Baptista J, Menck H, Preston-Martin S, Mack T. Risk factors for nodularsclerosis and other types of Hodgkin’s disease. Cancer Res 1979;39:4507-11.

Hessol NA, Katz MH, Liu JY, Buchbinder SP, Rubino CJ, Holmberg SD. Increased incidence of Hodgkin’s disease inhomosexual men with HIV infection. Ann Intern Med 1992;117:309-11.

Newell GR, Rawlings W, Kinnear BK, Correa P, Henderson BE, Dworsky R, Menck H, Thompson R, Sheehan WW.Case-control study of Hodgkin’s disease. I. Results of the interview questionnaire. J Natl Cancer Inst1973;51:1437-41.

HHHHHOOOOODDDDDGKGKGKGKGKINININININ’’’’’SSSSS D D D D DIIIIISSSSSEEEEEAAAAASSSSSEEEEE

Gill PS, Hamilton A, Naidu Y. Epidemic (AIDS-related) Kaposi’s sarcoma. AIDS Update 1994;7.

Hamilton AS, Radka SF, Bernstein L, Gill PS, Gonsalves M, Naemura JR, Ross RK. Relationship of serum levels ofoncostatin M to AIDS-related and classic Kaposi’s sarcoma. J Acquir Immune Defic Syndr 1994;7:410-4.

Masood R, Husain SR, Rahman A, Gill P. Potentiation of cytotoxicity of Kaposi’s sarcoma related to immunodeficiencysyndrome (AIDS) by liposome-encapsulated doxorubicin. AIDS Res Hum Retroviruses 1993;9:741-6.

Ross RK, Casagrande JT, Dworsky RL, Levine A, Mack T. Kaposi’s sarcoma in Los Angeles, California. J Natl CancerInst 1985;75:1011-5.

Gago-Dominguez M, Yuan JM, Castelao JE, Ross RK, Yu MC. Regular use of analgesics is a risk factor for renal cellcarcinoma. Br J Cancer 1999;81:542-8.

Gago-Dominguez M, Yuan JM, Castelao JE, Ross RK, Yu MC. Family history and risk of renal cell carcinoma. CancerEpidemiol Biomarkers Prev 2001;10:1001-4.

Gago-Dominguez M, Yuan JM, Castelao JE, Ross RK, Yu MC. Increased risk of renal cell carcinoma subsequent tohysterectomy. Cancer Epidemiol Biomarkers Prev 1999;8:999-1003.

Liaw KL, Linet MS, McLaughlin JK, Yu MC, Schoenberg JB, Lynch CF, Niwa S, Fraumeni JF, Jr. Possible relationbetween hypertension and cancers of the renal pelvis and ureter. Int J Cancer 1997;70:265-8.

Linet MS, Chow WH, McLaughlin JK, Wacholder S, Yu MC, Schoenberg JB, Lynch C, Fraumeni JF, Jr. Analgesics andcancers of the renal pelvis and ureter. Int J Cancer 1995;62:15-8.

Lowery JT, Peters JM, Deapen D, London SJ. Renal cell carcinoma among architects. Am J Ind Med 1991;20:123-5.

McLaughlin JK, Silverman DT, Hsing AW, Ross RK, Schoenberg JB, Yu MC, Stemhagen A, Lynch CF, Blot WJ, Fraumeni,JF, Jr. Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res 1992;52:254-7.

Paganini-Hill A, Ross RK, Henderson BE. Epidemiology of kidney cancer. In: Skinner D, ed. Urological Cancer:Grune & Stratton, Inc., 1983:383-407.

Paganini-Hill A, Ross RK, Henderson BE. Epidemiology of kidney cancer. In: Skinner DG, Lieskovsky G, eds. Diagnosis andManagement of Genitourinary Cancer. Philadelphia: W.B. Saunders & Co., 1988:32-9.



Ross RK, Paganini-Hill A, Landolph J, Gerkins V, Henderson BE. Analgesics, cigarette smoking, and other riskfactors for cancer of the renal pelvis and ureter. Cancer Res 1989;49:1045-8.

Semenza JC, Ziogas A, Largent J, Peel D, Anton-Culver H. Gene-environment interactions in renal cell carcinoma.Am J Epidemiol 2001;153:851-9.

Yu MC, Mack TM, Hanisch R, Cicioni C, Henderson BE. Cigarette smoking, obesity, diuretic use, and coffee con-sumption as risk factors for renal cell carcinoma. J Natl Cancer Inst 1986;77:351-6.

Yuan JM, Castelao JE, Gago-Dominguez M, Ross RK, Yu MC. Hypertension, obesity and their medications in rela-tion to renal cell carcinoma. Br J Cancer 1998;77:1508-13.

Yuan JM, Castelao JE, Gago-Dominguez M, Yu MC, Ross RK. Tobacco use in relation to renal cell carcinoma. CancerEpidemiol Biomarkers Prev 1998;7:429-33.

Yuan JM, Gago-Dominguez M, Castelao JE, Hankin JH, Ross RK, Yu MC. Cruciferous vegetables in relation to renalcell carcinoma. Int J Cancer 1998;77:211-6.

KKKKKIDNEYIDNEYIDNEYIDNEYIDNEY C C C C CANCERANCERANCERANCERANCER

LLLLLEUKEMIAEUKEMIAEUKEMIAEUKEMIAEUKEMIA

Bernstein L, Newton P, Ross RK. Epidemiology of hairy cell leukemia in Los Angeles County. Cancer Res1990;50:3605-9.

Bowman JD, Garabrant DH, Sobel E, Peters JM. Exposures to extremely low frequency (ELF) electromagneticfields in occupations with elevated leukemia rates. Appl Indust Hyg 1988;3:189-94.

Bowman JD, Thomas DC, London SJ, Peters JM. Hypothesis: the risk of childhood leukemia is related to combina-tions of power-frequency and static magnetic fields. Bioelectromagnetics 1995;16:48-59.

Curtis RE, Boice JD, Jr , Stovall M, Bernstein L, Holowaty E, Karjalainen S, Langmark F, Nasca PC, Schwartz AG,Schymura MJ, et al. Relationship of leukemia risk to radiation dose following cancer of the uterine corpus. JNatl Cancer Inst 1994;86:1315-24.

Douer D, Preston-Martin S, Levine AM. Promincence of acute promyelocytic leukemia subtype in Latino AMLpatients: Clinical observation confirmed by population-based data. J Registry Management 1996;23:88-91.

Douer D, Preston-Martin S, Chang E, Nichols PW, Watkins KJ, Levine AM. High frequency of acute promyelocyticleukemia among Latinos with acute myeloid leukemia [see comments]. Blood 1996;87:308-13.

Douer D, Cozen W, Wang F, Chang E, Preston-Martin S, Levine AM. Descriptive epidemiology of acute promyelocyticleukemia - report for the cancer registry for Los Angeles County. Blood 1997;90.

Gale RP, Cozen W, Goodman MT, Wang FF, Bernstein L. Decreased chronic lymphocytic leukemia incidence inAsians in Los Angeles County. Leuk Res 2000;24:665-9.

London SJ, Bowman JD, Sobel E, Thomas DC, Garabrant DH, Pearce N, Bernstein L, Peters JM. Exposure to Magnetic Fieldsamong Electrical Workers in Relation to Leukemia Risk in Los Angeles County. Am J Indust Med 1994;26:47-60.

Preston-Martin S, Peters JM, Yu MC, Garabrant DH, Bowman JD. Myelogenous leukemia and electric blanket use.Bioelectromagnetics 1988;9:207-13.



LLLLLIVERIVERIVERIVERIVER C C C C CANCERANCERANCERANCERANCER

LLLLLEUKEMIAEUKEMIAEUKEMIAEUKEMIAEUKEMIA

Preston-Martin S, Peters JM. Prior employment as a welder associated with the development of chronic myeloidleukaemia. Br J Cancer 1988;58:105-8.

Preston-Martin S, Thomas DC, Henderson BE. Medical x-rays and adult-onset myelogenous leukemia in Los Angeles. 100Jahre Roentgen: Medizinische Gesellscheft fur Strahlerschutze. V . 1997.

Preston-Martin S, Thomas DC, Yu MC, Henderson BE. Diagnostic radiography as a risk factor for chronic myeloidand monocytic leukaemia (CML). Br J Cancer 1989;59:639-44.

Thomas DC, Preston-Martin S. Risk of leukemia caused by diagnostic x-rays. Health Phys 1992;63:576-8.

Travis LB, Curtis RE, Hankey BF, Fraumeni JF, Jr. Second cancers in patients with chronic lymphocytic leukemia. JNatl Cancer Inst 1992;84:1422-7.

Wright WE, Peters JM, Mack TM. Leukaemia in workers exposed to electrical and magnetic fields [letter]. Lancet1982;2:1160-1.

Craig JR, Klatt EC, Yu MC. Role of cirrhosis and the development of HCC: Evidence from histologic studies andlarge population studies. In: Tabor E, Di Bisceglie AM, Purcell RH, eds. Etiology, Pathology, and Treatment ofHepatocelluar Carcinoma in North America. Houston: Portofolio Publishing Co., 1991:177-90.

De Benedetti VMG, Welsh JA, Yu MC, Bennett WP. p53 mutations in hepatocellular carcinomas related to oralcontraceptive use. Carcinogenesis 1996;17:145-9.

Edmondson HA, Henderson B, Benton B. Liver-cell adenomas associated with use of oral contraceptives. N EnglJ Med 1976;294:470-2.

Henderson BE, Preston-Martin S, Edmondson HA, Peters RL, Pike MC. Hepatocellular carcinoma and oral contraceptives. Br JCancer 1983;48:437-40.

Kwong S, Perkins CI, Wright WE. Liver Cancer Incidence and Mortality rates increasing among Asian/Other womenin California, 1988-1993, 1997.

Yu MC, Mack T, Hanisch R, Peters RL, Henderson BE, Pike MC. Hepatitis, alcohol consumption, cigarette smoking,and hepatocellular carcinoma in Los Angeles. Cancer Res 1983;43:6077-9.

Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE. Prevalence of hepatitis B and C viralmarkers in black and white patients with hepatocellular carcinoma in the United States [see comments]. JNatl Cancer Inst 1990;82:1038-41.

Yu MC, Tong MJ, Govindarajan S, Henderson BE. Nonviral risk factors for hepatocellular carcinoma in a low-riskpopulation, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-6.

Yu MC, Yuan JM, Ross RK, Govindarajan H. Presence of antibodies to the hepatitis B surface antigen is associatedwith an excess risk for hepatoceullar carcinoma among non-Asians in Los Angeles County, California. Hepatology1997;25:226-8.

Yu MC, Yuan JM, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol2000;14:703-9.



LLLLLUNGUNGUNGUNGUNG C C C C CANCERANCERANCERANCERANCER

Anton-Culver H, Culver BD, Kurosaki T, Osann KE, Lee JB. Incidence of lung cancer by histological type from apopulation-based registry. Cancer Res 1988;48:6580-3.

Carpenter CL, Jarvik ME, Morgenstern H, McCarthy WJ, London SJ. Mentholated cigarette smoking and lung-cancer risk.Ann Epidemiol 1999;9:114-20.

Carpenter CL, Morgenstern H, London SJ. Alcoholic beverage consumption and lung cancer risk among residents ofLos Angeles County. J Nutr 1998;128:694-700.

Cowling DL, Kwong S, Schlag RD, Lloyd JC, Bal DG. Decline in Lung Cancer Rates-California, 1988-1997. MMWR2000;49:1066-9.

Cress RD, Holly EA, Aston DA, Ahn DK, Kristiansen JJ. Characteristics of women nonsmokers exposed to passivesmoke. Prev Med 1994;23:40-7.

DuNah, RE, Jr, Holly EA, Ahn DK. Demographics and cigarette smoking among women. Prev Med 1991;20:262-70.

Fontham ET, Correa P, Reynolds P, Wu-Williams A, Buffler PA, Greenberg RS, Chen VW, Alterman T, Boyd P, Austin DF, etal. Environmental tobacco smoke and lung cancer in nonsmoking women. A multicenter study [published erratumappears in JAMA 1994 Nov 23- 30;272(20):1578]. JAMA 1994;271:1752-9.

Fontham ET, Correa P, Wu-Williams A, Reynolds P, Greenberg RS, Buffler PA, Chen VW, Boyd P, Alterman T, AustinDF, et al. Lung cancer in nonsmoking women: a multicenter case-control study [see comments]. CancerEpidemiol Biomarkers Prev 1991;1:35-43.

Fontham ETH, Correa P, Buffler PA, Greenberg RS, Reynolds P, Wu-Williams A. Environmental tobacco smoke andlung cancer. MD Anderson Cancer Bulletin 1993;45:92-4.

Henderson BE, Gordon RJ, Menck H, Soohoo J, Martin SP, Pike MC. Lung cancer and air pollution in South CentralLos Angeles County. Am J Epidemiol 1975;101:477-88.

Higgins MW, Enright PL, Kronmal RA, Schenker MB, Anton-Culver H, Lyles M. Smoking and lung function inelderly men and women. The Cardiovascular Health Study [see comments]. JAMA 1993;269:2741-8.

Holly EA, Cress RD, Ahn DK, Aston DA, Kristiansen JJ, Felton JS. Characteristics of women by smoking status in theSan Francisco Bay Area. Cancer Epidemiol Biomarkers Prev 1992;1:491-7.

Hull CJ, Doyle E, Peters JM, Garabrant DH, Bernstein L, Preston-Martin S. Case-control study of lung cancer in Los AngelesCounty welders. Am J Ind Med 1989;16:103-12.

London SJ, Daly AK, Cooper J, Navidi WC, Carpenter CL, Idle JR. Polymorphism of glutathione S-transferase M1(GMTM1) and lung cancer risk among African-Americans and Caucasians in Los Angeles County. J Natl CancerInst 1995;87:1246-53.

London SJ, Daly AK, Leathart JBS, Navidi WC, Carpenter CL, Idle JR. Genetic polymorphism of CYP2D6 and lungcancer risk in African-Americans and Caucasians in Los Angeles County. Carcinogenesis 1997;18:1203-14.

London SJ, Daly AK, Cooper J, Carpenter CL, Navidi WC, Ding L, Idle JR. Lung cancer risk in relation to the CYP2E1 RsaI genetic polymorphism among African-Americans and Caucasians in Los Angeles County. Pharmacogenetics1996;6:151-8.

Menck HR, Henderson BE. Occupational differences in rates of lung cancer. J Occup Med 1976;18:797-801.

Menck HR, Pike MC, Henderson BE, Jing JS. Lung cancer risk among beauticians and other female workers: briefcommunication. J Natl Cancer Inst 1977;59:1423-5.



LLLLLUNGUNGUNGUNGUNG C C C C CANCERANCERANCERANCERANCER

Osann KE, Anton-Culver H, Kurosaki T, Taylor T. Sex differences in lung-cancer risk associated with cigarette smoking. IntJ Cancer 1993;54:44-8.

Paganini-Hill A, Hsu G. Smoking and mortality among residents of a California retirement community. Am JPublic Health 1994;84:992-5.

Preston-Martin S, Henderson BE, Pike MC. Descriptive epidemiology of cancers of the upper respiratory tract inLos Angeles. Cancer 1982;49:2201-7.

Romano PS, Bloom J, Syme SL. Smoking, social support, and hassles in an urban African-American community.Am J Public Health 1991;81:1415-22.

Shimizu H, Preston-Martin S, Casagrande JT, Ross RK, Henderson BE, Pike MC. Epidemiological characteristics ofadenocarcinoma of the lung in Los Angeles County. Natl Cancer Inst Monogr 1982;62:161-4.

Shimizu H, Wu AH, Koo LC, Gao YT, Kolonel LN. Lung cancer in women living in the Pacific Basin area. Natl CancerInst Monogr 1985;69:197-201.

Wu AH. Exposure misclassification bias in studies of environmental tobacco smoke and lung cancer. EnvironHealth Perspect 1999;107 Suppl 6:873-7.

Wu AH, Fontham ET, Reynolds P, Greenberg RS, Buffler P, Liff J, Boyd P, Correa P. Family history of cancer and riskof lung cancer among lifetime nonsmoking women in the United States [see comments]. Am J Epidemiol1996;143:535-42.

Wu AH, Fontham ET, Reynolds P, Greenberg RS, Buffler P, Liff J, Boyd P, Henderson BE, Correa P. Previous lungdisease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol1995;141:1023-32.

Wu AH, Henderson BE, Pike MC, Yu MC. Smoking and other risk factors for lung cancer in women. J Natl CancerInst 1985;74:747-51.

Wu AH, Henderson BE, Thomas D, Mack TM. Secular trends in histologic types of lung cancer. J Natl Cancer Inst1986;77:53-6.

Wu AH, Yu MC, Thomas DC, Pike MC, Henderson BE. Personal and family history of lung disease as risk factors foradenocarcinoma of the lung. Cancer Res 1988;48:7279-84.

Wu-Williams AH, Fontham ETH, Correa P, et al. Previous lung disease and risk of lung cancer among lifetimenonsmoking women in the United States. Am J Epidemiol 1995;141:1023-32.

Wu-Williams AH, Samet JM. Cigarette smoking and lung cancer. In: Samet JM, ed. Lung Biology in Health andDisease: Marcel Dekker, Inc., 1994.

Yu MC, Ross RK, Chan KK, Henderson BE, Skipper PL, Tannenbaum SR, Coetzee GA. Glutathione S-transferase M1genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers.Cancer Epidemiol Biomarkers Prev 1995;4:861-4.

Yuan A, Yu CJ, Chen WJ, Lin FY, Kuo SH, Luh KT, Yang PC. Correlation of total VEGF mRNA and protein expressionwith histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer.Int J Cancer 2000;89:475-83.



MMMMMEEEEELLLLLANANANANANOOOOOMAMAMAMAMA

Cohn B, Cirillo P, Yen I, Roffers S, Austin D, Reynolds P. Gender differences by site and age suggest menopausemay impact survival for cutaneous melanoma. Am J Epidemiol 1996;143.

Cress RD, Davidson-Sawyer K. Cutaneous melanoma among Hispanic and non-Hispanic white men and womenin California, 1988-1993. J Registry Management 1996;23:24-7.

Cress RD, Holly EA, Ahn DK, LeBoit PE, Sagebiel RW. Cutaneous melanoma in women: anatomic distribution inrelation to sun exposure and phenotype. Cancer Epidemiol Biomarkers Prev 1995;4:831-6.

Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks:an analysis of California Cancer Registry data, 1988-93. J Registry Management 1997;23:24-7.

Cress RD, Holly EA, Ahn DK. Cutaneous melanoma in women. V. Characteristics of those who tan and those whoburn when exposed to summer sun. Epidemiol 1995;6:538-43.

Gong G, Whittemore AS, West DW, Moore DH. Cutaneous melanoma at Lawrence Livermore National Laboratory:Comparison with rates in two San Francisco Bay Area counties. Cancer Causes Control 1992;3:191-7.

Goodman KJ, Bible ML, London S, Mack TM. Proportional melanoma incidence and occupation among whitemales in Los Angeles County (California, United States). Cancer Causes Control 1995;6:451-9.

Holly EA, Aston DA, Ahn DK, Kristiansen JJ, Char DH. No excess prior cancer in patients with uveal melanoma.Ophthalmology 1991;98:608-11.

Holly EA, Aston DA, Ahn DK, Kristiansen JJ, Char DH. Uveal melanoma, hormonal and reproductive factors inwomen. Cancer Res 1991;51:1370-2.

Holly EA, Aston DA, Char DH, Kristiansen JJ, Ahn DK. Uveal melanoma in relation to ultraviolet light exposure andhost factors. Cancer Res 1990;50:5773-7.

Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. I. Exposure to sunlight, ability totan, and other risk factors related to ultraviolet light. Am J Epidemiol 1995;141:923-33.

Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. II. Phenotypic characteristicsand other host-related factors. Am J Epidemiol 1995;141:934-42.

Holly EA, Cress RD, Ahn DK. Cutaneous melanoma in women: IV. Ovulatory life, menopause, and use of exogenousestrogens. Cancer Epidemiol Biomarkers and Prev 1994;3:661-8.

Holly EA, Cress RD, Ahn DK. Cutaneous melanoma in women. III. Reproductive factors and oral contraceptiveuse. Am J Epidemiol 1995;141:943-50.

Horn-Ross PL, Holly EA, Brown SR, Aston DA. Temporal trends in the incidence of cutaneous malignant melanomaamong Caucasians in the San Francisco-Oakland MSA. Cancer Causes Control 1991;2:299-305.

Jonna BP, Delfino RJ, Newman WG, Tope WD. Positive predictive value for presumptive diagnoses of skin cancerand compliance with follow-up among patients attending a community screening program. Prev Med1998;27:611-6.

Kelly JW, Holly EA, Shpall SN, Ahn DK. The distribution of melanocytic naevi in melanoma patients and controlsubjects. Australas J Dermatol 1989;30:1-8.

Langholz B, Richardson J, Rappaport E, Waisman J, Cockburn M, Mack T. Skin characteristics and risk of superficialspreading and nodular melanoma (United States). Cancer Causes Control 2000;11:741-50.

Mack TM, Floderus B. Malignant melanoma risk by nativity, place of residence at diagnosis, and age at migration.Cancer Causes Control 1991;2:401-11.



MMMMMESOTHELIOMAESOTHELIOMAESOTHELIOMAESOTHELIOMAESOTHELIOMA

MMMMMEEEEELLLLLANANANANANOOOOOMAMAMAMAMAMack TM. The geography of skin cancer. Skin Cancer Foundation J 1992;10:37-40.

Wright WE, Peters JM, Mack TM. Organic chemicals and malignant melanoma. Am J Ind Med 1983;4:577-81.

Cicioni C, London SJ, Garabrant DH, Bernstein L, Phillips K, Peters JM. Occupational asbestos exposure andmesothelioma risk in Los Angeles County: application of an occupational hazard survey job-exposure matrix.Am J Ind Med 1991;20:371-9.

Delfino RJ, Anton-Culver H, Saltzstein SL. Gender-related differences in the distribution of thoracic versus abdominalmalignant mesothelioma. Cancer Detect Prev 1995;19:301-7.

Heineman EF, Bernstein L, Stark AD, Spirtas R. Mesothelioma, asbestos, and reported history of cancer in first-degreerelatives. Cancer 1996;77:549-54.

Peto J, Henderson BE, Pike MC. Trends in mesothelioma incidence in the United States and the forecast epidemicdue to asbestos exposure during World War II. In: Peto R, Schneiderman M, eds. Banbury Report 9: Quantificationof Occupational Cancer, 1981:51-69.

Spirtas R, Beebe GW, Connelly RR, Wright WE, Peters JM, Sherwin RP, Henderson BE, Stark A, Kovasznay BM,Davies JN, et al. Recent trends in mesothelioma incidence in the United States. Am J Ind Med 1986;9:397-407.

Spirtas R, Heineman EF, Bernstein L, Beebe GW, Keehn RJ, Stark A, Harlow BL, Benichou J. Malignant mesothelioma:attributable risk of asbestos exposure. Occup Environ Med 1994;51:804-11.

Wright WE, Sherwin RP, Dickson EA, Bernstein L, Fromm JB, Henderson BE. Malignant mesothelioma: incidence,asbestos exposure, and reclassification of histopathology. Br J Ind Med 1984;41:39-45.

MMMMMULULULULULTTTTTIPLIPLIPLIPLIPLEEEEE M M M M MYYYYYEEEEELLLLLOOOOOMAMAMAMAMA

Guidotti S, Wright WE, Peters JM. Multiple myeloma in cosmetologists. Am J Ind Med 1982;3:169-71.

MMMMMULULULULULTTTTTIPLIPLIPLIPLIPLEEEEE S S S S SITITITITITESESESESES

Allen M, Perkins CI, Wright WE. Using Medicare administrative files to evaluate case ascertainment in a centralcancer registry. J Registry Management 1998;25:13-6.

Anton-Culver H. Epidemiologic assessment of cancer risk: Applications from the Cancer Surveillance Programof Orange County. J Am College of Toxicol 1989;8:933-40.

Anton-Culver H. Cancer prevention strategies: use of cancer prevention research registries. Environ HealthPerspect 1995;103 Suppl 8:237-9.

Anton-Culver H. Cancer Incidence and Mortality in San Diego and Imperial Counties, 1988-1990, 1991-1993. Irvine:Cancer Surveillance Program of Orange County/San Diego Imperial Organization for Cancer Control, 1996.




Anton-Culver H, Cinar P, Taylor TH, Bringman D, Rowley K, Leach S, Robles Y. Cancer Incidence and Mortality inSan Diego and Imperial Counties, 1994-1998. Irvine: Cancer Surveillance Program of Orange County/San Diego ImperialOrganization for Cancer Control, Epidemiology Division, Department of Medicine, University of California, Irvine, 2001.

Anton-Culver H, Cohen PF, Gildea ME, Ziogas A. Characteristics of BRCA1 mutations in a population-based caseseries of breast and ovarian cancer. Eur J Cancer 2000;36:1200-8.

Anton-Culver H, Taylor TH, Bringman D, Leach S, Rowley K, Brunner D, Realo P. Cancer Incidence and Mortality inSan Diego and Imperial Counties, 1990-1994. Irvine, CA: Cancer Surveillance Program of Orange County/SanDiego Imperial Organization for Cancer Control, 1997.

Anton-Culver H, Taylor TH, Bringman D, Rowley K, Cinar P, Leach S, Realo P. Cancer Incidence and Mortality in San Diegoand Imperial Counties, 1993-1997. Irvine: Cancer Surveillance Program of Orange County/San Diego Imperial Organiza-tion for Cancer Control, Epidemiology Division, Department of Medicine, University of California, Irvine, 2000.

Anton-Culver H, Taylor TH, Bringman D, Rowley K, Jeffries C, Realo P. Cancer Incidence and Mortality in San Diegoand Imperial Counties, 1991-1995. Irvine: Cancer Surveillance Program of Orange County/San Diego ImperialOrganization for Cancer Control, 1998.

Anton-Culver H, Taylor TH, Bringman D, Rowley K, Leach S, Realo P. Cancer Incidence and Mortality in OrangeCounty, 1992-1996. Irvine: Cancer Surveillance Program of Orange County/San Diego Imperial Organizationfor Cancer Control, 1999.

Austin DF, Reynolds P, Boyd PT, Swain BE, Chiang M. Progress in the war against cancer [letter]. N Engl J Med1989;321:1197-8.

Bernstein L. La epidemiologia del cancer de mama. Medico Interamericano 1997;16:597-99.

Bernstein L, Henderson BE. Exogenous hormones. In: Schottenfeld D, Fraumeni JF, Jr, eds. Cancer Epidemiologyand Prevention, 2nd Edition. New York: Oxford University Press, 1996:462-88.

Bernstein L, Levin D, Menck H, Ross RK. AIDS-related secular trends in cancer in Los Angeles County men: acomparison by marital status. Cancer Res 1989;49:466-70.

Bernstein L, Flannery J, Reynolds P. Cancer in Italian migrant populations. The United States of America. IARC SciPubl 1993;123:67-94.

Bernstein L, Miu A, Monroe K, Henderson BE, Ross RK. Cancer incidence among Filipinos in Los Angeles County,1972-1991. Int J Cancer 1995;63:345-8.

Bernstein L, Ross RK, Henderson BE. Cancer prevention: Hormones. In: Devita V, Hellman S, Rosenberg SA, eds.Cancer Principles and Practices of Oncology, 5th Edition. Philadelphia: Lippincott-Raven Press, 1997:609-17.

Bernstein L, Ross RK, Henderson BE. Relationship of hormone use to cancer risk. J Natl Cancer Inst Monogr1992;12:137-47.

Boice JD, Jr, Blettner M, Kleinerman RA, Engholm G, Stovall M, Lisco H, Austin DF, Bosch A, Harlan L, Krementz ET,et al. Radiation dose and breast cancer risk in patients treated for cancer of the cervix [published erratumappears in Int J Cancer 1991 Jul;127(1):118]. Int J Cancer 1989;44:7-16.

Bond GG, Austin DF, Gondek MR, Chiang M, Cook RR. Use of a population-based tumor registry to estimatecancer incidence among a cohort of chemical workers. J Occup Med 1988;30:443-8.

California Cancer Registry, American Cancer Society. California Cancer Facts and Figures, 1993. Oakland: American CancerSociety, 1992.












California Cancer Registry, American Cancer Society. California Cancer Facts and Figures 2002. Oakland, CA: AmericanCancer Society, 2001.

Campleman SL, Dryden M. Cancer Incidence in Northern California, 1988-1995. Chico: Cancer Registry of NorthernCalifornia, 1998.


Campleman SL, Dryden M. Cancer in Northern California, 1988-1998. Chico: Cancer Registry of Northern California,2001.

Campleman SL, Dryden M, Curtis RL. Cancer in Northern California, 1988-1999. Chico: Cancer Registry of NorthernCalifornia, 2001.

Cote TR, O’Brien TR, Ward JW, Wilson SE, Blattner WA. AIDS and cancer registry linkage: measurement and enhancementof registry completeness. The National AIDS/Cancer Match Study Group. Prev Med 1995;24:375-7.

Cress RD, Holly EA, Ahn DK, Kristiansen JJ, Aston DA. Contraceptive use among women smokers and nonsmokersin the San Francisco Bay area. Prev Med 1994;23:181-9.

Cress RD, Creech C, Caggiano V. Cancer Incidence and Mortality in the Sacramento Region, 1988-1997. Sacramento:Cancer Surveillance Program, Region 3, 2000.

Cress RD, Davidson-Allen K, Caggiano V. Cancer Incidence in the Sacramento Region, 1988-1995. Sacramento:Cancer Surveillance Program, Region 3, 1998.

Cress RD, Davidson-Allen K, Caggiano V. Cancer Incidence in the Sacramento Region,1988-1996. Sacramento:Cancer Surveillance Program, Region 3, 1999.

Cress RD, Davidson-Sawyer K, Caggiano V. Cancer Incidence in the Sacramento Region, 1988-1993. Sacramento:Cancer Surveillance Program, Region 3, 1996.

Cress RD, Davidson-Sawyer K, Caggiano V. Cancer Incidence in the Sacramento Region, 1988-1994. Sacramento: CancerSurveillance Program, Region 3, 1997.




Cress RD, Davidson-Sawyer K. Conversion from SEER Extent of Disease to AJCC Stage Grouping. J Registry Management1999;26:89-91.

Curtis RE, Boice JD, Jr, Stovall M, Bernstein L, Greenberg RS, Flannery JT, Schwartz AG, Weyer P, Moloney WC,Hoover RN. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med1992;326:1745-51.

Curtis RE, Boice JD, Jr, Stovall M, Bernstein L, Holowaty E, Karjalainen S, Langmark F, Nasca PC, Schwartz AG,Schymura MJ, et al. Relationship of leukemia risk to radiation dose following cancer of the uterine corpus. JNatl Cancer Inst 1994;86:1315-24.

Daly AK, Leathart JB, London SJ, Idle JR. An inactive cytochrome P450 CYP2D6 allele containing a deletion and abase substitution. Hum Genet 1995;95:337-41.

Dworsky R, Baptista J, Parker J, Chandor S, Noble G, Herrmann K, Henle W, Henderson B. Immune function inhealthy relatives of patients with malignant disease. J Natl Cancer Inst 1978;60:27-30.

Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JK, Henderson BE. Genetic susceptibility to cancer fromexogenous and endogenous exposures. J Cell Biochem Suppl 1996;25:15-22.

Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JKV, Henderson BE. Sex steroid hormones and geneticsusceptibility to breast and prostate cancer. Drug Metabolism Rev 1998;30:421-34.

Garabrant DH, Held J, Langholz B, Bernstein L. Mortality of aircraft manufacturing workers in Southern California. Am JInd Med 1988;13:683-93.

Garland C, Saltzstein SL, Raffa JV, Garland FC, Gorham ED. How to teach students to conquer cancer with curiosity anda cancer registry. J Cancer Educ 1988;3:290.

Gill PS. Pathogenesis of HIV-related malignancies. Curr Opin Oncol 1991;3:867-71.

Harnly ME, Swan SH, Kelter A. The authors reply. Am J Epidemiol 1989;130:1070-1.

Henderson BE, Benton BD, Weaver PT, Linden G, Nolan JF. Stilbestrol and urogenital-tract cancer in adolescentsand young adults. N Engl J Med 1973;288:354.

Henderson BE, Bernstein L, Ross RK. Cancer prevention: Hormones. In: DeVita VT, Hellman S, Rosenberg SA, eds. CancerPrinciples and Practice of Oncology. Philadelphia: J.B. Lippincott, 1993:474-80.

Henderson BE, Bernstein L, Ross RK. Etiology of cancer: hormones. In: Devita V, Hellman S, Rosenberg SA, eds. Cancer:Principles and Practices of Oncology, Fifth Edition. Philadelphia: Lippincott-Raven, 1997:219-29.

Henderson BE, Bernstein L, Ross RK. Hormones and the etiology of cancer. In: Holland JF, Frei E, Bast RC, Kine DW, Morton DL,Weichselbaum RR, eds. Cancer Medicine, 4th Edition. Philadelphia: Lei and Freiberger, 1993:233-2.

Henderson BE, Gerkins VR, Pike MC. Sexual factors and pregnancy. In: Persons at High Risk to Cancer: An Approach to CancerEtiology and Control. In: Fraumeni JF, Jr, ed. J Natl Cancer Inst Monogr: Academic Press, 1975.

Henderson BE, Ross RK, Pike MC, Casagrande JT. Endogenous hormones as a major factor in human cancer.Cancer Res 1982;42:3232-9.

Henderson BE, Ross R, Bernstein L. Estrogens as a cause of human cancer: the Richard and Hinda RosenthalFoundation award lecture. Cancer Res 1988;48:246-53.

Henderson SO, Coetzee GA, Ross RK, Yu MC, Henderson BE. Elevated mortality rates from circulatory disease in AfricanAmerican men and women of Los Angeles County, California—a possible genetic susceptibility? Am J Med Sci2000;320:18-23.




Hiatt RA, Fireman BH. Serum uric acid unrelated to cancer incidence in humans. Cancer Res 1988;48:2916-8.

Hoegh H, McKendry CJ, Wright WE, Young JL. Cancer Incidence by Race/Ethnicity: California, 1988-1989. Sacramento:California Department of Health Services, Cancer Surveillance Section, 1992.

Horn-Ross PL, Lee M, John EM, Koo J. Sources of phytoestrogen exposure among non-Asian women in California,USA. Cancer Causes Control 2000;11:299-302.

Howard J, Hankey BF, Greenberg RS, Austin DF, Correa P, Chen VW, Durako S. A collaborative study of differencesin the survival rates of black patients and white patients with cancer. Cancer 1992;69:2349-60.

Hsu JL, Glaser SL. Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications. CritRev Oncol Hematol 2000;34:27-53.

Ingles SA, Haile RW, Henderson BE, Kolonel LN, Nakaichi G, Shi CY, Yu MC, Ross RK, Coetzee GA. Strength of linkagedisequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies.Cancer Epidemiol Biomarkers Prev 1997;6:93-8.

Kang SH, Bloom JR. Social support and cancer screening among older black Americans. J Natl Cancer Inst1993;85:737-42.

Kang SH, Bloom JR, Romano PS. Cancer screening among African-American women: their use of tests and socialsupport. Am J Public Health 1994;84:101-3.

Kaplan GA, Reynolds P. Depression and cancer mortality and morbidity: prospective evidence from the AlamedaCounty study. J Behav Med 1988;11:1-13.

Katz MH, Hessol NA, Buchbinder SP, Hirozawa A, O’Malley P, Holmberg SD. Temporal trends of opportunisticinfections and malignancies in homosexual men with AIDS. J Infect Dis 1994;170:198-202.

Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, Pike MC, Stram DO, Monroe KR, Earle ME, NagamineFS. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 2000;151:346-57.

Krailo MD, Bernstein L, Sullivan-Halley J, Hammond GD. Patterns of enrollment on cooperative group studies. Ananalysis of trends from the Los Angeles County Cancer Surveillance Program. Cancer 1993;71:3325-30.

Kpblin B, Hessol NA, Zauber AG. Increased incidence of cancer among homosexual men, New York and SanFrancisco, 1978-1990. Am J Epidemiol 1996;144:916-23.

Kwong Sl, Perkins CI, Snipes KP, Wright WE. Improving American Indian cancer data in the California CancerRegistry. J of Registry Management 1998;25:17-20.

Kwong S, Perkins CI, Morris CR, Cohen R, Allen M, Schlag RD, Wright WE. Cancer in California: 1988-1998. Sacramento:California Dept. of Health Services, Cancer Surveillance Section, 2000.

Langholz B, Thomas D, Huberman M, Ziogas A, Faucett C, Goldstein L. Ascertainment bias rate ratio estimationfrom case-sibling control studies of variable age-at-onset diseases. Biometrics 1999;55:1129-36.

Le G, Leung R, O’Malley C, Clarke CA, Lin SS, Glaser SL, West DW. Cancer Incidence and Mortality in the SanFrancisco Bay Area, 1988-1998. Union City: Northern California Cancer Center, 2001.

Le G, Leung R, O’Malley C, Clarke CA, Lin SS, Glaser SL, West DW. Cancer Incidence and Mortality in the SantaClara Region, 1988-1998. Union City: Northern California Cancer Center, 2001.

Lee MM, Wu-Williams A, Whittemore AS, Zheng S, Gallagher R, Teh CZ, Zhou L, Wang X, Chen K, Ling C, et al. Compari-son of dietary habits, physical activity and body size among Chinese in North America and China. Int J Epidemiol1994;23:984-90.




Leong SPL, Wrigh TW, Fink DJ, Blankenship CM. Success Stories II: Cancer Liaison Physicians Using NCDB Data to InfluencePatient Care. In: Strutkus W, Blankenship W, Menck HR, eds. The California Triad Project. Chicago: American Collegeof Surgeons, 1998:57-62.

LeTendre D, Cress RD, Riddle S. Where did they really live? Resolving discrepancies in address at diagnosis. JRegistry Management 2000;27:57-8.

Liu L, Deapen D, Bernstein L, Ross RK. Cancer Incidence in Los Angeles County by Race-Ethnicity, 1988-1993. LosAngeles: University of Southern California, Los Angeles Cancer Surveillance Program, 1996.

Liu L, Deapen D, Bernstein L, Ross RK. Cancer in Los Angeles County: Incidence by Race/Ethnicity 1988-1994. LosAngeles: University of Southern California, Los Angeles Cancer Surveillance Program, 1997.

Liu L, Deapen D, Bernstein L, Ross RK. Cancer in Los Angeles County: Incidence and Mortality by Race/Ethnicity 1988-1995. Los Angeles: Los Angeles County Cancer Surveillance Program, University of Southern California, 1998.


Liu L, Deapen D, Bernstein L, Ross RK. Cancer in Los Angeles County: Incidence and Mortality by Race/Ethnicity,1988-1997. Los Angeles: Cancer Surveillance Program, University of Southern California, 2000.


Lum R, O’Malley C, Lui S, Topol B, Clarke C, Lin S, Prehn AW, Glaser S, West D. Cancer Incidence and Mortality in theSan Francisco Bay Area. Union City: Northern California Cancer Center, 2000.

Lum R, O’Malley C, Lui S, Topol B, Clarke C, Lin S, Prehn AW, Glaser S, West D. Cancer Incidence and Mortality in theSanta Clara Region, 1988-1997. Union City: Northern California Cancer Center, 2000.

Lum R, Prehn AW, Topol B, Lui S, Clarke C, Glaser S, West D. Cancer Incidence and Mortality in the San FranciscoBay Area, 1988-1996. Union City: Northern California Cancer Center, 1999.

Lum R, Prehn AW, Topol B, Lui S, Clarke C, Lin S, Glaser S, West D. Cancer Incidence and Mortality in the Santa ClaraRegion, 1988-1996. Union City: Northern California Cancer Center, 1999.

Mack TM, Henderson BE. Cause-specific mortality among newspaper web pressman. J Occup Med 1980;22:542-4.

Mack TM, Preston-Martin S. Trends in the epidemiology of the leukemias and lymphomas. In: Yon DS, Lapin BA,Blakeslee JR, eds. Advances in Comparative Leukemia Research 1979. New York: Elsevier North Holland,1980:431-38.

Mack TM, Berkel J, Bernstein L, Mack W. Religion and cancer in Los Angeles County. Natl Cancer Inst Monogr1985;69:235-45.

Mack TM, Cozen W, Quinn M. Epidemiology of cancer of the endometrium, ovary, vulva and vagina. In: CopplesonM, ed. Gynecologic Oncology. London: Churchill Livingston, 1991.

Menck HR, Henderson BE, Pike MC, Mack T, Martin SP, SooHoo J. Cancer incidence in the Mexican-American. JNatl Cancer Inst 1975;55:531-6.

McGuire V, Whittemore AS, Norris R, Oakley-Girvan I. Survival in epithelial ovarian cancer patients with prior breastcancer. Am J Epidemiol 2000;152:528-32.

McKean-Cowdin R, Feigelson HS, Ross RK, Pike MC, Henderson BE. Declining cancer rates in the 1990s. J Clin Oncol2000;18:2258-68.




Miller BA, Kolonel LN, Bernstein L, Young JL, Jr, Swanson GM, West DW, Key CR, Liff JM, Glover CS, Alexander GA. Racial/EthnicPatterns of Cancer in the United States, 1988-1992. National Cancer Institute, Publ No. 96-4104 1996.

Mills PK. Cancer Incidence in the Central Valley, 1988-1993. Fresno, CA: Cancer Registry of Central California,California Health Collaborative, 1996.

Mills PK. Cancer Incidence in the Central Valley, 1988-1998. Fresno, CA: Cancer Registry of Central California,California Health Collaborative, 1997.

Mills PK. Cancer Incidence and Mortality in the Central Valley. 1999: Cancer Registry of Central California, California HealthCollaborative, 1999.

Mills PK. Cancer Incidence and Mortality in the Central Valley, 1988-1998. Fresno: Cancer Registry of CentralCalifornia, 2000.

Mills PK. Correlation analysis of pesticide use data and cancer incidence rates in California counties. Arch Environ Health1998;53:410-3.

Mills PK, Kwong S. Cancer incidence in the United Farmworkers of America (UFW), 1987-1997. Am J Ind Med2001;40:596-603.

Mills PK, Yang R. Cancer incidence in the Hmong of Central California, United States, 1987-94. Cancer CausesControl 1997;8:705-12.

Mishra SI, Luce-Aoela P, Wilkins L, Bernstein L. Cancer among American Samoans: Site-specific incidence in Californiaand Hawaii. Int J Epidemiol 1996;25:713-21.

Moradi T, Delfino RJ, Bergstrom SR, Yu ES, Adami HO, Yuen J. Cancer risk among Scandinavian immigrants in theUS and Scandinavian residents compared with US whites, 1973-89. Eur J Cancer Prev 1998;7:117-25.

Morgan JW, Cassady RE, King AR, Lu JK. Cancer Incidence and Mortality in Inyo, Mono, Riverside and San Bernar-dino Counties, 1988-1997. Loma Linda: Desert Sierra Cancer Surveillance Program, 2000.

Morgan JW, Enders JA, King AR, Gladson JE. Cancer Incidence in Inyo, Mono, Riverside, and San BernardinoCounties, 1988-1993. Loma Linda: Desert Sierra Cancer Surveillance Program, Loma Linda University MedicalCenter, 1996.

Morgan JW, Gladson JE, Cassady RE, Woodward SM, King AR. Cancer Incidence and Mortality in Inyo, Mono,Riverside, and San Bernardino Counties, 1988-1995. Loma Linda: Desert Sierra Cancer Program, Loma LindaUniversity Medical Center, 1998.

Morgan JW, Law JH, Cassady RE, King AR. Cancer Incidence and Mortality in Inyo, Mono, Riverside, and SanBernardino Counties, 1988-1998. Loma Linda: Desert Sierra Cancer Surveillance Program, Loma Linda Univer-sity Medical Center, 2001.

Morgan JW, Woodward SM, Cassady RE, King AR, Jog S. Cancer Incidence and Mortality in Inyo, Mono, Riversideand San Bernardino Counties, 1988-1996. Loma Linda: Desert Sierra Cancer Surveillance Program, Loma LindaUniversity Medical Center, 1999.

Morris CR, Perkins CI, Wright WE, Snipes KP, Young Jr JL. Impact of inclusion of subsequent primary cancers onestimates of risks of developing cancer. J Natl Cancer Inst 1996;88:456-8.

Morris CR, Cohen R, Perkins C, Allen M, Kwong S, Schlag RD, Wright WE. Cancer in California: 1988-1997. Sacramento:California Department of Health Services, Cancer Surveillance Section, 2000.

Morris CR, Cohen R, Perkins CI, Allen M, Kwong SL, Schlag RD, Wright WE. Cancer in California: 1988-1996. Sacramento:California Department of Health Services, Cancer Surveillance Section, 1999.




Nasseri K. Cancer Incidence and Mortality in the Tri-Counties, California, 1988-1993. Santa Barbara: Tri-Counties RegionalCancer Registry, 1996.

Nasseri K, Casagande C. Cancer Incidence and Mortality by Race/Ethnicity in the Tri-Counties, California, 1988-1997. Santa Barbara: Tri-Counties Regional Cancer Registry, 2000.

Nasseri K, Casagrande C. Cancer Incidence and Mortality by Race/Ethnicity in the Tri-Counties, California, 1988-1999. Santa Barbara: Tri-Counties Regional Cancer Registry, 2001.

Nasseri K. Statistical Process Control and Monitoring Time trends by Population based Cancer Registries. J RegistryManagement 1999;26:93-7.

Nasseri K, Watkins S. Timeliness in Reporting Cancer Incidence to a Population-based Regional Registry. J RegistryManagement 1998:21-7.

Neutra R, Swan S, Mack T. Clusters galore: insights about environmental clusters from probability theory. SciTotal Environ 1992;127:187-200.

Paganini-Hill A, Glazer E, Henderson BE, Ross RK. Cause-specific mortality among newspaper web pressmen. JOccup Med 1980;22:542-4.

Paganini-Hill A, Hsu G. Morbidity and mortality changes with estrogen replacement changes. In: Lobo R, ed.Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. New York: Raven Press, 1994:399-404.

Perkins CI, Cohen R, Morris CR, Allen M, Kwong SL, Schlag RD, Wright WE. Cancer in California: 1988-1995. Sacra-mento: California Department of Health Services, Cancer Surveillance Section, 1998.

Perkins CI, Cohen R, Young JL, Schlag RD, Wright WE. Cancer in California: Detailed site and Histology, 1990-1994.Sacramento: California Department of Health Services, Cancer Surveillance Section, 1997.

Perkins CI, Hoegh HJ, Wright WE, Young JL. Cancer Incidence and Mortality by Race/Ethnicity in California, 1988-1990. Sacramento: California Department of Health Services, Cancer Surveillance Section, 1993.

Perkins CI, Kwong Sl, Morris CR, Cohen R, Allen M, Schlag RD, Wright WE. Cancer in California, 2001. Sacramento:Department of Health Services, Cancer Surveillance Section, 2000.

Perkins CI, Morris CR, Wright WE. Cancer Incidence and Mortality in California by Race/Ethnicity, 1988-1993.Sacramento: California Department of Health Services, Cancer Surveillance Section, 1996.

Perkins CI, Morris CR, Wright WE, Young JL. Cancer Incidence and Mortality in California by Detailed Race/Ethnicity,1988-1992. Sacramento: California Department of Health Services, Cancer Surveillance Section, 1995.

Perkins CI, Wright WE, Schlag RD. Cancer Incidence and Mortality in California by Race/Ethnicity, 1988-1994.Sacramento: California Department of Health Services, Cancer Surveillance Section, 1997.

Peters JM, Wright WE, Garabrant DH. Occupational epidemiology: detection of cancer in the workplace. West JMed 1982;137:555-9.

Peters JM, Garabrant DH, Wright WE, Bernstein L, Mack TM. Uses of a cancer registry in the assessment ofoccupational cancer risks. Natl Cancer Inst Monogr 1985;69:157-61.

Pike MC, Peters RK, Bernstein L. Re: “Total energy intake: Implications for epidemiologic analyses.” Am J Epidemiol1993;137:811-2.

Pike MC, Ross RK. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.Steroids 2000;65:659-64.




Plummer SJ, Santibanez-Koref M, Kurosaki T, Liao S, Noble B, Fain PR, Anton-Culver H, Casey G. A germline 2.35 kbdeletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumenisyndrome family. Oncogene 1994;9:3273-80.

Pogoda JM, Preston-Martin S, Paoff KJ, Lijinsky W. Survey of residual nitrite levels in cured meats in the UnitedStates and Canada, 1970-1991. In Press.

Prehn AW, Leung R, Davis MM, Brown SR, Glaser S, West DW. Cancer Incidence in the Santa Clara Region, 1988-1994. Union City: Northern California Cancer Center, 1997.

Prehn AW, Satriano ER, Leung R, Davis MM, Brown SR, Glaser S, West D. Cancer Incidence in the San Francisco BayArea, 1988-1994. Union City: Northern California Cancer Center, 1997.

Prehn AW, Topol B, Lin S, Clarke C, Davis MM, Glaser S, West D. Cancer Incidence in the San Francisco Bay Area,1988-1995. Union City: Northern California Cancer Center, 1998.

Prehn AW, Topol B, Lin S, Clarke C, Davis MM, Glaser S, West D. Cancer Incidence in the Santa Clara Region, 1988-1995. Union City: Northern California Cancer Center, 1998.

Preston-Martin S. N-nitroso compounds as a cause of human cancer. IARC Sci Publ 1987;84:477-84.

Preston-Martin S, Pike MC, Ross RK, Henderson BE. Epidemiologic evidence for the increased cell proliferationmodel of carcinogenesis. Environ Health Perspect 1993;101 Suppl 5:137-8.

Preston-Martin S, Pike MC, Ross RK, Henderson BE. Epidemiologic evidence for the increased cell proliferationmodel of carcinogenesis. Prog Clin Biol Res 1991;369:21-34.

Preston-Martin S, White SC. Brain and salivary gland tumors related to prior dental radiography: implications forcurrent practice. J Am Dent Assoc 1990;120:151-8.

Ragland KE, Selvin S, Merrill DW. Black-white differences in stage-specific cancer survival: analysis of sevenselected sites. Am J Epidemiol 1991;133:672-82.

Re A, Taylor TH, DiSaia PJ, Anton-Culver H. Risk for breast and colorectal cancers subsequent to cancer of theendometrium in a population-based case series. Gynecol Oncol 1997;66:255-7.

Renneker M. An inner city cancer prevention clinic. Design, methods, and early results. Cancer 1991;67:1802-7.

Reynolds P, Saunders LD, Layefsky ME, Lemp GF. The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980-1987. Am J Epidemiol 1993;137:19-30.

Reynolds P, Elkin E, Layefsky M, Lee G. Cancer in California School Employees, 1988-1992. Am J Ind Med1999;36:271-8.

Ross RK, McCurtis JW, Henderson BE, Menck HR, Mack TM, Martin SP. Descriptive epidemiology of testicular andprostatic cancer in Los Angeles. Br J Cancer 1979;39:284-92.

Ross RK, Henderson BE. Epidemiology of Hodgkin’s and non-Hodgkin’s lymphomas. In: Aoki K, Tominaga S, HirayamaT, Hirota Y, eds. Proceedings of the First UICC Conference on Cancer Prevention in Developing Countries.Nagoya, Japan: University of Nagoya Press, 1982:515-7.

Ross R, Dworsky R, Paganini-Hill A, Boone J, Nichols P, Mack T. The occurrence of multiple lymphoreticular andhematological malignancies in the same households. Br J Cancer 1983;47:853-6.

Ross RK, Bernstein L, Garabrant D, Henderson BE. Avoidable nondietary risk factors for cancer. Am Fam Physician1988;38:153-60.



Ross RK, Hartnett N, Bernstein L, Henderson BE. A portrait of incidence and mortality, 1972-1987. Kenneth Norris Jr.Comprehensive Cancer Center 1991.

Ross RK, Bernstein L, Hartnett NM, Boone JR. Cancer patterns among Vietnamese immigrants in Los AngelesCounty. Br J Cancer 1991;64:185-6.

Ruder AM, Ward EM, Brown DP. Cancer mortality in female and male dry-cleaning workers. J Occup Med1994;36:867-74.

Saltzstein SL, Behling C, Baergen R. Features of cancer in nonagenarians and centenarians. J Am Geriatr Soc1998;46:994-8.

Satriano E, Darbinian J, Leung R, Glaser S, West D. Cancer Incidence in the San Francisco Bay Area, 1988-1993.Union City: Northern California Cancer Center, 1996.

Satriano E, Darbinian J, Leung R, Glaser S, West D. Cancer Incidence in the Santa Clara Region, 1988-1993. Union City:Northern California Cancer Center, 1996.

Seiffert JE. Editorial - Special Focus: Central Cancer Registries. J of Registry Management 1998;25:5.

Selby JV, Friedman GD. Epidemiologic evidence of an association between body iron stores and risk of cancer.Int J Cancer 1988;41:677-82.

Selby JV, Friedman GD, Fireman BH. Screening prescription drugs for possible carcinogenicity: eleven to fifteenyears of follow-up. Cancer Res 1989;49:5736-47.

Selvin S, Merrill D, Schulman J, Sacks S, Bedell L, Wong L. Transformations of maps to investigate clusters ofdisease. Soc Sci Med 1988;26:215-21.

Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast amongJapanese and white immigrants in Los Angeles County. Br J Cancer 1991;63:963-6.

Slattery ML, Edwards SL, Palmer L, Curtin K, Morse J, Anderson K, Samowitz W. Use of archival tissue in epidemio-logic studies: collection procedures and assessment of potential sources of bias. Mutat Res 2000;432:7-14.

Snipes KP, Perkins CI, Wright WE, Young JL. Cancer Incidence and Mortality by Race/Ethnicity in California, 1988-1991. Sacramento: California Dept. of Health Services, Cancer Surveillance Section, 1994.

Stewart SL, Swallen KC, Glaser SL, Horn-Ross PL, West DW. Comparison of methods for classifying Hispanic ethnicityin a population-based cancer registry. Am J Epidemiol 1999;149:1063-71.

Swallen KC, Glaser SL, Stewart SL, West DW, Jenkins CN, McPhee SJ. Accuracy of racial classification of Vietnam-ese patients in a population-based cancer registry. Ethn Dis 1998;8:218-27.

Swallen KC, West DW, Stewart SL, Glaser SL, Horn-Ross PL. Predictors of misclassification of Hispanic ethnicity ina population- based cancer registry. Ann Epidemiol 1997;7:200-6.

Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW. HL-A antigens in solid tumors. CancerRes 1973;33:648-50.

Taylor TH, Anton-Culver H. Let’s leave the date out of the name of the standard population. J Natl Cancer Inst2000;92:1269-70.

Theuer CP, Taylor TH, Anton-Culver H. Different racial/ethnic groups may require different screening guidelines. N EnglJ Med 2000;343:1652.

Travis LB, Gonzalez CL, Hankey BF, Jaffe ES. Hodgkin’s disease following non-Hodgkin’s lymphoma. Cancer1992;69:2337-42.




Tu IP, Balise RR, Whittemore AS. Detection of disease genes by use of family data. II. Application to nuclear families.Am J Hum Genet 2000;66:1341-50.

Walker A, Ross RK, Pike MC, Henderson BE. A possible rising incidence of malignant germ cell tumors in youngwomen. Br J Cancer 1984;49:669-72.

Wilkinson T. Features of cancer in nonagenarians and centenarians (Letter to the Editor). J Am Geriatr Soc 1999;47.

Wu AH. Soy and risk of hormone-related and other cancer. New York: Kluwer Academic/Plenum Publishers, 2000.

Wu AH, Pike MC. Phytoestrogen content in foods and their role in decreasing cancer risk. Handbook of Antioxidants,Biochemical, Nutritional, and Clinical Aspects, 2nd edition: Marcel Dekker, Inc., In Press.

Wu ML, Whittemore AS, Jung DL. Errors in reported dietary intakes. II. Long-term recall. Am J Epidemiol1988;128:1137-45.

Wu AH, Whittemore AS, Kolonel LN, Stanczyk FZ, John EM, Gallagher RP, West DW. Lifestyle determinants of5alpha-reductase metabolites in older African-American, white, and Asian-American men. Cancer EpidemiolBiomarkers Prev 2001;10:533-8.

Ziogas A, Gildea M, Cohen P, Bringman D, Taylor TH, Seminara D, Barker D, Casey G, Haile R, Liao SY, Thomas D,Noble B, Kurosaki T, Anton-Culver H. Cancer risk estimates for family members of a population-based familyregistry for breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 2000;9:103-11.

Zippin C, Lum D. Study of completeness of the surveillance, epidemiology and end results (SEER) program caseascertainment by hospital size and casefinding source. Health Rep 1993;5:87-90.




NNNNNOOOOONNNNN-H-H-H-H-HOOOOODDDDDGKGKGKGKGKINININININ’’’’’SSSSS L L L L LYYYYYMPHMPHMPHMPHMPHOOOOOMAMAMAMAMA

Bernstein L, Deapen D, Ross RK. Mycosis fungoides. JAMA 1989;261:1882.

Bernstein L, Ross RK. Prior medication use and health history as risk factors for non-Hodgkin’s lymphoma: preliminaryresults from a case-control study in Los Angeles County. Cancer Res 1992;52:5510s-15s.

Cote TR, Manns A, Hardy CR, Yellin FJ, Hartge P. Epidemiology of brain lymphoma among people with or withoutacquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 1996;88:675-9.

Harnly ME, Swan SH, Holly EA, Kelter A, Padian N. Temporal trends in the incidence of non-Hodgkin’s lymphomaand selected malignancies in a population with a high incidence of acquired immunodeficiency syndrome(AIDS) [see comments]. Am J Epidemiol 1988;128:261-7.

Horn PL, Delorenze GN, Brown SR, Holly EA, West DW. Re: “Temporal trends in the incidence of non-Hodgkin’slymphoma and selected malignancies in a population with a high incidence of acquired immunodeficiencysyndrome (AIDS)”. Am J Epidemiol 1989;130:1069-70.

Levine AM, Shibata D, Sullivan-Halley J, Nathwani B, Brynes R, Slovak ML, Mahterian S, Riley CL, Weiss L, Levine PH,et al. Epidemiological and biological study of acquired immunodeficiency syndrome-related lymphoma inthe County of Los Angeles: preliminary results. Cancer Res 1992;52:5482s-5484s.

Levine AM, Bernstein L, Sullivan-Halley J, Shibata D, Mahterian SB, Nathwani BN. Role of zidovudine antiretroviral therapyin the pathogenesis of acquired immunodeficiency syndrome-related lymphoma. Blood 1995;86:4612-6.

Nelson RA, Levine AM, Marks G, Bernstein L. Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin’slymphoma. Br J Cancer 1997;76:1532-7.

Ross R, Dworsky R, Nichols P, Paganini-Hill A, Wright W, Koss M, Lukes R, Henderson B. Asbestos exposure andlymphomas of the gastrointestinal tract and oral cavity. Lancet 1982;2:1118-20.

Ross R, Dworsky R, Paganini-Hill A, Levine A, Mack T. Non-Hodgkin’s lymphomas in never married men in Los Angeles.Br J Cancer 1985;52:785-7.

Ross RK, Dworsky R, Paganini-Hill A, Nichols P. The epidemiology of lymphomas. In: Pattengale P, Lukes R, TaylorC, eds. Lymphoproliferative Diseases: Pathogenesis, Diagnosis, Therapy. Boston: Martinez-Nijhoff Publishers,1985:55-71.

Shibata D, Weiss LM, Hernandez AM, Nathwani BN, Bernstein L, Levine AM. Epstein-Barr virus-associated non-Hodgkin’s lymphoma in patients infected with the human immunodeficiency virus. Blood 1993;81:2102-9.

Slovak ML, Weiss LM, Nathwani BN, Bernstein L, Levine AM. Cytogenetic studies of composite lymphomas:monocytoid B-cell lymphoma and other B-cell non-Hodgkin’s lymphomas. Hum Pathol 1993;24:1086-94.

Whittemore AS, Holly EA, Lee IM, Abel EA, Adams RM, Nickoloff BJ, Bley L, Peters JM, Gibney C. Mycosis fungoidesin relation to environmental exposures and immune response: a case-control study. J Natl Cancer Inst1989;81:1560-7.



OOOOORRRRRALALALALAL,,,,, H H H H HEEEEEADADADADAD,,,,, ANDANDANDANDAND N N N N NEEEEECKCKCKCKCK

Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, StemhagenA, Fraumeni, JF, Jr. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988;48:3282-7.

Day GL, Blot WJ, Austin DF, Bernstein L, Greenberg RS, Preston-Martin S, Schoenberg JB, Winn DM, McLaughlin JK,Fraumeni, JF, Jr. Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco, and other determinants. JNatl Cancer Inst 1993;85:465-73.

Day GL, Blot WJ, Shore RE, McLaughlin JK, Austin DF, Greenberg RS, Liff JM, Preston-Martin S, Sarkar S, SchoenbergJB, et al. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst1994;86:131-7.

Day GL, Shore RE, Blot WJ, McLaughlin JK, Austin DF, Greenberg RS, Liff JM, Preston-Martin S, Sarkar S, SchoenbergJB, et al. Dietary factors and second primary cancers: a follow-up of oral and pharyngeal cancer patients. NutrCancer 1994;21:223-32.

Demers PA, Kogevinas M, Boffetta P, Leclerc A, Luce D, Gerin M, Battista G, Belli S, Bolm-Audorf U, Brinton LA, etal. Wood dust and sino-nasal cancer: pooled reanalysis of twelve case-control studies. Am J Ind Med1995;28:151-66.

Flagg EW, Coates RJ, Jones DP, Byers TE, Greenberg RS, Gridley G, McLaughlin JK, Blot WJ, Haber M, Preston-Martin S, etal. Dietary glutathione intake and the risk of oral and pharyngeal cancer. Am J Epidemiol 1994;139:453-65.

Goldstein AM, Blot WJ, Greenberg RS, Schoenberg JB, Austin DF, Preston-Martin S, Winn DM, Bernstein L,McLaughlin JK, Fraumeni, JF, Jr. Familial risk in oral and pharyngeal cancer. Eur J Cancer B Oral Oncol1994;30B:319-22.

Greenberg RS, Haber MJ, Clark WS, Brockman JE, Liff JM, Schoenberg JB, Austin DF, Preston-Martin S, Stemhagen A,Winn DM, et al. The relation of socioeconomic status to oral and pharyngeal cancer. Epidemiology 1991;2:194-200.

Gridley G, McLaughlin JK, Block G, Blot WJ, Winn DM, Greenberg RS, Schoenberg JB, Preston-Martin S, Austin DF,Fraumeni, JF, Jr. Diet and oral and pharyngeal cancer among blacks. Nutr Cancer 1990;14:219-25.

Henderson BE, Louie E. Discussion of risk factors for nasopharyngeal carcinoma. IARC Sci Publ 1978;20:251-60.

Henderson BE, Louie E, Bogdanoff E, Henle W, Alena B, Henle G. Antibodies to herpes group viruses in patientswith nasopharyngeal and other head and neck cancers. Cancer Res 1974;34:1207-10.

Henderson BE, Louie E, SooHoo Jing J, Buell P, Gardner MB. Risk factors associated with nasopharyngeal carcinoma.N Engl J Med 1976;295:1101-6.

Horn-Ross PL, Ljung BM, Morrow M. Environmental factors and the risk of salivary gland cancer. Epidemiology1997;8:414-9.

Horn-Ross PL, Morrow M, Ljung BM. Diet and the risk of salivary gland cancer. Am J Epidemiol 1997;146:171-6.

Horn-Ross PL, West DW, Brown SR. Recent trends in the incidence of salivary gland cancer. Int J Epidemiol1991;20:628-33.

Huebner WW, Schoenberg JB, Kelsey JL, Wilcox HB, McLaughlin JK, Greenberg RS, Preston-Martin S, Austin DF,Stemhagen A, Blot WJ, et al. Oral and pharyngeal cancer and occupation: a case-control study. Epidemiology1992;3:300-9.



OOOOORRRRRALALALALAL,,,,, H H H H HEEEEEADADADADAD,,,,, ANDANDANDANDAND N N N N NEEEEECKCKCKCKCK

Liu L, Deapen D, Bernstein L, Ross RK. Second cancers following oral and pharyngeal cancer: patients’ characteristics andsurvival patterns. Eur J Cancer B Oral Oncol 1994;30B:381-6.

Louie E, Henderson BE, Buell P, Jing JS, Menck HR, Pike MC. Selected observations on the epidemiology ofpharyngeal cancers. Natl Cancer Inst Monogr 1977;47:129-33.

Luce D, Gerin M, Morcet JF, Leclerc A. Sinonasal cancer and occupational exposure to textile dust. Am J Ind Med1997;32:205-10.

McLaughlin JK, Gridley G, Block G, Winn DM, Preston-Martin S, Schoenberg JB, Greenberg RS, Stemhagen A,Austin DF, Ershow AG, et al. Dietary factors in oral and pharyngeal cancer. J Natl Cancer Inst 1988;80:1237-43.

Pogoda JM, Preston-Martin S. Solar radiation, lip protection, and lip cancer risk in Los Angeles County women(California, United States). Cancer Causes Control 1996;7:458-63.

Preston-Martin S. Prior x-ray therapy for acne related to tumors of the parotid gland. Arch Dermatol 1989;125:921-4.

Preston-Martin S, Henderson BE, Bernstein L. Medical and dental x rays as risk factors for recently diagnosedtumors of the head. Natl Cancer Inst Monogr 1985;69:175-9.

Preston-Martin S, Thomas DC, White SC, Cohen D. Prior exposure to medical and dental x-rays related to tumorsof the parotid gland. J Natl Cancer Inst 1988;80:943-9.

Silverman S, Jr, Gorsky M. Epidemiologic and demographic update in oral cancer: California and national data -1973 to 1985. J Am Dental Assoc 1990;120:495-9.

Walton L, Silverman SJ, Costa CR. Epidemiology and Demographic Update in Oral Cancer: California 1973-1990.CA Dental Assoc J 1991;19:17-22.

Winn DM, Blot WJ, McLaughlin JK, Austin DF, Greenberg RS, Preston-Martin S, Schoenberg JB, Fraumeni, JF, Jr.Mouthwash use and oral conditions in the risk of oral and pharyngeal cancer. Cancer Res 1991;51:3044-7.

Yu MC, Ho JH, Ross RK, Henderson BE. Nasopharyngeal carcinoma in Chinese—salted fish or inhaled smoke?Prev Med 1981;10:15-24.

Yu MC, Ross RK. Risk factors in head and neck cancer. New Engl J Med 1982;307:54-5.

Yuan JM, Wang XL, Xiang YB, Gao YT, Ross RK, Yu MC. Non-dietary risk factors for nasopharyngeal carcinoma inShanghai, China. Int J Cancer 2000;85:364-9.

Yuan JM, Wang XL, Xiang YB, Gao YT, Ross RK, Yu MC. Preserved foods in relation to risk of nasopharyngealcarcinoma in Shanghai, China. Int J Cancer 2000;85:358-63.

Yuan JM, Wang XL, Xiang YB, Gao YT, Ross RK, Yu MC. Active and passive cigarette smoking in relation to nasopharyngealcarcinoma in Shanghai, China. Int J Cancer In Press.



OOOOOVVVVVARIANARIANARIANARIANARIAN C C C C CANANANANANCECECECECERRRRR

Casagrande JT, Pike MC, Henderson BE. Oral contraceptives and ovarian cancer [letter]. N Engl J Med 1983;308:843-4.

Cheng P, Schmutte C, Cofer KF, Felix JC, Yu MC, Dubeau L. Alterations in DNA methylation are early, but not initial,events in ovarian tumorigenesis. Br J Cancer 1997;75:396-402.

Gnagy S, Ming EE, Devesa SS, Hartge P, Whittemore AS. Declining ovarian cancer rates in U.S. women in relationto parity and oral contraceptive use. Epidemiology 2000;11:102-5.

Harris R, Whittemore AS, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 UScase-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative OvarianCancer Group. Am J Epidemiol 1992;136:1204-11.

Horn-Ross PL, Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborativeanalysis of 12 U.S. case-control studies. VI. Nonepithelial cancers among adults. Collaborative Ovarian CancerGroup. Epidemiology 1992;3:490-5.

Janezic SA, Ziogas A, Krumroy L, Kranser M, Plummer S, Barker D, Haile R, Casey G, Anton-Culver H. BRCA1 mutationsand polymorphisms in a population-based series of ovarian cancer. Human Molecular Genetics 1999;8:889-97.

Kerlikowske K, Brown JS, Grady DG. Should women with familial ovarian cancer undergo prophylactic oophorectomy?Obstet Gynecol 1992;80:700-7.

John EM, Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysisof seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian CancerGroup. J Natl Cancer Inst 1993;85:142-7.

Schlag RD, Harris D, Kwong S. Ovarian Cancer in California, 2001. Sacramento: California Department of HealthServices, Cancer Surveillance Section, 2001.

Walker AH, Ross RK, Haile RWC, Henderson BE. Hormonal factors and risk of ovarian germ cell cancer in youngwomen. Br J Cancer 1988;57:418-22.

Whittemore AS. Fertility drugs and risk of ovarian cancer. Hum Reprod 1993;8:999-1000.

Whittemore AS. Personal characteristics relating to risk of invasive epithelial ovarian cancer in older women inthe United States. Cancer 1993;71:558-65.

Whittemore AS, Harris R, Itnyre J, Halpern J. Characteristics relating to ovarian cancer risk: collaborative analysis of12 US case-control studies. I. Methods. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1175-83.

Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 UScase-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian CancerGroup. Am J Epidemiol 1992;136:1184-203.

Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 UScase-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group.Am J Epidemiol 1992;136:1212-20.

Whittemore AS, Wu ML, Paffenbarger RS, Jr, Sarles DL, Kampert JB, Grosser S, Jung DL, Ballon S, Hendrickson M. Personaland environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco,alcohol, and coffee. Am J Epidemiol 1988;128:1228-40.



PPPPPANANANANANCRECRECRECRECREAAAAASSSSS

OOOOOVVVVVARIANARIANARIANARIANARIAN C C C C CANANANANANCECECECECERRRRR

Whittemore AS, Wu ML, Paffenbarger RS, Jr, Sarles DL, Kampert JB, Grosser S, Jung DL, Ballon S, Hendrickson M, Mohle-Boetani J. Epithelial ovarian cancer and the ability to conceive. Cancer Res 1989;49:4047-52.

Wu ML, Whittemore AS, Paffenbarger RS, Jr, Sarles DL, Kampert JB, Grosser S, Jung DL, Ballon S, Hendrickson M, Mohle-Boetani J. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive andmenstrual events and oral contraceptive use. Am J Epidemiol 1988;128:1216-27.

Anderson KE, Potter JD, Mack TM. Pancreatic cancer. In: Schottenfeld D, Fraumeni J, eds. Cancer Epidemiologyand Prevention, 2nd Edition. New York: Oxford University Press, 1996:725-71.

Hiatt RA, Klatsky AL, Armstrong MA. Pancreatic cancer, blood glucose and beverage consumption. Int J Cancer1988;41:794-7.

Mack TM, Paganini-Hill A. Epidemiology of pancreas cancer in Los Angeles. Cancer 1981;47:1474-84.

Mack TM, Peters JM, Yu MC, Hanisch R, Wright WE, Henderson BE. Pancreas cancer is unrelated to the workplacein Los Angeles. Am J Ind Med 1985;7:253-66.

Mack TM, Yu MC, Hanisch R, Henderson BE. Pancreas cancer and smoking, beverage consumption, and pastmedical history. J Natl Cancer Inst 1986;76:49-60.

Mack TM. Current views on the epidemiology and etiology of pancreas cancer. In: Wanebo H, ed. PancreasCancer: Williams and Wilkins, In Press.

Shibata A, Mack TM, Paganini-Hill A, Ross RK, Henderson BE. A prospective study of pancreatic cancer in theelderly. Int J Cancer 1994;58:46-9.

Slebos RJ, Hoppin JA, Tolbert PE, Holly EA, Brock JW, Zhang RH, Bracci PM, Foley J, Stockton P, McGregor LM, Flake GP,Taylor JA. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmentalexposures in a population-based study. Cancer Epidemiol Biomarkers Prev 2000;9:1223-32.



PPPPPRRRRROOOOOSSSSSTTTTTAAAAATTTTTEEEEE C C C C CANANANANANCECECECECERRRRR

Albertsen PC, Hanley JA, Harlan LC, Gilliland FD, Hamilton A, Liff JM, Stanford JL, Stephenson RA. The positiveyield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population basedanalysis. J Urol 2000;163:1138-43.

Danley KL, Richardson JL, Bernstein L, Langholz B, Ross RK. Prostate cancer: trends in mortality and stage-specificincidence rates by racial/ethnic group in Los Angeles County, California (United States). Cancer Causes Control1995;6:492-8.

Delfino RJ, Ferrini RL, Taylor TH, Howe S, Anton-Culver H. Demographic differences in prostate cancer incidenceand stage: an examination of population diversity in California. Am J Prev Med 1998;14:96-102.

Devgan SA, Henderson BE, Yu MC, Shi CY, Pike MC, Ross RK, Reichardt JK. Genetic variation of 3 beta-hydroxysteroiddehydrogenase type II in three racial/ethnic groups: implications for prostate cancer risk. Prostate 1997;33:9-12.

Friedman GD, Hiatt RA, Quesenberry CP, Jr, Selby JV. Case-control study of screening for prostatic cancer bydigital rectal examinations [see comments]. Lancet 1991;337:1526-9.

Honda GD, Bernstein L, Ross RK, Greenland S, Gerkins V, Henderson BE. Vasectomy, cigarette smoking, and age atfirst sexual intercourse as risk factors for prostate cancer in middle-aged men. Br J Cancer 1988;57:326-31.

Hsieh CL, Oakley-Girvan I, Gallagher RP, Wu AH, Kolonel LN, Teh CZ, Halpern J, West DW, Paffenbarger RS, Jr.,Whittemore AS. Re: prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J NatlCancer Inst 1997;89:1893-4.

Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA. Association of prostate cancer risk withgenetic polymorphisms in vitamin D receptor and androgen receptor [see comments]. J Natl Cancer Inst1997;89:166-70.

Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are inlinkage disequilibrium in men with prostate cancer. Cancer Res 1995;55:1937-40.

John EM, Whittemore AS, Wu AH, Kolonel LN, Hislop TG, Howe GR, West DW, Hankin J, Dreon DM, Teh CZ, et al.Vasectomy and prostate cancer: results from a multiethnic case-control study [see comments]. J Natl CancerInst 1995;87:662-9.

Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR, John EM, Howe GR, Dreon DM, West DW,Paffenbarger RS, Jr. Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. CancerEpidemiol Biomarkers Prev 2000;9:795-804.

Liu L, Cozen W, Bernstein L, Ross RK, Deapen D. Changing relationship between socioeconomic status and pros-tate cancer incidence. J Natl Cancer Inst 2001;93:705-9.

Makridakis N, Ross RK, Pike MC, Chang L, Stanczyk FZ, Kolonel LN, Shi CY, Yu MC, Henderson BE, Reichardt JK. Aprevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase. Cancer Res1997;57:1020-2.

Mills PK, (ed). Prostate Cancer in California: A Special Report. Berkeley, CA: Public Health Institute, June 2000.

Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, Henderson BE. Evidence of an X-linked orrecessive genetic component to prostate cancer risk [see comments]. Nat Med 1995;1:827-9.

Morris CR, Snipes KP, Schlag RD, Wright WE. Sociodemographic factors associated with prostatectomy utilizationand concordance with the physician data query for prostate cancer (United States). Cancer Causes Control1999;10:503-11.



Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, Eley JW, Stephenson RA, Harlan LC. Healthoutcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.J Natl Cancer Inst 2000;92:1582-92.

Reichardt JK, Makridakis N, Henderson BE, Yu MC, Pike MC, Ross RK. Genetic variability of the human SRD5A2gene: implications for prostate cancer risk. Cancer Res 1995;55:3973-5.

Robbins AS, Whittemore AS, Thom DH. Differences in socioeconomic status and survival among white and blackmen with prostate cancer. Am J Epidemiol 2000;151:409-16.

Ross RK. Epidemiology of prostate cancer: Prospects for prevention. Accomplishments in Cancer Research 1992General Motors Cancer Research Foundation: J.P. Lippincott, 1992:219-28.

Ross RK, Paganini-Hill A, Henderson BE. The etiology of prostate cancer: what does the epidemiology suggest?Prostate 1983;4:333-44.

Ross RK, Paganini-Hill A, Henderson BE. Epidemiology of prostate cancer. In: Skinner DG, ed. Urological Cancer:Grune & Stratton, Inc., 1983:1-19.

Ross RK, Paganini-Hill A, Henderson BE. Epidemiology of prostatic cancer. In: Skinner D, Lieskovsky G, eds. Diag-nosis and Management of Genitourinary Cancer. Philadelphia: W.B. Saunders & Co., 1988:40-45.

Ross RK, Schottenfeld D. Prostate cancer. In: Schottenfeld D, Fraumeni JF, Jr, eds. Cancer Epidemiology andPrevention, 2nd Edition. New York: Oxford University Press, 1996:1022-39.

Schmid HP, Stamey TA, McNeal JE, Freiha FS, Redwine EA, Whittemore AS. [Effect of the natural history on managementof adenocarcinoma of the prostate]. Urologe A 1994;33:144-8.

Shibata A, Whittemore AS, Imai K, Kolonel LN, Wu AH, John EM, Stamey TA, Paffenbarger RS. Serum levels of prostate-specific antigen among Japanese-American and native Japanese men. J Natl Cancer Inst 1997;89:1716-20.

Shimizu H, Ross RK, Bernstein L. Possible underestimation of the incidence rate of prostate cancer in Japan. Jpn J CancerRes 1991;82:483-5.

Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP. Localized Prostate Cancer. Relationship ofTumor Volume to Clinical Significance for Treatment of Prostate Cancer. Cancer 1993;71:933-8.

Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, Albertsen PC, Harlan LC, Potosky AL.Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The ProstateCancer Outcomes Study. JAMA 2000;283:354-60.

Thomas DB, Kolonel LN, Ross RK, Thompson DJ. Proposal for a collaborative epidemiology study of prostatecancer in the Pacific Basin. Natl Cancer Inst Monogr 1982;62:151-5.

Vatten LJ, Ursin G, Ross RK, Stanczyk FZ, Lobo RA, Harvei S, Jellum E. Androgens in serum and the risk of prostatecancer: a nested case-control study from the Janus serum bank in Norway. Cancer Epidemiol Biomarkers Prev1997;6:967-9.

Whittemore AS, Keller JB, Betensky R. Low-grade, latent prostate cancer volume: predictor of clinical cancerincidence? [see comments]. J Natl Cancer Inst 1991;83:1231-5.

Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, Burch JD, Hankin J, Dreon DM, West DW, etal. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in theUnited States and Canada [see comments]. J Natl Cancer Inst 1995;87:652-61.




SSSSSTTTTTOOOOOMAMAMAMAMACHCHCHCHCH C C C C CANANANANANCECECECECERRRRR


Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh CZ, Stamey T. Family historyand prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol1995;141:732-40.

Wu AH, Whittemore AS, Kolonel LN, John EM, Gallagher RP, West DW, Hankin J, Teh CZ, Dreon DM, PaffenbargerRS, Jr. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev1995;4:735-41.

Xu J. Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancerfamilies from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet 2000;66:945-57.

Xue W, Irvine RA, Yu MC, Ross RK, Coetzee GA, Ingles SA. Susceptibility to prostate cancer: interaction betweengenotypes at the androgen receptor and prostate-specific antigen loci. Cancer Res 2000;60:839-41.

Young JL, Snipes KP, Perkins CI, Wright WE. Prostate Cancer: The Relationship among Incidence, Treatment andStaging. J of Registry Management 1995;22:21-5.

SSSSSARARARARARCCCCCOOOOOMAMAMAMAMAHolly EA, Aston DA, Ahn DK, Kristiansen JJ. Ewing’s bone sarcoma, paternal occupational exposure, and other

factors. Am J Epidemiol 1992;135:122-9.

Mack TM. Sarcomas and other malignancies of soft tissue, retroperitoneum, peritoneum, pleura, heart, mediastinum,and spleen. Cancer 1995;75:211-44.

Operskalski EA, Preston-Martin S, Henderson BE, Visscher BR. A case-control study of osteosarcoma in youngpersons. Am J Epidemiol 1987;126:118-26.

Bernstein L, Wu A. Adenocarcinoma at the EGJ: What is the role of dietary intake in their development? In: GuiliR, Tytgat T, DeMeester T, Glamiche J, eds. The Esophagogastric Junction. Amsterdam: Elsevier.

Bernstein L. What are the epidemiologic similaritites and differences between carcinomas arising in Barrett’smucosa and in the gastric cardia? In: Guili R, Galmiche JP, Jamieson GG, Scarpignato C, eds. Barrett’s Esopha-gus. Amsterdam: Elsevier, In Press.

Ross RK, Hartnett NM, Bernstein L, Henderson BE. Epidemiology of adenocarcinomas of the small intestine: isbile a small bowel carcinogen? Br J Cancer 1991;63:143-5.

Shimizu H, Mack TM, Ross RK, Henderson BE. Cancer of the gastrointestinal tract among Japanese and whiteimmigrants in Los Angeles County. J Natl Cancer Inst 1987;78:223-8.

Theuer CP, Nastanski F, Butler JA, Anton-Culver H. Signet-ring cell histology is associated with unique clinicalfeatures but does not affect gastric-cancer survival: a population-based multivariate analysis of more than3,000 cases. Am Surgeon 1999;65:915-21.



TTTTTESTISESTISESTISESTISESTIS

Theuer CP. Asian gastric cancer patients at a Southern California comprehensive cancer center are diagnosedwith less advanced disease and have superior stage-stratified survival. Am Surg 2000;66:821-6.

Theuer CP, Anton-Culver H. Important prognostic factor in patients with gastric cancer. West J Med 1998;169:254.

Theuer CP, Kurosaki T, Ziogas A, Butler J, Anton-Culver H. Asian patients with gastric carcinoma in the UnitedStates exhibit unique clinical features and superior overall and cancer specific survival rates. Cancer2000;89:1883-92.

Wright WE, Bernstein L, Peters JM, Garabrant DH, Mack TM. Adenocarcinoma of the stomach and exposure tooccupational dust. Am J Epidemiol 1988;128:64-73.

Wu AH, Yu MC, Mack TM. Smoking, alcohol use, dietary factors and risk of small intestinal adenocarcinoma. Int JCancer 1997;70:512-7.

Wu-Williams AH, Yu MC, Mack TM. Life-style, workplace, and stomach cancer by subsite in young men of LosAngeles County. Cancer Res 1990;50:2569-76.

SSSSSTTTTTOOOOOMAMAMAMAMACHCHCHCHCH C C C C CANANANANANCECECECECERRRRR

Depue R, Pike MC, Henderson BE. Estrogen exposure during gestation and risk of cancer of the testis. J NatlCancer Inst 1983;71:1151-55.

Henderson BE, Benton B, Jing J, Yu MC, Pike MC. Risk factors for cancer of the testis in young men. Int J Cancer1979;23:598-602.

Henderson BE, Ross RK, Pike MC. Epidemiology of testicular cancer. In: Skinner D, Lieskovsky G, eds. Diagnosisand Management of Genitourinary Cancer. Philadelphia: W.B. Saunders & Co., 1988:46-51.

Henderson BE, Ross RK, Pike MC, Depue R. Epidemiology of testis cancer. In: Skinner D, ed. Urological Cancer:Grune & Stratton, Inc., 1983:237-50.

Henderson BE, Ross RK, Yu MC, Bernstein L. An explanation for the increasing incidence of testis cancer: de-creasing age at first full-term pregnancy [letter]. J Natl Cancer Inst 1997;89:818-20.

Kolonel LN, Ross RK, Thomas DB, Thompson DJ. Epidemiology of testicular cancer in the Pacific Basin. Natl CancerInst Monogr 1982;62:157-60.



TTTTTHYROIDHYROIDHYROIDHYROIDHYROID

Blot WJ, Le Marchand L, Boice JD, Jr., Henderson BE. Thyroid cancer in the Pacific [letter]. J Natl Cancer Inst1997;89:90-1.

Bosetti C, Kolonel L, Negri E, Ron E, Franceschi S, Dal Maso L, Galanti MR, Mark SD, Preston-Martin S, McTiernan A, LandC, Jin F, Wingren G, Hallquist A, Glattre E, Lund E, Levi F, Linos D, La Vecchi C. A pooled analysis of case-control studiesof thyroid cancer. VI. Fish and shellfish consumption. Cancer Causes Control 2001;12:375-82.

Dal Maso L, La Vecchia C, Franceschi S, Preston-Martin S, Ron E, Levi F, Mack W, Mark SD, McTiernan A, Kolonel L,Mabuchi K, Jin F, Wingren G, Galanti MR, Hallquist A, Glattre E, Lund E, Linos D, Negri E. A pooled analysis ofthyroid cancer studies. V. Anthropometric factors. Cancer Causes Control 2000;11:137-44.

Franceschi S, Preston-Martin S, Dal Maso L, Negri E, La Vecchia C, Mack WJ, McTiernan A, Kolonel L, Mark SD,Mabuchi K, Jin F, Wingren G, Galanti MR, Hallquist A, Glattre E, Lund E, Levi F, Linos D, Ron E. A pooled analysisof case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control 1999;10:583-95.

Haselkorn T, Bernstein L, Preston-Martin S, Cozen W, Mack WJ. Descriptive epidemiology of thyroid cancer in LosAngeles County, 1972-1995. Cancer Causes Control 2000;11:163-70.

Preston-Martin S, Bernstein L, Pike MC, Maldonado AA, Henderson BE. Thyroid cancer among young womenrelated to prior thyroid disease and pregnancy history. Br J Cancer 1987;55:191-5.

Preston-Martin S, Menck HR. The epidemiology of thyroid cancer in Los Angeles County. West J Med1979;131:369-72.

Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, Harris BS, III, Hoffman DA, McConahey WM, MaxonHR, Preston-Martin S, Warshauer ME, Wong FL, Boice JD, Jr. Cancer mortality following treatment for adulthyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 1998;280:347-55.

BBBBBYYYYY AAAAAUTUTUTUTUTHHHHHOOOOORRRRRSSSSS



AAAAABreast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast

cancer and 100,239 women without breast cancer from 54 epidemiological studies. Collaborative Group on HormonalFactors in Breast Cancer. Lancet 1996;347:1713-27.

Albertsen PC, Hanley JA, Harlan LC, Gilliland FD, Hamilton A, Liff JM, Stanford JL, Stephenson RA. The positive yieldof imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis.J Urol 2000;163:1138-43.

Aldape K, Simmons ML, Davis RL, Miike R, Wiencke J, Barger G, Lee M, Chen P, Wrensch M. Discrepancies in diag-noses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study. Cancer 2000;88:2342-9.

Allen M, Perkins CI, Wright WE. Using Medicare administrative files to evaluate case ascertainment in a centralcancer registry. J Registry Management 1998;25:13-6.

Anderson KE, Potter JD, Mack TM. Pancreatic cancer. In: Schottenfeld D, Fraumeni J, eds. Cancer Epidemiology andPrevention, 2nd Edition. New York: Oxford University Press, 1996:725-71.

Anthone G, Brophy M, Fals J, Vukasin P, Ortega A, Ross RK, Beart RW. Does designated surgical interest improve thesurgical management of colorectal cancer? Dis Colon Rectum In Press.

Anton-Culver H. Epidemiologic Assessment of Cancer Risk: Application from the Cancer Surveillance Program of OrangeCounty. J Am College of Toxicol 1989;8:933-40.

Anton-Culver H. Cancer Incidence and Mortality in San Diego and Imperial Counties, 1988-1990, 1991-1993. Irvine:Cancer Surveillance Program of Orange County/San Diego Imperial Organization for Cancer Control, 1996.

Anton-Culver H. Cancer prevention strategies: use of cancer prevention research registries. Environ Health Perspect1995;103 Suppl 8:237-9.

Anton-Culver H. Smoking and other risk factors associated with the stage and age of diagnosis of colon andrectum cancers. Cancer Detect Prev 1991;15:345-50.

Anton-Culver H, Bloss JD, Bringman D, Lee-Feldstein A, DiSaia P, Manetta A. Comparison of adenocarcinoma andsquamous cell carcinoma of the uterine cervix: a population-based epidemiologic study. Am J Obstet Gynecol1992;166:1507-14.

Anton-Culver H, Cinar P, Taylor TH, Bringman D, Rowley K, Leach S, Robles Y. Cancer Incidence and Mortality in SanDiego and Imperial Counties, 1994-1998. Irvine: Cancer Surveillance Program of Orange County/San Diego Im-perial Organization for Cancer Control, Epidemiology Division, Department of Medicine, University of California,Irvine, 2001.

Anton-Culver H, Cohen PF, Gildea ME, Ziogas A. Characteristics of BRCA1 mutations in a population-based caseseries of breast and ovarian cancer. Eur J Cancer 2000;36:1200-8.

Anton-Culver H, Culver BD, Kurosaki T, Osann KE, Lee JB. Incidence of lung cancer by histological type from apopulation-based registry. Cancer Res 1988;48:6580-3.

Anton-Culver H, Kurosaki T, Taylor TH, Gildea M, Brunner D, Bringman D. Validation of Family History of Breast Cancerand Identification of the BRCA1 and Other Syndromes Using a Population-Based Cancer Registry. Genetic Epidemiol1996;13:193-205.

Anton-Culver H, Lee-Feldstein A, Taylor TH. The association of bladder cancer risk with ethnicity, gender, and smoking. AnnEpidemiol 1993;3:429-33.



AAAAA-----BBBBBAnton-Culver H, Taylor TH, Bringman D, Leach S, Rowley K, Brunner D, Realo P. Cancer Incidence and Mortality in San Diego

and Imperial Counties, 1990-1994. Irvine, CA: Cancer Surveillance Program of Orange County/San Diego ImperialOrganization for Cancer Control, 1997.

Anton-Culver H, Taylor TH, Bringman D, Rowley K, Cinar P, Leach S, Realo P. Cancer Incidence and Mortality in SanDiego and Imperial Counties, 1993-1997. Irvine: Cancer Surveillance Program of Orange County/San Diego Im-perial Organization for Cancer Control, Epidemiology Division, Department of Medicine, University of California,Irvine, 2000.

Anton-Culver H, Taylor TH, Bringman D, Rowley K, Jeffries C, Realo P. Cancer Incidence and Mortality in San Diegoand Imperial Counties, 1991-1995. Irvine: Cancer Surveillance Program of Orange County/San Diego ImperialOrganization for Cancer Control, 1998.

Anton-Culver H, Taylor TH, Bringman D, Rowley K, Leach S, Realo P. Cancer Incidence and Mortality in OrangeCounty, 1992-1996. Irvine: Cancer Surveillance Program of Orange County/San Diego Imperial Organization forCancer Control, 1999.

Armstrong BG, Whittemore AS, Howe GR. Analysis of case-control data with covariate measurement error: applica-tion to diet and colon cancer. Stat Med 1989;8:1151-63; 1165-6.

Astin JA, Anton-Culver H. Sense of control and adjustment to breast cancer: the importance of balancing controlcoping styles. Beh Med 1999.

Austin DF, Reynolds P, Boyd PT, Swain BE, Chiang M. Progress in the war against cancer [letter]. N Engl J Med1989;321:1197-8.

Barker DF, Almeida ER, Casey G, Fain PR, Liao SY, Masunaka I, Noble B, Kurosaki T, Anton-Culver H. BRCA1 R841W: astrong candidate for a common mutation with moderate phenotype. Genet Epidemiol 1996;13:595-604.

Bentley JR, Delfino RJ, Taylor TH, Howe S, Anton-Culver H. Differences in breast cancer stage at diagnosis betweennon-Hispanic white and Hispanic populations, San Diego County 1988-1993. Breast Cancer Res Treat 1998;50:1-9.

Benton B, Henderson BE. Environmental exposure and bladder cancer in young males. J Natl Cancer Inst 1973;51:269-70.

Bernstein JL, Thompson WD, Risch N, Holford TR. Risk factors predicting the incidence of second primary breastcancer among women diagnosed with a first primary breast cancer. Am J Epidemiol 1992;136:925-36.

Bernstein JL, Thompson WD, Risch N, Holford TR. The genetic epidemiology of second primary breast cancer. Am JEpidemiol 1992;136:937-48.

Bernstein L. La epidemiologia del cancer de mama. Medico Interamericano 1997;16:597-99.

Bernstein L. The incidence of adenocarcinoma of the esophagus is currently increasing and accounts for 50% ofesophageal carcinomas in some series. In: Guili R, Tytgat TNJ, DeMeester TR, Galmiche JP, eds. The EsophagealMucosa. Amsterdam: Elsevier, 1994:1059-65.

Bernstein L. What are the epidemiologic similaritites and differences between carcinomas arising in Barrett’smucosa and in the gastric cardia? In: Guili R, Galmiche JP, Jamieson GG, Scarpignato C, eds. Barrett’s Esophagus.Amsterdam: Elsevier, In Press.

Bernstein L, Deapen D, Ross RK. Mycosis fungoides. JAMA 1989;261:1882.

Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast.Cancer 1993;71:3020-4.



BBBBBBernstein L, Flannery J, Reynolds P. Cancer in Italian migrant populations. The United States of America. IARC Sci Publ

1993;123:67-94.

Bernstein L, Hanisch R, Sullivan-Halley J, Ross RK. Treatment with human chorionic gonadotropin and risk of breast cancer.Cancer Epidemiol Biomarkers Prev 1995;4:437-40.

Bernstein L, Henderson BE. Exogenous hormones. In: Schottenfeld D, Fraumeni JF, Jr, eds. Cancer Epidemiology andPrevention, 2nd Edition. New York: Oxford University Press, 1996:462-88.

Bernstein L, Henderson BE, Hanisch R, Sullivan-Halley J, Ross RK. Physical exercise and reduced risk of breast cancerin young women. J Natl Cancer Inst 1994;86:1403-8.

Bernstein L, Levin D, Menck H, Ross RK. AIDS-related secular trends in cancer in Los Angeles County men: a com-parison by marital status. Cancer Res 1989;49:466-70.

Bernstein L, Miu A, Monroe K, Henderson BE, Ross RK. Cancer incidence among Filipinos in Los Angeles County,1972-1991. Int J Cancer 1995;63:345-8.

Bernstein L, Newton P, Ross RK. Epidemiology of hairy cell leukemia in Los Angeles County. Cancer Res 1990;50:3605-9.

Bernstein L, Pike MC, Krailo M, Henderson BE. Update of the Los Angeles study of oral contraceptives and breast cancer:1981 and 1983. In: Mann R, ed. Oral Contraceptives and Breast Cancer. London: Parthenon Press in Association with TheRoyal Society of Medicine, 1990.

Bernstein L, Pike MC, Ross RK, Henderson BE. Age at menarche and estrogen concentrations of adult women.Cancer Causes Control 1991;2:221-5.

Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993;15:48-65.

Bernstein L, Ross RK. Prior medication use and health history as risk factors for non-Hodgkin’s lymphoma: prelimi-nary results from a case-control study in Los Angeles County. Cancer Res 1992;52:5510s-15s.

Bernstein L, Ross RK, Henderson BE. Cancer prevention: Hormones. In: Devita V, Hellman S, Rosenberg SA, eds.Cancer Principles and Practices of Oncology, 5th Edition. Philadelphia: Lippincott-Raven Press, 1997:609-17.

Bernstein L, Ross RK, Henderson BE. Relationship of hormone use to cancer risk. J Natl Cancer Inst Monogr1992;12:137-47.

Bernstein L, Ross RK, Pike MC, Casagrande JT, Henderson BE. Urinary estrogens and male-to-female breast cancerratios. Int J Cancer 1989;44:954-6.

Bernstein L, Sullivan-Halley J, Krailo MD, Hammond GD. Trends in patterns of treatment of childhood cancer in LosAngeles County. Cancer 1993;71:3222-8.

Bernstein L, Wu A. Adenocarcinoma at the EGJ: What is the role of dietary intake in their development? In: Guili R,Tytgat T, DeMeester T, Glamiche J, eds. The Esophagogastric Junction. Amsterdam: Elsevier.

Bernstein L, Wu HT. Colon and rectal cancer among Asian Americans and Pacific Islanders. Asian Am Pac Island JHealth In Press.

Bernstein L, Yuan JM, Ross RK, Pike MC, Hanisch R, Lobo R, Stanczyk F, Gao YT, Henderson BE. Serum hormone levelsin pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancercase-control studies. Cancer Causes Control 1990;1:51-8.



BBBBBBlake C, Tsao JL, Wu A, Shibata D. Stepwise deletions of polyA sequences in mismatch repair-deficient colorectal cancers.

Am J Pathol 2001;158:1867-70.

Blanco D, Ross RK, Paganini-Hill A, Henderson BE. Cholecystectomy and colonic cancer. Dis Colon Rectum 1984;27:290-2.

Bloom JR, Grazier K, Hodge F, Hayes WA. Factors affecting the use of screening mammography among AfricanAmerican women. Cancer Epidemiol Biomarkers Prev 1991;1:75-82.

Blot WJ, Le Marchand L, Boice JD, Jr., Henderson BE. Thyroid cancer in the Pacific [letter]. J Natl Cancer Inst 1997;89:90-1.

Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, StemhagenA, Fraumeni JF, Jr. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988;48:3282-7.

Blowers L, Preston-Martin S, Mack WJ. Dietary and other lifestyle factors of women with brain gliomas in LosAngeles County (California, USA). Cancer Causes Control 1997;8:5-12.

Boice JD, Jr, Blettner M, Kleinerman RA, Engholm G, Stovall M, Lisco H, Austin DF, Bosch A, Harlan L, Krementz ET, etal. Radiation dose and breast cancer risk in patients treated for cancer of the cervix [published erratum appearsin Int J Cancer 1991 Jul;127(1):118]. Int J Cancer 1989;44:7-16.

Boice JD, Jr, Engholm G, Kleinerman RA, Blettner M, Stovall M, Lisco H, Moloney WC, Austin DF, Bosch A, Cookfair DL, etal. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 1988;116:3-55.

Boivin JF, Hutchison GB, Zauber AG, Bernstein L, Davis FG, Michel RP, Zanke B, Tan CT, Fuller LM, Mauch P, et al.Incidence of second cancers in patients treated for Hodgkin’s disease [see comments]. J Natl Cancer Inst1995;87:732-41.

Bond GG, Austin DF, Gondek MR, Chiang M, Cook RR. Use of a population-based tumor registry to estimate cancerincidence among a cohort of chemical workers. J Occup Med 1988;30:443-8.

Bosetti C, Kolonel L, Negri E, Ron E, Franceschi S, Dal Maso L, Galanti MR, Mark SD, Preston-Martin S, McTiernan A,Land C, Jin F, Wingren G, Hallquist A, Glattre E, Lund E, Levi F, Linos D, La Vecchi C. A pooled analysis of case-controlstudies of thyroid cancer. VI. Fish and shellfish consumption. Cancer Causes Control 2001;12:375-82.

Bowman JD, Garabrant DH, Sobel E, Peters JM. Exposures to extremely low frequency (ELF) electromagnetic fieldsin occupations with elevated leukemia rates. Appl Indust Hyg 1988;3:189-94.

Bowman JD, Sobel E, London SJ, Thomas DC, Garabrant DH, Pearce N, Peters JM. Electric and magnetic field exposures,chemical exposures in leukemia risk in “electrical” occupations: Electric Power Research Institute 1992:799-827.

Bowman JD, Thomas DC, London SJ, Peters JM. Hypothesis: the risk of childhood leukemia is related to combina-tions of power-frequency and static magnetic fields. Bioelectromagnetics 1995;16:48-59.

Boyer-Chammard A, Taylor TH, Anton-Culver H. Survival differences in breast cancer among racial/ethnic groups: apopulation-based study. Cancer Detection and Prev 1999;23:463-73.

Brewster WR, DiSaia PJ, Monk BJ, Ziogas A, Yamada SK, Anton-Culver H. Young age as a prognostic factor in cervicalcancer: results of a population-based study. J Am Obstet Gynecol 1999.

Brewster WR, Monk BJ, Ziogas A, Anton-Culver H, Yamada SD, Berman ML. Intent-to-treat analysis of stage Ib and IIa cervicalcancer in the United States: radiotherapy or surgery 1988-1995. Obstet Gynecol 2001;97:248-54.

Buckley J. Choriocarcinoma. In: Schottenfeld D, Fraumeni J, eds. Cancer Epidemiology and Prevention, 2nd Edition. NewYork: Oxford University Press, 1996:1130-41.



BBBBB-----CCCCCBuckley JD, Henderson BE, Morrow CP, Hammond CB, Kohorn EI, Austin DF. Case-control study of gestational choriocarci-

noma. Cancer Res 1988;48:1004-10.

Buckley JD, Sather H, Ruccione K, Rogers PC, Haas JE, Henderson BE, Hammond GD. A case-control study of riskfactors for hepatoblastoma. A report from the Childrens Cancer Study Group. Cancer 1989;64:1169-76.

Bunin G, Surawicz T, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology ofcraniopharygioma. Neurosurgical Focus 1997;3.

Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, Wilczynski SP. Human papillomavirus type18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 1996;88:1361-8.

Burger RA, Monk BJ, Van Nostrand KM, Greep N, Anton-Culver H, Manetta A. Single-visit program for cervical cancerprevention in a high-risk population. Obstet Gynecol 1995;86:491-8.










California Cancer Registry, American Cancer Society. California Cancer Facts and Figures 2002. Oakland, CA: AmericanCancer Society, 2001.



Campleman SL, Dryden M. Cancer in Northern California, 1988-1998. Chico: Cancer Registry of Northern California, 2001.

Campleman SL, Dryden M, Curtis RL. Cancer in Northern California, 1988-1999. Chico: Cancer Registry of Northern California,2001.



CCCCCCampleman SL, Schlag RD, Perkins CI, Glazer E, Kwong SL, Cress RD, Wright WE. Childhood Cancer in California 1988-1994.

Sacramento: California Department of Health Services, Cancer Surveillance Section, 1999.

Carozza SE, Wrensch M, Miike R, Newman B, Olshan AF, Savitz DA, Yost M, Lee M. Occupation and adult gliomas. Am JEpidemiol 2000;152:838-46.

Carpenter CL, Jarvik ME, Morgenstern H, McCarthy WJ, London SJ. Mentholated cigarette smoking and lung-cancer risk.Ann Epidemiol 1999;9:114-20.

Carpenter CL, Morgenstern H, London SJ. Alcoholic beverage consumption and lung cancer risk among residents of LosAngeles County. J Nutr 1998;128:694-700.

Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L. Lifetime exercise activity and breast cancer risk among post-meno-pausal women. Br J Cancer 1999;80:1852-8.

Casagrande J, Gerkins V, Henderson BE, Mack T, Pike MC. Exogenous estrogens and breast cancer in women with naturalmenopause. J Natl Cancer Inst 1976;56:839-41.

Casagrande JT, Hanisch R, Pike MC, Ross RK, Brown JB, Henderson BE. A case-control study of male breast cancer. Cancer Res1988;48:1326-30.

Casagrande JT, Pike MC, Henderson BE. Oral contraceptives and ovarian cancer [letter]. N Engl J Med 1983;308:843-4.

Castelao JE, Yuan JM, Gago-Dominguez M, Yu MC, Ross RK. Non-steroidal anti-inflammatory drugs and bladder cancerprevention. Br J Cancer 2000;82:1364-9.

Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Yu MC, Ross RK. Gender-and smoking-related bladder cancer risk. J Natl Cancer Inst 2001;4:538-45.

Cheng P, Schmutte C, Cofer KF, Felix JC, Yu MC, Dubeau L. Alterations in DNA methylation are early, but not initial, eventsin ovarian tumorigenesis. Br J Cancer 1997;75:396-402.

Chen P, Wiencke J, Aldape K, Kesler-Diaz A, Miike R, Kelsey K, Lee M, Liu J, Wrensch M. Association of an ERCC1 polymor-phism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev 2000;9:843-7.

Chen P, Wiencke JK, Conway K, Edmiston SN, Miike R, Wrensch M. Lack of association of rare alleles in the HRAS variablenumber of tandem repeats (VNTR) region with adult glioma. Neuro-oncol 2000;2:120-4.

Chow WH, McLaughlin JK, Menck HR, Mack TM. Risk factors for extrahepatic bile duct cancers: Los Angeles County,California (USA). Cancer Causes Control 1994;5:267-72.

Chu KC, Tarone RE, Chow WH, Hankey BF, Ries LA. Temporal patterns in colorectal cancer incidence, survival, and mortalityfrom 1950 through 1990 [see comments]. J Natl Cancer Inst 1994;86:997-1006.

Cicioni C, London SJ, Garabrant DH, Bernstein L, Phillips K, Peters JM. Occupational asbestos exposure and mesothelioma risk inLos Angeles County: application of an occupational hazard survey job-exposure matrix. Am J Ind Med 1991;20:371-9.

Clarke CA, Glaser SL, Dorfman RF, Mann R, DiGiuseppe JA, Prehn AW, Ambinder RF. Epstein-Barr virus and survival afterHodgkin disease in a population-based series of women. Cancer 2001;91:1579-87.

Coates RJ, Bransfield DD, Wesley M, Hankey B, Eley JW, Greenberg RS, Flanders D, Hunter CP, Edwards BK, Forman M, et al.Differences between black and white women with breast cancer in time from symptom recognition to medicalconsultation. Black/White Cancer Survival Study Group. J Natl Cancer Inst 1992;84:938-50.



CCCCCCohn B, Cirillo P, Yen I, Roffers S, Austin D, Reynolds P. Gender differences by site and age suggest menopause may impact

survival for cutaneous melanoma. Am J Epidemiol 1996;143.

Cote TR, Manns A, Hardy CR, Yellin FJ, Hartge P. Epidemiology of brain lymphoma among people with or without acquiredimmunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 1996;88:675-9.

Cote TR, O’Brien TR, Ward JW, Wilson SE, Blattner WA. AIDS and cancer registry linkage: measurement and enhancement ofregistry completeness. The National AIDS/Cancer Match Study Group. Prev Med 1995;24:375-7.

Courtney JG, Longnecker MP, Peters RK. Psychosocial aspects of work and the risk of colon cancer. Epidemiology1996;7:175-81.

Cowling DL, Kwong S, Schlag RD, Lloyd JC, Bal DG. Decline in Lung Cancer Rates-California, 1988-1997. MMWR2000;49:1066-9.

Cozen W, Katz J, Mack TM. Risk patterns of Hodgkin’s disease in Los Angeles vary by cell type. Cancer Epidemiol BiomarkersPrev 1992;1:261-8.

Craig JR, Klatt EC, Yu MC. Role of cirrhosis and the development of HCC: Evidence from histologic studies and largepopulation studies. In: Tabor E, Di Bisceglie AM, Purcell RH, eds. Etiology, Pathology, and Treatment of HepatocelluarCarcinoma in North America. Houston: Portofolio Publishing Co., 1991:177-90.

Cress RD, Creech C, Caggiano V. Cancer Incidence and Mortality in the Sacramento Region, 1988-1997. Sacramento:Cancer Surveillance Program, Region 3, 2000.

Cress RD, Davidson-Allen K, Caggiano V. Cancer Incidence in the Sacramento Region, 1988-1995. Sacramento: CancerSurveillance Program, Region 3, 1998.

Cress RD, Davidson-Allen K, Caggiano V. Cancer Incidence in the Sacramento Region,1988-1996. Sacramento: CancerSurveillance Program, Region 3, 1999.

Cress RD, Davidson-Sawyer K. Cancer of the colon and rectum in California: Anatomic site and stage at diagnosis by genderand race/ethnicity. J Registry Management 1997;24:120-24.

Cress RD, Davidson-Sawyer K. Conversion from SEER Extent of Disease to AJCC Stage Grouping. J Registry Management1999;26:89-91.

Cress RD, Davidson-Sawyer K. Cutaneous melanoma among Hispanic and non-Hispanic white men and women in Califor-nia, 1988-1993. J Registry Management 1996;23:24-27.



Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: ananalysis of California Cancer Registry data, 1988-93. J Registry Management 1997;23:24-27.

Cress RD, Holly EA, Ahn DK. Cutaneous melanoma in women. V. Characteristics of those who tan and those who burn whenexposed to summer sun. Epidemiol 1995;6:538-43.

Cress RD, Holly EA, Ahn DK, Kristiansen JJ, Aston DA. Contraceptive use among women smokers and nonsmokers inthe San Francisco Bay area. Prev Med 1994;23:181-9.



CCCCC-----DDDDDCress RD, Holly EA, Ahn DK, LeBoit PE, Sagebiel RW. Cutaneous melanoma in women: anatomic distribution in relation to

sun exposure and phenotype. Cancer Epidemiol Biomarkers Prev 1995;4:831-6.

Cress RD, Holly EA, Aston DA, Ahn DK, Kristiansen JJ. Characteristics of women nonsmokers exposed to passivesmoke. Prev Med 1994;23:40-7.

Cress RD, Morris CR, Wolfe BM. Cancer of the colon and rectum in California: trends in incidence by race/ethnicity,stage, and subsite. Prev Med 2000;31:447-53.

Curtis RE, Boice JD, Jr, Stovall M, Bernstein L, Greenberg RS, Flannery JT, Schwartz AG, Weyer P, Moloney WC, Hoover RN.Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 1992;326:1745-51.

Curtis RE, Boice JD, Jr, Stovall M, Bernstein L, Holowaty E, Karjalainen S, Langmark F, Nasca PC, Schwartz AG, SchymuraMJ, et al. Relationship of leukemia risk to radiation dose following cancer of the uterine corpus. J Natl Cancer Inst1994;86:1315-24.

Dal Maso L, La Vecchia C, Franceschi S, Preston-Martin S, Ron E, Levi F, Mack W, Mark SD, McTiernan A, Kolonel L,Mabuchi K, Jin F, Wingren G, Galanti MR, Hallquist A, Glattre E, Lund E, Linos D, Negri E. A pooled analysis of thyroidcancer studies. V. Anthropometric factors. Cancer Causes Control 2000;11:137-44.

Daly AK, Leathart JB, London SJ, Idle JR. An inactive cytochrome P450 CYP2D6 allele containing a deletion and abase substitution. Hum Genet 1995;95:337-41.

Danley KL, Richardson JL, Bernstein L, Langholz B, Ross RK. Prostate cancer: trends in mortality and stage-specificincidence rates by racial/ethnic group in Los Angeles County, California (United States). Cancer Causes Control1995;6:492-8.

Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis: xenoestrogens as preventablecauses of breast cancer. Environ Health Perspect 1993;101:372-7.

Davis F, Preston-Martin S. Epidemiology — Incidence and survival in central nervous system neoplasia. In: BignerDD, ed. Russell and Rubenstein’s Pathology of Tumors of the Nervous System, 6th Edition. London: Edward ArnoldPublishers, Ltd., In Press.

Day GL, Blot WJ, Austin DF, Bernstein L, Greenberg RS, Preston-Martin S, Schoenberg JB, Winn DM, McLaughlin JK,Fraumeni JF, Jr. Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco, and other determinants.J Natl Cancer Inst 1993;85:465-73.

Day GL, Blot WJ, Shore RE, McLaughlin JK, Austin DF, Greenberg RS, Liff JM, Preston-Martin S, Sarkar S, SchoenbergJB, et al. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst1994;86:131-7.

Day GL, Shore RE, Blot WJ, McLaughlin JK, Austin DF, Greenberg RS, Liff JM, Preston-Martin S, Sarkar S, SchoenbergJB, et al. Dietary factors and second primary cancers: a follow-up of oral and pharyngeal cancer patients. NutrCancer 1994;21:223-32.

De Benedetti VMG, Welsh JA, Yu MC, Bennett WP. p53 mutations in hepatocellular carcinomas related to oral contraceptiveuse. Carcinogenesis 1996;17:145-149.

Deapen D, Brody G. Re: Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice [letter;comment]. J Natl Cancer Inst 1995;87:315-6.

Deapen D, Hamilton A, Bernstein L, Brody GS. Breast cancer stage at diagnosis and survival among patients withprior breast implants. Plast Reconstr Surg 2000;105:535-40.



DDDDDDeapen DM, Bernstein L, Brody GS. Are breast implants anticarcinogenic? A 14-year follow-up of the Los Angeles Study.

Plast Reconstr Surg 1997;99:1346-53.

Deapen DM, Brody GS. Augmentation mammaplasty and breast cancer: a 5-year update of the Los Angeles study.Plast Reconstr Surg 1992;89:660-5.

Delfino RJ, Anton-Culver H, Saltzstein SL. Gender-related differences in the distribution of thoracic versus abdominalmalignant mesothelioma. Cancer Detect Prev 1995;19:301-7.

Delfino RJ, Ferrini RL, Taylor TH, Howe S, Anton-Culver H. Demographic differences in prostate cancer incidenceand stage: an examination of population diversity in California. Am J Prev Med 1998;14:96-102.

Delfino RJ, Sinha R, Smith C, West J, White E, Lin HJ, Liao SY, Gim JS, Ma HL, Butler J, Anton-Culver H. Breast cancer,heterocyclic aromatic amines from meat and N- acetyltransferase 2 genotype. Carcinogenesis 2000;21:607-15.

Delfino RJ, Smith C, West J, White E, Lin HJ, Liao SY, Butler J, Anton-Culver H. Breast cancer, cigarette smoking, and n-acetyltransferase2genotype: a pre-incident case-control study. Pharmacogenetics 2000;21:101-9.

Demers PA, Kogevinas M, Boffetta P, Leclerc A, Luce D, Gerin M, Battista G, Belli S, Bolm-Audorf U, Brinton LA, et al. Wooddust and sino-nasal cancer: pooled reanalysis of twelve case-control studies. Am J Ind Med 1995;28:151-66.

Demers PA, Thomas DB, Rosenblatt KA, Jimenez LM, McTiernan A, Stalsberg H, Stemhagen A, Thompson WD, CurnenMG, Satariano W, et al. Occupational exposure to electromagnetic fields and breast cancer in men. Am J Epidemiol1991;134:340-7.

Depue R, Pike MC, Henderson BE. Estrogen exposure during gestation and risk of cancer of the testis. J Natl CancerInst 1983;71:1151-55.

Devgan SA, Henderson BE, Yu MC, Shi CY, Pike MC, Ross RK, Reichardt JK. Genetic variation of 3 beta-hydroxysteroiddehydrogenase type II in three racial/ethnic groups: Implications for prostate cancer risk. Prostate 1997;33:9-12.

DiSaia PJ, Brewster WR, Ziogas A, Anton-Culver H. Breast cancer survival and hormone replacement therapy: Acohort analysis. Am J Clin Oncol 2000;23:541-5.

DiSaia PJ, Grosen EA, Kurosaki T, Gildea M, Cowan B, Anton-Culver H. Hormone replacement therapy in breastcancer survivors: A cohort study. Am J Obstet Gynecol 1996;174:1494-8.

Douer D, Cozen W, Wang F, Chang E, Preston-Martin S, Levine AM. Descriptive epidemiology of acute promyelocyticleukemia - report for the cancer registry for Los Angeles County. Blood 1997;90.

Douer D, Preston-Martin S, Chang E, Nichols PW, Watkins KJ, Levine AM. High frequency of acute promyelocyticleukemia among Latinos with acute myeloid leukemia [see comments]. Blood 1996;87:308-13.

Douer D, Preston-Martin S, Levine AM. Promincence of acute promyelocytic leukemia subtype in Latino AMLpatients: Clinical observation confirmed by population-based data. J Registry Management 1996;23:88-91.

DuNah RE, Jr, Holly EA, Ahn DK. Demographics and cigarette smoking among women. Prev Med 1991;20:262-70.

Dworsky R, Baptista J, Parker J, Chandor S, Noble G, Herrmann K, Henle W, Henderson B. Immune function in healthyrelatives of patients with malignant disease. J Natl Cancer Inst 1978;60:27-30.

Dworsky R, Paganini-Hill A, Spicer D. Breast cancer screening and education in high risk women. Prog Clin Biol Res1989;293:115-24.



DDDDD-F-F-F-F-FDworsky RL, Henderson BE. Hodgkin’s disease clustering in families and communities. Cancer Res 1974;34:1161-3.

Edmondson HA, Henderson B, Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl JMed 1976;294:470-2.

Eley JW, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, Greenberg RS, Coates RJ, Correa P, Redmond CK, et al.Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White CancerSurvival Study. JAMA 1994;272:947-54.

Enger SM, Ross RK, Henderson B, Bernstein L. Breastfeeding history, pregnancy experience and risk of breastcancer. Br J Cancer 1997;76:118-23.

Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L. Body size, physical activity, and breast cancer hor-mone receptor status: Results from two case-control studies. Cancer Epidemiol Biomarkers Prev 2000;9:681-7.

Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE. A polymorphism in the CYP17 gene increases therisk of breast cancer. Cancer Res 1997;57:1063-5.

Feigelson HS, McKean-Cowdin R, Coetzee GA, Stram DO, Kolonel LN, Henderson BE. Building a multigenic model ofbreast cancer susceptibility: CYP17 and HSD17B1 are two important candidates. Cancer Res 2001;61:785-9.

Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JK, Henderson BE. Genetic susceptibility to cancer fromexogenous and endogenous exposures. J Cell Biochem Suppl 1996;25:15-22.

Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JKV, Henderson BE. Sex steroid hormones and genetic suscep-tibility to breast and prostate cancer. Drug Metabolism Rev 1998;30:421-34.

Flagg EW, Coates RJ, Jones DP, Byers TE, Greenberg RS, Gridley G, McLaughlin JK, Blot WJ, Haber M, Preston-MartinS, et al. Dietary glutathione intake and the risk of oral and pharyngeal cancer. Am J Epidemiol 1994;139:453-65.

Fontham ET, Correa P, Reynolds P, Wu-Williams A, Buffler PA, Greenberg RS, Chen VW, Alterman T, Boyd P, Austin DF,et al. Environmental tobacco smoke and lung cancer in nonsmoking women. A multicenter study [publishederratum appears in JAMA 1994 Nov 23- 30;272(20):1578]. JAMA 1994;271:1752-9.

Fontham ET, Correa P, WuWilliams A, Reynolds P, Greenberg RS, Buffler PA, Chen VW, Boyd P, Alterman T, Austin DF, etal. Lung cancer in nonsmoking women: a multicenter case-control study [see comments]. Cancer EpidemiolBiomarkers Prev 1991;1:35-43.

Fontham ETH, Correa P, Buffler PA, Greenberg RS, Reynolds P, Wu-Williams A. Environmental tobacco smoke andlung cancer. MD Anderson Cancer Bulletin 1993;45:92-4.

Franceschi S, Preston-Martin S, Dal Maso L, Negri E, La Vecchia C, Mack WJ, McTiernan A, Kolonel L, Mark SD, MabuchiK, Jin F, Wingren G, Galanti MR, Hallquist A, Glattre E, Lund E, Levi F, Linos D, Ron E. A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control 1999;10:583-95.

Friedman GD. Cancer of the large bowel after cholecystectomy. Biomed Pharmacother 1988;42:369-72.

Friedman GD, Fireman BH. Appendectomy, appendicitis, and large bowel cancer. Cancer Res 1990;50:7549-51.

Friedman GD, Hiatt RA, Quesenberry CP, Jr, Selby JV. Case-control study of screening for prostatic cancer by digital rectalexaminations [see comments]. Lancet 1991;337:1526-9.

Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, Ponder BA, Anton-Culver H. Mutation analysis of BRCA1and BRCA2 in a male breast cancer population. Am J Hum Genet 1997;60:313-9.



GGGGGGago-Dominguez M, Castelao JE, Yuan JM, Yu MC, Ross RK. Use of permanent hair dyes and bladder-cancer risk. Int J Cancer

2001;91:575-9.

Gago-Dominguez M, Yuan JM, Castelao JE, Ross R, Yu MC. Family history and risk of renal cell carcinoma. CancerEpidemiol Biomarkers Prev 2001;10:1001-4.

Gago-Dominguez M, Yuan JM, Castelao JE, Ross RK, Yu MC. Regular use of analgesics is a risk factor for renal cellcarcinoma. Br J Cancer 1999;81:542-8.

Gago-Dominguez M, Yuan JM, Castelao JE, Ross RK, Yu MC. Increased risk of renal cell carcinoma subsequent tohysterectomy. Cancer Epidemiol Biomarkers Prev 1999;8:999-1003.

Gale RP, Cozen W, Goodman MT, Wang FF, Bernstein L. Decreased chronic lymphocytic leukemia incidence in Asiansin Los Angeles County. Leuk Res 2000;24:665-9.

Garabrant DH, Held J, Langholz B, Bernstein L. Mortality of aircraft manufacturing workers in Southern California.Am J Ind Med 1988;13:683-93.

Garabrant DH, Peters JM, Bernstein L, Mack T. Job activity and colon cancer risk. Am J Epidemiol 1984;119:1005-14.

Garabrant DH, Peters RK, Homa DM. Asbestos and colon cancer: lack of association in a large case-control study.Am J Epidemiol 1992;135:843-53.

Garland C, Saltzstein SL, Raffa JV, Garland FC, Gorham ED. How to teach students to conquer cancer with curiosityand a cancer registry. J Cancer Educ 1988;3:290.

Gill PS. Pathogenesis of HIV-related malignancies. Curr Opin Oncol 1991;3:867-71.

Gill PS, Hamilton A, Naidu Y. Epidemic (AIDS-related) Kaposi’s sarcoma. AIDS Update 1994;7.

Glaser SL. Black-white differences in Hodgkin’s disease incidence in the United States by age, sex, histology subtype andtime. Int J Epidemiol 1991;20:68-75.

Glaser SL. Hodgkin’s disease in black populations: a review of the epidemiologic literature. Semin Oncol 1990;17:643-59.

Glaser SL. Reproductive factors in Hodgkin’s disease in women: a review. Am J Epidemiol 1994;139:237-46.

Glaser SL. Spatial clustering of Hodgkin’s disease in the San Francisco Bay area. Am J Epidemiol 1990;132:S167-77.

Glaser SL, Ambinder RF, DiGiuseppe JA, Horn-Ross PL, Hsu JL. Absence of Epstein-Barr virus EBER-1 transcripts in anepidemiologically diverse group of breast cancers. Int J Cancer 1998;75:555-8.

Glaser SL, Dorfman RF, Clarke CA. Expert review of the diagnosis and histologic classification of Hodgkin disease ina population-based cancer registry: interobserver reliability and impact on incidence and survival rates. Cancer2001;92:218-24.

Glaser SL, Jarrett RF. The epidemiology of Hodgkin’s disease. Baillieres Clin Haematol 1996;9:401-16.

Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, Pallesen G, Gulley ML, al. e. Epstein-Barr Virus-AssociatedHodgkin’s Disease: Epidemiologic Characteristics in International Data. Int J Cancer 1997;70:375-82.

Glaser SL, Swartz WG. Time trends in Hodgkin’s disease incidence. The role of diagnostic accuracy. Cancer1990;66:2196-204.



GGGGGGnagy S, Ming EE, Devesa SS, Hartge P, Whittemore AS. Declining ovarian cancer rates in U.S. women in relation to parity and

oral contraceptive use. Epidemiology 2000;11:102-5.

Gold EB, Leviton A, Lopez R, Aschenbrener C, Austin DF. Parental smoking and risk of childhood brain tumors. Am JEpidemiol 1993;147:620-28.

Goldhaber MK, Selby JV, Hiatt RA, Quesenberry CP. Exposure to barbiturates in utero and during childhood risk ofintracranial and spinal cord tumors. Cancer Res 1990;50:4600-3.

Goldstein AM, Blot WJ, Greenberg RS, Schoenberg JB, Austin DF, Preston-Martin S, Winn DM, Bernstein L, McLaughlinJK, Fraumeni JF, Jr. Familial risk in oral and pharyngeal cancer. Eur J Cancer B Oral Oncol 1994;30B:319-22.

Goldstein AM, Haile RW, Hodge SE, Paganini-Hill A, Spence MA. Possible heterogeneity in the segregation patternof breast cancer in families with bilateral breast cancer. Genet Epidemiol 1988;5:121-33.

Goldstein AM, Haile RW, Marazita ML, Paganini-Hill A. A genetic epidemiologic investigation of breast cancer infamilies with bilateral breast cancer. I. Segregation analysis. J Natl Cancer Inst 1987;78:911-8.

Goldstein AM, Haile RW, Spence MA, Sparkes RS, Paganini-Hill A. A genetic epidemiologic investigation of breastcancer in families with bilateral breast cancer. II. Linkage analysis. Clin Genet 1989;36:100-6.

Gong G, Whittemore AS, Grosser S. Censored survival data with misclassified covariates: A case study of breastcancer mortality. J Am Stat Assoc 1990;85:20-28.

Gong G, Whittemore AS, West DW, Moore DH. Cutaneous melanoma at Lawrence Livermore National Laboratory:Comparison with rates in two San Francisco Bay Area counties. Cancer Causes Control 1992;3:191-7.

Goodman KJ, Bible ML, London S, Mack TM. Proportional melanoma incidence and occupation among white malesin Los Angeles County (California, United States). Cancer Causes Control 1995;6:451-9.

Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN. Association of soy and fiber consumption with therisk of endometrial cancer. Am J Epidemiol 1997;146:294-306.

Goodson WH, III, Moore DH, III, Ljung BM, Chew K, Mayall B, Smith HS, Waldman FM. The prognostic value of proliferationindices: A study with in vivo bromodeoxyuridine and Ki-67. Breast Cancer Res Treat 2000;59:113-23.

Gray GE, Henderson BE, Pike MC. Changing ratio of breast cancer incidence rates with age of black females comparedwith white females in the United States. J Natl Cancer Inst 1980;64:461-3.

Greenberg RS, Haber MJ, Clark WS, Brockman JE, Liff JM, Schoenberg JB, Austin DF, Preston-Martin S, Stemhagen A,Winn DM, et al. The relation of socioeconomic status to oral and pharyngeal cancer. Epidemiology 1991;2:194-200.

Gridley G, McLaughlin JK, Block G, Blot WJ, Winn DM, Greenberg RS, Schoenberg JB, Preston-Martin S, Austin DF,Fraumeni JF, Jr. Diet and oral and pharyngeal cancer among blacks. Nutr Cancer 1990;14:219-25.

Guidotti S, Wright WE, Peters JM. Multiple myeloma in cosmetologists. Am J Ind Med 1982;3:169-71.

Gurney JG, Mueller BA, Preston-Martin S, McDaniel AM, Holly EA, Pogoda JM, Davis RL. A study of pediatric brain tumors andtheir association with epilepsy and anticonvulsant use. Neuroepidemiology 1997;16:248-55.

Gurney JG, Pogoda JM, Holly EA, Hecht SS, Preston-Martin S. Aspartame consumption in relation to childhood brain tumorrisk: results from a case-control study [published erratum appears in J Natl Cancer Inst 1997 Oct 1;89(19):1460]. J NatlCancer Inst 1997;89:1072-4.



GGGGG-H-H-H-H-HGurney JG, Preston-Martin S, McDaniel AM, Mueller BA, Holly EA. Head injury as a risk factor for brain tumors in children:

results from a multicenter case-control study. Epidemiology 1996;7:485-9.

Haile RW, Goldstein AM, Weeks DE, Sparkes RS, Paganini-Hill A. Genetic epidemiology of bilateral breast cancer: a linkageanalysis using the affected-pedigree-member method. Genet Epidemiol 1990;7:47-55.

Haile RW, Witte JS, Ursin G, Siemiatycki J, Bertolli J, Douglas Thompson W, Paganini-Hill A. A case-control study ofreproductive variables, alcohol, and smoking in premenopausal bilateral breast cancer. Breast Cancer Res Treat1996;37:49-56.

Hamilton AS, Radka SF, Bernstein L, Gill PS, Gonsalves M, Naemura JR, Ross RK. Relationship of serum levels ofoncostatin M to AIDS-related and classic Kaposi’s sarcoma. J Acquir Immune Defic Syndr 1994;7:410-4.

Harnly ME, Swan SH, Holly EA, Kelter A, Padian N. Temporal trends in the incidence of non-Hodgkin’s lymphoma andselected malignancies in a population with a high incidence of acquired immunodeficiency syndrome (AIDS)[see comments]. Am J Epidemiol 1988;128:261-7.

Harnly ME, Swan SH, Kelter A. The authors reply. Am J Epidemiol 1989;130:1070-1071.

Harris R, Whittemore AS, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 UScase-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative OvarianCancer Group. Am J Epidemiol 1992;136:1204-11.

Haselkorn T, Bernstein L, Preston-Martin S, Cozen W, Mack WJ. Descriptive epidemiology of thyroid cancer in Los AngelesCounty, 1972-1995. Cancer Causes Control 2000;11:163-70.

Heineman EF, Bernstein L, Stark AD, Spirtas R. Mesothelioma, asbestos, and reported history of cancer in first-degree relatives. Cancer 1996;77:549-54.

Henderson BE, Benton B, Jing J, Yu MC, Pike MC. Risk factors for cancer of the testis in young men. Int J Cancer1979;23:598-602.

Henderson BE, Benton BD, Weaver PT, Linden G, Nolan JF. Stilbestrol and urogenital-tract cancer in adolescents andyoung adults. N Engl J Med 1973;288:354.

Henderson BE, Bernstein L. Etiology and pathogensis: endogenous and exogenous hormonal factors. In: Harris J,Lippman M, Morrow M, Hellman S, eds. Diseases of the Breast. Philadelphia: Lippincott-Raven Press, 1996:185-200.

Henderson BE, Bernstein L. The international variation in breast cancer rates: an epidemiological assessment.Breast Cancer Res Treat 1991;18 Suppl 1:S11-7.

Henderson BE, Bernstein L, Ross RK. Cancer prevention: Hormones. In: DeVita VT, Hellman S, Rosenberg SA, eds.Cancer Principles and Practice of Oncology. Philadelphia: J.B. Lippincott, 1993:474-80.

Henderson BE, Bernstein L, Ross RK. Hormones and the etiology of cancer. In: Holland JF, Frei E, Bast RC, Kine DW,Morton DL, Weichselbaum RR, eds. Cancer Medicine, 4th Edition. Philadelphia: Lei and Freiberger, 1993:233-2.

Henderson BE, Bernstein L, Ross RK. Etiology of cancer: hormones. In: Devita V, Hellman S, Rosenberg SA, eds. Cancer:Principles and Practices of Oncology, Fifth Edition. Philadelphia: Lippincott-Raven, 1997:219-29.

Henderson BE, Casagrande JT, Pike MC, Mack T, Rosario I, Duke A. The epidemiology of endometrial cancer inyoung women. Br J Cancer 1983;47:749-56.



HHHHHHenderson BE, Dworsky R, Menck H, Alena B, Henle W, Henle G, Terasaki P, Newell GR, Rawlings W, Kinnear BK. Case-control

study of Hodgkin’s disease. II. Herpesvirus group antibody titers and HL-A type. J Natl Cancer Inst 1973;51:1443-7.

Henderson BE, Dworsky R, Pike MC, Baptista J, Menck H, Preston-Martin S, Mack T. Risk factors for nodular sclerosis and othertypes of Hodgkin’s disease. Cancer Res 1979;39:4507-11.

Henderson BE, Gerkins VR, Pike MC. Sexual factors and pregnancy. In: Persons at High Risk to Cancer: An Approachto Cancer Etiology and Control. In: Fraumeni JF, ed. J Natl Cancer Inst Monogr: Academic Press, 1975.

Henderson BE, Gordon RJ, Menck H, Soohoo J, Martin SP, Pike MC. Lung cancer and air pollution in South CentralLos Angeles County. Am J Epidemiol 1975;101:477-88.

Henderson BE, Louie E. Discussion of risk factors for nasopharyngeal carcinoma. IARC Sci Publ 1978;20:251-60.

Henderson BE, Louie E, Bogdanoff E, Henle W, Alena B, Henle G. Antibodies to herpes group viruses in patients withnasopharyngeal and other head and neck cancers. Cancer Res 1974;34:1207-10.

Henderson BE, Louie E, SooHoo Jing J, Buell P, Gardner MB. Risk factors associated with nasopharyngeal carcinoma.N Engl J Med 1976;295:1101-6.

Henderson BE, Pike MC, Bernstein L, Ross RK. Breast cancer. In: Schottenfeld D, Fraumeni J, eds. Cancer Epidemiology andPrevention, 2nd Edition. New York: Oxford University Press, 1996:1022-39.

Henderson BE, Pike MC, Ross RK. Epidemiology and risk factors. In: Bonadonna G, ed. Breast Disease. Recent Ad-vances in Diagnosis and Treatment. Chichester: John Wiley and Sons, Inc.,, 1983:15-33.

Henderson BE, Powell D, Rosario I, Keys C, Hanisch R, Young M, Casagrande J, Gerkins V, Pike MC. An epidemiologicstudy of breast cancer. J Natl Cancer Inst 1974;53:609-14.

Henderson BE, Preston-Martin S, Edmondson HA, Peters RL, Pike MC. Hepatocellular carcinoma and oral contra-ceptives. Br J Cancer 1983;48:437-40.

Henderson BE, Ross R, Bernstein L. Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Founda-tion award lecture. Cancer Res 1988;48:246-53.

Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC. Do regular ovulatory cycles increase breast cancer risk?Cancer 1985;56:1206-8.

Henderson BE, Ross RK, Pike MC. Breast neoplasia. In: Mischell D, ed. The Menopause. Chicago: Yearbook MedicalPublishing, 1986:261-74.

Henderson BE, Ross RK, Pike MC. Epidemiology of testicular cancer. In: Skinner D, Lieskovsky G, eds. Diagnosis andManagement of Genitourinary Cancer. Philadelphia: W.B. Saunders & Co., 1988:46-51.

Henderson BE, Ross RK, Pike MC, Casagrande JT. Endogenous hormones as a major factor in human cancer. CancerRes 1982;42:3232-9.

Henderson BE, Ross RK, Pike MC, Depue R. Epidemiology of testis cancer. In: Skinner D, ed. Urological Cancer: Grune& Stratton, Inc., 1983:237-50.

Henderson BE, Ross RK, Yu MC, Bernstein L. An explanation for the increasing incidence of testis cancer: decreasing ageat first full-term pregnancy [letter]. J Natl Cancer Inst 1997;89:818-20.



HHHHHHenderson BR, Gerkins V, Rosario I, Casagrande J, Pike MC. Elevated serum levels of estrogen and prolactin in daughters

of patients with breast cancer. N Engl J Med 1975;293:790-5.

Henderson SO, Coetzee GA, Ross RK, Yu MC, Henderson BE. Elevated mortality rates from circulatory disease inAfrican American men and women of Los Angeles County, California—a possible genetic susceptibility? Am JMed Sci 2000;320:18-23.

Hessol NA, Katz MH, Liu JY, Buchbinder SP, Rubino CJ, Holmberg SD. Increased incidence of Hodgkin’s disease inhomosexual men with HIV infection. Ann Intern Med 1992;117:309-11.

Hiatt RA. Alcohol consumption and breast cancer. Med Oncol Tumor Pharmacother 1990;7:143-51.

Hiatt RA, Fireman BH. Serum uric acid unrelated to cancer incidence in humans. Cancer Res 1988;48:2916-8.

Hiatt RA, Klatsky A, Armstrong MA. Alcohol and breast cancer. Prev Med 1988;17:683-5.

Hiatt RA, Klatsky AL, Armstrong MA. Alcohol consumption and the risk of breast cancer in a prepaid health plan.Cancer Res 1988;48:2284-7.

Hiatt RA, Klatsky AL, Armstrong MA. Pancreatic cancer, blood glucose and beverage consumption. Int J Cancer1988;41:794-7.

Higgins MW, Enright PL, Kronmal RA, Schenker MB, Anton-Culver H, Lyles M. Smoking and lung function in elderlymen and women. The Cardiovascular Health Study [see comments]. JAMA 1993;269:2741-8.

Hoegh H, McKendry CJ, Wright WE, Young JL. Cancer Incidence by Race/Ethnicity: California, 1988-1989. Sacra-mento: California Department of Health Services, Cancer Surveillance Section, 1992.

Holly EA, Aston DA, Ahn DK, Kristiansen JJ. Ewing’s bone sarcoma, paternal occupational exposure, and otherfactors. Am J Epidemiol 1992;135:122-9.

Holly EA, Aston DA, Ahn DK, Kristiansen JJ, Char DH. No excess prior cancer in patients with uveal melanoma.Ophthalmology 1991;98:608-11.

Holly EA, Aston DA, Ahn DK, Kristiansen JJ, Char DH. Uveal melanoma, hormonal and reproductive factors in women.Cancer Res 1991;51:1370-2.

Holly EA, Aston DA, Char DH, Kristiansen JJ, Ahn DK. Uveal melanoma in relation to ultraviolet light exposure andhost factors. Cancer Res 1990;50:5773-7.

Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. I. Exposure to sunlight, abilityto tan, and other risk factors related to ultraviolet light. Am J Epidemiol 1995;141:923-33.

Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. II. Phenotypic characteristicsand other host-related factors. Am J Epidemiol 1995;141:934-42.

Holly EA, Cress RD, Ahn DK. Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use.Am J Epidemiol 1995;141:943-50.

Holly EA, Cress RD, Ahn DK. Cutaneous melanoma in women: IV. Ovulatory life, menopause and use of exogenousestrogens. Cancer Epidemiol Biomarkers and Prev 1994;3:661-8.

Holly EA, Cress RD, Ahn DK, Aston DA, Kristiansen JJ, Felton JS. Characteristics of women by smoking status in theSan Francisco Bay Area. Cancer Epidemiol Biomarkers Prev 1992;1:491-7.



HHHHHHolly EA, Cress RD, Ahn DK, Aston DA, Kristiansen JJ, Wu R, Felton JS. Detection of mutagens in cervical mucus in smokers

and nonsmokers. Cancer Epidemiol Biomarkers Prev 1993;2:223-8.

Holly EA, Whittemore AS, Aston DA, Ahn DK, Nickoloff BJ, Kristiansen JJ. Anal cancer incidence: genital warts, analfissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst 1989;81:1726-31.

Honda GD, Bernstein L, Ross RK, Greenland S, Gerkins V, Henderson BE. Vasectomy, cigarette smoking, and age atfirst sexual intercourse as risk factors for prostate cancer in middle-aged men. Br J Cancer 1988;57:326-31.

Horn PL, Delorenze GN, Brown SR, Holly EA, West DW. Re: “Temporal trends in the incidence of non-Hodgkin’s lymphomaand selected malignancies in a population with a high incidence of acquired immunodeficiency syndrome (AIDS)”. AmJ Epidemiol 1989;130:1069-70.

Horn-Ross PL. Multiple primary cancers involving the breast. Epidemiol Rev 1993;15:169-76.

Horn-Ross PL. Phytoestrogens, body composition, and breast cancer. Cancer Causes Control 1995;6:567-73.

Horn-Ross PL, Barnes S, Kirk M, Coward L, Parsonnet J, Hiatt RA. Urinary phytoestrogen levels in young womenfrom a multiethnic population. Cancer Epidemiol Biomarkers Prev 1997;6:339-45.

Horn-Ross PL, Holly EA, Brown SR, Aston DA. Temporal trends in the incidence of cutaneous malignant melanomaamong Caucasians in the San Francisco-Oakland MSA. Cancer Causes Control 1991;2:299-305.

Horn-Ross PL, Lee M, John EM, Koo J. Sources of phytoestrogen exposure among non-Asian women in California,USA. Cancer Causes Control 2000;11:299-302.

Horn-Ross PL, Ljung BM, Morrow M. Environmental factors and the risk of salivary gland cancer. Epidemiology1997;8:414-9.

Horn-Ross PL, Morrow M, Ljung BM. Diet and the risk of salivary gland cancer. Am J Epidemiol 1997;146:171-6.

Horn-Ross PL, West DW, Brown SR. Recent trends in the incidence of salivary gland cancer. Int J Epidemiol 1991;20:628-33.

Horn-Ross PL, Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12U.S. case-control studies. VI. Nonepithelial cancers among adults. Collaborative Ovarian Cancer Group. Epidemiology1992;3:490-5.

Howard J, Hankey BF, Greenberg RS, Austin DF, Correa P, Chen VW, Durako S. A collaborative study of differences inthe survival rates of black patients and white patients with cancer. Cancer 1992;69:2349-60.

Howe GR, Aronson KJ, Benito E, Castelleto R, Cornee J, Duffy S, Gallagher RP, Iscovich JM, Deng-ao J, Kaaks R, KuneGA, Kune S, Lee HP, Lee M, Miller AB, Peters RK, Potter JD, Riboli E, Slattery ML, Trichopoulos D, Tuyns A, Tzonou A,Watson LF, Whittemore AS, Shu Z, et al. The relationship between dietary fat intake and risk of colorectal cancer:evidence from the combined analysis of 13 case-control studies. Cancer Causes Control 1997;8:215-28.

Howe GR, Peters RK. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: Evidence fromthe combined analysis of 13 case-control studies. J Natl Cancer Inst 1992;84:1887-95.

Howe SL, Delfino RJ, Taylor TH, Anton-Culver H. The risk of invasive cervical cancer among Hispanics: evidence fortargeted preventive interventions. Prev Med 1998;27:674-80.

Hsieh CL, Oakley-Girvan I, Gallagher RP, Wu AH, Kolonel LN, Teh CZ, Halpern J, West DW, Paffenbarger RS, Jr.,Whittemore AS. Re: prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl CancerInst 1997;89:1893-4.



H-H-H-H-H-JJJJJHsu JL, Glaser SL. Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev

Oncol Hematol 2000;34:27-53.

Hsu JL, Glaser SL, West DW. Racial/ethnic differences in breast cancer survival among San Francisco Bay Areawomen. J Natl Cancer Inst 1997;89:1311-2.

Huebner WW, Schoenberg JB, Kelsey JL, Wilcox HB, McLaughlin JK, Greenberg RS, Preston-Martin S, Austin DF,Stemhagen A, Blot WJ, et al. Oral and pharyngeal cancer and occupation: a case-control study. Epidemiology1992;3:300-9.

Hull CJ, Doyle E, Peters JM, Garabrant DH, Bernstein L, Preston-Martin S. Case-control study of lung cancer in LosAngeles county welders. Am J Ind Med 1989;16:103-12.

Hunter CP, Redmond CK, Chen VW, Austin DF, Greenberg RS, Correa P, Muss HB, Forman MR, Wesley MN, Blacklow RS, etal. Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer SurvivalStudy Group. J Natl Cancer Inst 1993;85:1129-37.

Inciardi JF, Lee JG, Stijnen T. Incidence trends for colorectal cancer in California: implications for current screeningpractices [In Process Citation]. Am J Med 2000;109:277-81.

Ingles SA, Haile R, Henderson BE, Kolonel l, Coetzee GA. Association of vitamin D receptor genetic polymorphismwith breast cancer risk in African-American and Hispanic women. In: Norman A, Bouillon R, Thomasset M, eds. Vitamin D:Chemistry, Biology, and Clinical Applications of the Steroid Hormone. Riverside, CA: University of California, Printing andReprographics, 1997:813-814.

Ingles SA, Haile RW, Henderson BE, Kolonel LN, Nakaichi G, Shi CY, Yu MC, Ross RK, Coetzee GA. Strength of linkagedisequilibrium between two vitamin D receptor markers in five ethnic groups: implications for associationstudies. Cancer Epidemiol Biomarkers Prev 1997;6:93-8.

Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA. Association of prostate cancer risk withgenetic polymorphisms in vitamin D receptor and androgen receptor [see comments]. J Natl Cancer Inst1997;89:166-70.

Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are inlinkage disequilibrium in men with prostate cancer. Cancer Res 1995;55:1937-40.

Janezic SA, Ziogas A, Krumroy L, Kranser M, Plummer S, Barker D, Haile R, Casey G, Anton-Culver H. BRCA1 mutationsand polymorphisms in a population-based series of ovarian cancer. Human Molecular Genetics, 1999;8:889-97.

Ji H, Yu MC, Stillwell WG, Skipper PL, Ross RK, Henderson BE, Tannenbaum SR. Urinary excretion of 2-amino-3,8-dimethylimidazo-[4,5-f ]quinoxaline in white, black, and Asian men in Los Angeles County. Cancer EpidemiolBiomarkers Prev 1994;3:407-11.

John EM, Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis ofseven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group.J Natl Cancer Inst 1993;85:142-7.

John EM, Whittemore AS, Wu AH, Kolonel LN, Hislop TG, Howe GR, West DW, Hankin J, Dreon DM, Teh CZ, et al.Vasectomy and prostate cancer: results from a multiethnic case-control study [see comments]. J Natl CancerInst 1995;87:662-9.

Jonna BP, Delfino RJ, Newman WG, Tope WD. Positive predictive value for presumptive diagnoses of skin cancer andcompliance with follow-up among patients attending a community screening program. Prev Med 1998;27:611-6.



KKKKKKampert JB, Whittemore AS, Paffenbarger RS, Jr. Combined effect of childbearing, menstrual events, and body size

on age-specific breast cancer risk. Am J Epidemiol 1988;128:962-79.

Kang SH, Bloom JR. Social support and cancer screening among older black Americans. J Natl Cancer Inst 1993;85:737-42.

Kang SH, Bloom JR, Romano PS. Cancer screening among African-American women: their use of tests and socialsupport. Am J Public Health 1994;84:101-3.

Kaplan GA, Reynolds P. Depression and cancer mortality and morbidity: prospective evidence from the AlamedaCounty study. J Behav Med 1988;11:1-13.

Katz MH, Hessol NA, Buchbinder SP, Hirozawa A, O’Malley P, Holmberg SD. Temporal trends of opportunistic infectionsand malignancies in homosexual men with AIDS. J Infect Dis 1994;170:198-202.

Kelly JW, Holly EA, Shpall SN, Ahn DK. The distribution of melanocytic naevi in melanoma patients and controlsubjects. Australas J Dermatol 1989;30:1-8.

Kelsey JL, Horn-Ross PL. Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev1993;15:7-16.

Kelsey KT, Wrensch M, Zuo ZF, Miike R, Wiencke JK. A population-based case-control study of the CYP2D6 andGSTT1 polymorphisms and malignant brain tumors. Pharmacogenetics 1997;7:463-8.

Kerlikowske K, Brown JS, Grady DG. Should women with familial ovarian cancer undergo prophylactic oophorectomy?Obstet Gynecol 1992;80:700-7.

Klatsky AL, Armstrong MA, Friedman GD, Hiatt RA. The relations of alcoholic beverage use to colon and rectalcancer. Am J Epidemiol 1988;128:1007-15.

Klonoff-Cohen H, Schaffroth L, Edelstein S, Molgaard C, Saltzstein SL. Breast Cancer Histology in Caucasians, AfricanAmericans, Hispanics, Asians, and Pacific Islanders. Ethnicity & Health 1998;3:189-198.

Kolodner R, Tytell J, Schmeits J, Kane M, Gupta R, Wahlber S, Fox E, Garber J, Syngal S, Peel D, Ziogas A, Anton-CulverH, Li F. Germline msh6 mutations in colorectal cancer families. Cancer Research 1999;59:5068-5074.

Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR, John EM, Howe GR, Dreon DM, West DW,Paffenbarger RS, Jr. Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. CancerEpidemiol Biomarkers Prev 2000;9:795-804.

Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, Pike MC, Stram DO, Monroe KR, Earle ME, NagamineFS. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 2000;151:346-57.

Kolonel LN, Ross RK, Thomas DB, Thompson DJ. Epidemiology of testicular cancer in the Pacific Basin. Natl CancerInst Monogr 1982;62:157-60.

Kpblin B, Hessol NA, Zauber AG. Increased incidence of cancer among homosexual men, New York and San Francisco,1978-1990. Am J Epidemiol 1996;144:916-23.

Krailo MD, Bernstein L, Sullivan-Halley J, Hammond GD. Patterns of enrollment on cooperative group studies. Ananalysis of trends from the Los Angeles County Cancer Surveillance Program. Cancer 1993;71:3325-30.

Krieger N. Social class and the black/white crossover in the age-specific incidence of breast cancer: a study linkingcensus-derived data to population-based registry records. Am J Epidemiol 1990;131:804-14.



KKKKK-L-L-L-L-LKrieger N, Hiatt RA. Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at

biopsy, and length of follow- up. Am J Epidemiol 1992;135:619-31.

Kwong S, Perkins CI, Morris CR, Cohen R, Allen M, Schlag RD, Wright WE. Cancer in California: 1988-1998. Sacramento:California Department of Health Services, Cancer Surveillance Section, 2000.

Kwong S, Perkins CI, Wright WE. Liver Cancer Incidence and Mortality rates increasing among Asian/Other womenin California, 1988-1993, 1997.

Kwong Sl, Perkins CI, Snipes KP, Wright WE. Improving American Indian cancer data in the California Cancer Regis-try. J of Registry Management 1998;25:17-20.

Langholz B, Richardson J, Rappaport E, Waisman J, Cockburn M, Mack T. Skin characteristics and risk of superficialspreading and nodular melanoma (United States). Cancer Causes Control 2000;11:741-50.

Langholz B, Thomas D, Huberman M, Ziogas A, Faucett C, Goldstein L. Ascertainment bias rate ratio estimation fromcase-sibling control studies of variable age-at-onset diseases. Biometrics 1999;55:1129-36.

Le G, Leung R, O’Malley C, Clarke CA, Lin SS, Glaser SL, West DW. Cancer Incidence and Mortality in the San Francisco BayArea, 1988-1998. Union City: Northern California Cancer Center, 2001.

Le G, Leung R, O’Malley C, Clarke CA, Lin SS, Glaser SL, West DW. Cancer Incidence and Mortality in the Santa ClaraRegion, 1988-1998. Union City: Northern California Cancer Center, 2001.

Lee M, Wrensch M, Miike R. Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area(California, USA). Cancer Causes Control 1997;8:13-24.

Lee M, Wrensch MR, Miike R, Petrakis N. The association of dietary fat with ability to obtain breast fluid. CancerEpidemiol Biom Prev 1994;1:277-280.

Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D. Alternative therapies used by women with breast cancer infour ethnic populations. J Natl Cancer Inst 2000;92:42-7.

Lee MM, Petrakis NL, Wrensch MR, King EB, Miike R, Sickles E. Association of abnormal nipple aspirate cytology andmammographic pattern and density. Cancer Epidemiol Biomarkers Prev 1994;3:33-6.

Lee MM, Wu-Williams A, Whittemore AS, Zheng S, Gallagher R, Teh CZ, Zhou L, Wang X, Chen K, Ling C, et al.Comparison of dietary habits, physical activity and body size among Chinese in North America and China. Int JEpidemiol 1994;23:984-90.

Lee-Feldstein A, Anton-Culver H, Feldstein PJ. Treatment differences and other prognostic factors related to breastcancer survival. Delivery systems and medical outcomes. JAMA 1994;271:1163-8.

Lee-Feldstein A, Feldstein PJ, Buchmueller T, Katterhagen G. Breast cancer outcomes among older women: HMO,fee-for-service, and delivery system comparisons. J Gen Intern Med 2001;16:189-99.

Lee-Feldstein A, Feldstein PJ, Buchmueller T, Katterhagen G. The relationship of HMOs, health insurance, and deliverysystems to breast cancer outcomes. Med Care 2000;38:705-18.

Leong SPL, Wrigh TW, Fink DJ, Blankenship CM. Success Stories II: Cancer Liaison Physicians Using NCDB Data toInfluence Patient Care. In: Strutkus W, Blankenship W, Menck HR, eds. The California Triad Project. Chicago: AmericanCollege of Surgeons, 1998:57-62.



LLLLLLeTendre D, Cress RD, Riddle S. Where did they really live? Resolving discrepancies in address at diagnosis. J Registry

Management 2000;27:57-8.

Levine AM, Bernstein L, Sullivan-Halley J, Shibata D, Mahterian SB, Nathwani BN. Role of zidovudine antiretroviral therapy in thepathogenesis of acquired immunodeficiency syndrome-related lymphoma. Blood 1995;86:4612-6.

Levine AM, Shibata D, Sullivan-Halley J, Nathwani B, Brynes R, Slovak ML, Mahterian S, Riley CL, Weiss L, Levine PH, etal. Epidemiological and biological study of acquired immunodeficiency syndrome-related lymphoma in theCounty of Los Angeles: preliminary results. Cancer Res 1992;52:5482s-5484s.

Li Y, Millikan RC, Carozza S, Newman B, Liu E, Davis R, Miike R, Wrensch M. p53 mutations in malignant gliomas.Cancer Epidemiol Biomarkers Prev 1998;7:303-8.

Liaw KL, Linet MS, McLaughlin JK, Yu MC, Schoenberg JB, Lynch CF, Niwa S, Fraumeni JF, Jr. Possible relation betweenhypertension and cancers of the renal pelvis and ureter. Int J Cancer 1997;70:265-8.

Linet MS, Chow WH, McLaughlin JK, Wacholder S, Yu MC, Schoenberg JB, Lynch C, Fraumeni JF, Jr. Analgesics andcancers of the renal pelvis and ureter. Int J Cancer 1995;62:15-8.

Liu L, Cozen W, Bernstein L, Ross RK, Deapen D. Changing relationship between socioeconomic status and prostatecancer incidence. J Natl Cancer Inst 2001;93:705-9.

Liu L, Deapen D, Bernstein L. Socioeconomic status and cancers of the female breast and reproductive organs: acomparison across racial/ethnic populations in Los Angeles County, California (United States). Cancer CausesControl 1998;9:369-80.

Liu L, Deapen D, Bernstein L, Ross RK. Cancer Incidence in Los Angeles County by Race-Ethnicity, 1988-1993. Los Angeles:University of Southern California, Los Angeles Cancer Surveillance Program, 1996.

Liu L, Deapen D, Bernstein L, Ross RK. Cancer in Los Angeles County: Incidence by Race/Ethnicity 1988-1994. Los Angeles:University of Southern California, Los Angeles Cancer Surveillance Program, 1997.

Liu L, Deapen D, Bernstein L, Ross RK. Cancer in Los Angeles County: Incidence and Mortality by Race/Ethnicity1988-1995. Los Angeles: Los Angeles County Cancer Surveillance Program, University of Southern California,1998.


Liu L, Deapen D, Bernstein L, Ross RK. Cancer in Los Angeles County: Incidence and Mortality by Race/Ethnicity,1988-1997. Los Angeles: Cancer Surveillance Program, University of Southern California, 2000.


Liu L, Deapen D, Bernstein L, Ross RK. Hormone levels in older women: a study of post-menopausal breast cancerpatients and healthy population controls. Br J Cancer 1990;61:298-302.

Liu L, Deapen D, Bernstein L, Ross RK. Oral contraceptive use and adenocarcinoma of cervix [see comments]. Lancet1994;344:1390-4.

Liu L, Deapen D, Bernstein L, Ross RK. Second cancers following oral and pharyngeal cancer: patients’ characteristics andsurvival patterns. Eur J Cancer B Oral Oncol 1994;30B:381-6.



LLLLL-M-M-M-M-MLondon SJ, Bowman JD, Sobel E, Thomas DC, Garabrant DH, Pearce N, Bernstein L, Peters JM. Exposure to magnetic fields among

electrical workers in relations to leukemia risk in Los Angeles County. Am J Indust Med 1994;26:47-60.

London SJ, Daly AK, Cooper J, Carpenter CL, Navidi WC, Ding L, Idle JR. Lung cancer risk in relation to the CYP2E1Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County. Pharmacogenet-ics 1996;6:151-8.

London SJ, Daly AK, Cooper J, Navidi WC, Carpenter CL, Idle JR. Polymorphism of glutathione S-transferase M1(GMTM1) and lung cancer risk among African-Americans and Caucasians in Los Angeles County. J Natl CancerInst 1995;87:1246-53.

London SJ, Daly AK, Leathart JBS, Navidi WC, Carpenter CL, Idle JR. Genetic polymorphism of CYP2D6 and lungcancer risk in African-Americans and Caucasians in Los Angeles County. Carcinogenesis 1997;18:1203-1214.

Longnecker MP, Bernstein L, Paganini-Hill A, Enger SM, Ross RK. Risk factors for in situ breast cancer. Cancer EpidemiolBiomarkers Prev 1996;5:961-5.

Longnecker MP, Paganini-Hill A, Ross RK. Lifetime alcohol consumption and breast cancer risk among postmenopausalwomen in Los Angeles. Cancer Epidemiol Biomarkers Prev 1995;4:721-5.

Longnecker MP, Paganini-Hill A, Ross RK. Risk of breast cancer in relation to lifetime alcohol consumption: Resultsfrom Los Angeles. Am J Epidemiol 1995;141:853.

Louie E, Henderson BE, Buell P, Jing JS, Menck HR, Pike MC. Selected observations on the epidemiology of pharyngealcancers. Natl Cancer Inst Monogr 1977;47:129-33.

Lowengart RA, Peters JM, Cicioni C, Buckley J, Bernstein L, Preston-Martin S, Rappaport E. Childhood leukemia andparents’ occupational and home exposures. J Natl Cancer Inst 1987;79:39-46.

Lowery JT, Peters JM, Deapen D, London SJ. Renal cell carcinoma among architects. Am J Ind Med 1991;20:123-5.

Luce D, Gerin M, Morcet JF, Leclerc A. Sinonasal cancer and occupational exposure to textile dust. Am J Ind Med1997;32:205-10.

Lum R, O’Malley C, Lui S, Topol B, Clarke C, Lin S, Prehn AW, Glaser S, West D. Cancer Incidence and Mortality in theSan Francisco Bay Area. Union City: Northern California Cancer Center, 2000.

Lum R, O’Malley C, Lui S, Topol B, Clarke C, Lin S, Prehn AW, Glaser S, West D. Cancer Incidence and Mortality in theSanta Clara Region, 1988-1997. Union City: Northern California Cancer Center, 2000.

Lum R, Prehn AW, Topol B, Lui S, Clarke C, Glaser S, West D. Cancer Incidence and Mortality in the San Francisco BayArea, 1988-1996. Union City: Northern California Cancer Center, 1999.

Lum R, Prehn AW, Topol B, Lui S, Clarke C, Lin S, Glaser S, West D. Cancer Incidence and Mortality in the Santa ClaraRegion, 1988-1996. Union City: Northern California Cancer Center, 1999.

Mack TM. Current views on the epidemiology and etiology of pancreas cancer. In: Wanebo H, ed. Pancreas Cancer:Williams and Wilkins, In Press.

Mack TM. Sarcomas and other malignancies of soft tissue, retroperitoneum, peritoneum, pleura, heart, mediastinum, andspleen. Cancer 1995;75:211-44.

Mack TM. The geography of skin cancer. Skin Cancer Foundation J 1992;10:37-40.



MMMMMMack TM, Berkel J, Bernstein L, Mack W. Religion and cancer in Los Angeles County. Natl Cancer Inst Monogr 1985;69:235-45.

Mack TM, Cozen W, Quinn M. Epidemiology of cancer of the endometrium, ovary, vulva and vagina. In: CopplesonM, ed. Gynecologic Oncology. London: Churchill Livingston, 1991.

Mack TM, Floderus B. Malignant melanoma risk by nativity, place of residence at diagnosis, and age at migration.Cancer Causes Control 1991;2:401-11.

Mack TM, Henderson BE. Cause-specific mortality among newspaper web pressman. J Occup Med 1980;22:542-4.

Mack TM, Menck H. Epidemiology of cancer of the gallbladder and extra hepatic biliary passages. In: Correa P, HaenxzelW, eds. Epidemiology of cancer of the gallbladder and extra hepatic biliary passages. Boston: Nijhoff, 1982.

Mack TM, Paganini-Hill A. Epidemiology of pancreas cancer in Los Angeles. Cancer 1981;47:1474-84.

Mack TM, Peters JM, Yu MC, Hanisch R, Wright WE, Henderson BE. Pancreas cancer is unrelated to the workplace inLos Angeles. Am J Ind Med 1985;7:253-66.

Mack TM, Preston-Martin S. Trends in the epidemiology of the leukemias and lymphomas. In: Yon DS, Lapin BA, BlakesleeJR, eds. Advances in Comparative Leukemia Research 1979. New York: Elsevier North Holland, 1980:431-38.

Mack TM, Yu MC, Hanisch R, Henderson BE. Pancreas cancer and smoking, beverage consumption, and past medicalhistory. J Natl Cancer Inst 1986;76:49-60.

Mack W, Preston-Martin S, Peters JM. Astrocytoma risk related to job exposure to electric and magnetic fields.Bioelectromagnetics 1991;12:57-66.

Makridakis N, Ross RK, Pike MC, Chang L, Stanczyk FZ, Kolonel LN, Shi CY, Yu MC, Henderson BE, Reichardt JK. Aprevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase. Cancer Res1997;57:1020-2.

Maltzman TH, Mueller BA, Schroeder J, Rutledge JC, Patterson K, Preston-Martin S, Faustman EM. Ras oncogenemutations in childhood brain tumors. Cancer Epidemiol Biomarkers Prev 1997;6:239-43.

Masood R, Husain SR, Rahman A, Gill P. Potentiation of cytotoxicity of Kaposi’s sarcoma related to immunodeficiencysyndrome (AIDS) by liposome-encapsulated doxorubicin. AIDS Res Hum Retroviruses 1993;9:741-6.

McGuire V, Whittemore AS, Norris R, Oakley-Girvan I. Survival in epithelial ovarian cancer patients with prior breastcancer. Am J Epidemiol 2000;152:528-32.

McKean-Cowdin R, Feigelson HS, Ross RK, Pike MC, Henderson BE. Declining cancer rates in the 1990s. J Clin Oncol2000;18:2258-68.

McKean-Cowdin R, Preston-Martin S, Pogoda JM, Holly EA, Mueller BA, Davis RL. Parental occupation and childhood braintumors: astroglial and primitive neuroectodermal tumors. J Occup Environ Med 1998;40:332-40.

McKean-Cowdin R, Preston-Martin S, Pogoda JM, Mueller BA, Holly EA. Reliability of demographic, smoking andoccupational data provided by mothers vs. fathers in a childhood cancer study. Paediatr Perinat Epidemiol2000;14:257-62.

McLaughlin JK, Gridley G, Block G, Winn DM, Preston-Martin S, Schoenberg JB, Greenberg RS, Stemhagen A, Austin DF,Ershow AG, et al. Dietary factors in oral and pharyngeal cancer. J Natl Cancer Inst 1988;80:1237-43.

McLaughlin JK, Silverman DT, Hsing AW, Ross RK, Schoenberg JB, Yu MC, Stemhagen A, Lynch CF, Blot WJ, FraumeniJF, Jr. Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res 1992;52:254-7.



MMMMMMenck HR, Henderson BE. Occupational differences in rates of lung cancer. J Occup Med 1976;18:797-801.

Menck HR, Henderson BE, Pike MC, Mack T, Martin SP, SooHoo J. Cancer incidence in the Mexican-American. J NatlCancer Inst 1975;55:531-6.

Menck HR, Mack TM. Incidence of biliary tract cancer in Los Angeles. Natl Cancer Inst Monogr 1982;62:95-9.

Menck HR, Mills PK. The influence of urbanization, age, ethnicity, and income on the early diagnosis of breastcarcinoma: opportunity for screening improvement. Cancer 2001;92:1299-304.

Menck HR, Pike MC, Henderson BE, Jing JS. Lung cancer risk among beauticians and other female workers: briefcommunication. J Natl Cancer Inst 1977;59:1423-5.

Miller BA, Kolonel LN, Bernstein L, Young JL, Jr, Swanson GM, West DW, Key CR, Liff JM, Glover CS, Alexander GA. Racial/ethnicpatterns of cancer in the United States, 1988-1992. National Cancer Institute, Publ No. 96-4104 1996.

Mills PK. Cancer Incidence in the Central Valley, 1988-1993. Fresno, CA: Cancer Registry of Central California, California HealthCollaborative, 1996.

Mills PK. Cancer Incidence in the Central Valley, 1988-1998. Fresno, CA: Cancer Registry of Central California, California HealthCollaborative, 1997.

Mills PK. Cancer Incidence and Mortality in the Central Valley. 1999: Cancer Registry of Central California, CaliforniaHealth Collaborative, 1999.

Mills PK. Cancer Incidence and Mortality in the Central Valley, 1988-1998. Fresno: Cancer Registry of Central California, 2000.

Mills PK. Correlation analysis of pesticide use data and cancer incidence rates in California counties. Arch EnvironHealth 1998;53:410-3.

Mills PK, Kwong S. Cancer incidence in the United Farmworkers of America (UFW), 1987-1997. Am J Ind Med2001;40:596-603.

Mills PK, (ed). Prostate Cancer in California: A Special Report. Berkeley, CA: Public Health Insitute, June 2000.

Mills PK, Yang R. Cancer incidence in the Hmong of Central California, United States, 1987-94. Cancer CausesControl 1997;8:705-12.

Mishra SI, Luce-Aoela P, Wilkins L, Bernstein L. Cancer among American Samoans: Site-specific incidence in Califor-nia and Hawaii. Int J Epidemiol 1996;25:713-21.

Mohle-Boetani JC, Grosser S, Whittemore AS, Malec M, Kampert JB, Paffenbarger RS, Jr. Body size, reproductivefactors, and breast cancer survival. Prev Med 1988;17:634-42.

Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, Henderson BE. Evidence of an X-linked or recessivegenetic component to prostate cancer risk [see comments]. Nat Med 1995;1:827-9.

Moradi T, Delfino RJ, Bergstrom SR, Yu ESH, Adami HO, Yuen J. Cancer rates among Scandinavian immigrants to the U.S. andresidents of Scandinavian coutries compared to the U.S. whites, 1973-89. Eur J Cancer Prev 1998;7:117-25.

Morgan JW, Cassady RE, King AR, Lu JK. Cancer Incidence and Mortality in Inyo, Mono, Riverside and San BernardinoCounties, 1988-1997. Loma Linda: Desert Sierra Cancer Surveillance Program, 2000.



M-NM-NM-NM-NM-NMorgan JW, Enders JA, King AR, Gladson JE. Cancer Incidence in Inyo, Mono, Riverside, and San Bernardino Counties,

1988-1993. Loma Linda: Desert Sierra Cancer Surveillance Program, Loma Linda University Medical Center,1996.

Morgan JW, Gladson JE, Cassady RE, Woodward SM, King AR. Cancer Incidence and Mortality in Inyo, Mono,Riverside, and San Bernardino Counties, 1988-1995. Loma Linda: Desert Sierra Cancer Program, Loma LindaUniversity Medical Center, 1998.

Morgan JW, Gladson JE, Rau KS. Position Paper of the American Council on Science and Health on Risk Factors forBreast Cancer: Established, Speculated, and Unsupported. Breast J 1998;4:177-197.

Morgan JW, Law JH, Cassady RE, King AR. Cancer Incidence and Mortality in Inyo, Mono, Riverside, and San BernardinoCounties, 1988-1998. Loma Linda: Desert Sierra Cancer Surveillance Program, Loma Linda University Medical Center,2001.

Morgan JW, Sharma S, Lukachko A. The Breast Cancer Prevention Diet. A Position Paper from the Am Council on Sci andHlth 1998:1-17.

Morgan JW, Woodward SM, Cassady RE, King AR, Jog S. Cancer Incidence and Mortality in Inyo, Mono, Riverside and SanBernardino Counties, 1988-1996. Loma Linda: Desert Sierra Cancer Surveillance Program, Loma Linda University MedicalCenter, 1999.

Morris CR, Cohen R, Perkins CI, Allen M, Kwong SL, Schlag RD, Wright WE. Cancer in California: 1988-1996. Sacramento:California Department of Health Services, Cancer Surveillance Section, 1999.

Morris C, Cohen R, Perkins C, Allen M, Kwong SL, Schlag RD, Wright WE. Cancer in California: 1988-1997. Sacramento:California Department of Health Services, Cancer Surveillance Section, 2000.

Morris CR, Cohen R, Schlag RD, Wright WE. Increasing Trends in the Use of Breast-Conserving Surgery in California.Am J Public Health 2000;90:281-4.

Morris CR, Perkins CI, Wright WE, Snipes KP, Young JL, Jr. Impact of inclusion of subsequent primary cancers onestimates of risks of developing cancer. J Natl Cancer Inst 1996;88:456-8.

Morris CR, Snipes KP, Schlag RD, Wright WE. Sociodemographic factors associated with prostatectomy utilizationand concordance with the physician data query for prostate cancer (United States). Cancer Causes Control1999;10:503-11.

Morris CR, Wright WE. Breast Cancer in California. Sacramento, CA: California Department of Health Services, CancerSurveillance Section, 1996.

Morris CR, Wright WE, Schlag RD. The risk of developing breast cancer within the next five, ten, or 20 years of awoman’s life. Am J Prev Med 2001;20:214-8.

Mueller BA, Newton K, Holly EA, Preston-Martin S. Residential water source and the risk of childhood brain tumors.Environ Health Perspect 2001;109:551-6.

Nasseri K. Cancer Incidence and Mortality in the Tri-Counties, California, 1988-1993. Santa Barbara: Tri-CountiesRegional Cancer Registry, 1996.

Nasseri K. Statistical Process Control and Monitoring Time trends by Population based Cancer Registries. J Registry Man-agement 1999;26:93-97.

Nasseri K, Casagande C. Cancer Incidence and Mortality by Race/Ethnicity in the Tri-Counties, California, 1988-1997. Santa Barbara: Tri-Counties Regional Cancer Registry, 2000.



N-PN-PN-PN-PN-PNasseri K, Casagrande C. Cancer Incidence and Mortality by Race/Ethnicity in the Tri-Counties, California, 1988-1999. Santa

Barbara: Tri-Counties Regional Cancer Registry, 2001.

Nasseri K, Watkins S. Timeliness in Reporting Cancer Incidence to a Population-based Regional Registry. J RegistryManagement 1998:21-27.

Nelson RA, Levine AM, Marks G, Bernstein L. Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin’s lymphoma. Br J Cancer 1997;76:1532-7.

Neutra R, Swan S, Mack T. Clusters galore: insights about environmental clusters from probability theory. Sci TotalEnviron 1992;127:187-200.

Newell GR, Rawlings W, Kinnear BK, Correa P, Henderson BE, Dworsky R, Menck H, Thompson R, Sheehan WW. Case-control study of Hodgkin’s disease. I. Results of the interview questionnaire. J Natl Cancer Inst 1973;51:1437-41.

Norman MA, Holly EA, Ahn DK, Preston-Martin S, Mueller BA, Bracci PM. Prenatal exposure to tobacco smoke andchildhood brain tumors: results from the United States West Coast childhood brain tumor study. Cancer EpidemiolBiomarkers Prev 1996;5:127-33.

Norman MA, Holly EA, Preston-Martin S. Childhood brain tumors and exposure to tobacco smoke. Cancer EpidemiolBiomarkers Prev 1996;5:85-91.

Operskalski EA, Preston-Martin S, Henderson BE, Visscher BR. A case-control study of osteosarcoma in young persons. AmJ Epidemiol 1987;126:118-26.

Osann KE, Anton-Culver H, Kurosaki T, Taylor T. Sex differences in lung-cancer risk associated with cigarette smok-ing. Int J Cancer 1993;54:44-8.

Ottman R, Pike MC, King M, Henderson BE. Practical guide for estimating risk for familial breast cancer. Lancet1983:556-58.

Ottman R, Pike MC, King M-C, Casagrande JT, Henderson BE. Familial breast cancer in a population-based series.Am J Epidemiol 1986;123:15-21.

Paganini-Hill A. Aspirin and colorectal cancer: the Leisure World cohort revisited. Prev Med 1995;24:113-5.

Paganini-Hill A, Glazer E, Henderson BE, Ross RK. Cause-specific mortality among newspaper web pressmen. JOccup Med 1980;22:542-4.

Paganini-Hill A, Hsu G. Morbidity and mortality changes with estrogen replacement changes. In: Lobo R, ed. Treat-ment of the Postmenopausal Woman: Basic and Clinical Aspects. New York: Raven Press, 1994:399-404.

Paganini-Hill A, Hsu G. Smoking and mortality among residents of a California retirement community. Am J PublicHealth 1994;84:992-5.

Paganini-Hill A, Ross RK. Breast lumps and consultation delays [letter]. Lancet 1981;1:995.

Paganini-Hill A, Ross RK, Henderson BE. Epidemiology of kidney cancer. In: Skinner D, ed. Urological Cancer: Grune &Stratton, Inc., 1983:383-407.

Paganini-Hill A, Ross RK, Henderson BE. Epidemiology of kidney cancer. In: Skinner DG, Lieskovsky G, eds. Diagnosisand Management of Genitourinary Cancer. Philadelphia: W.B. Saunders & Co., 1988:32-39.



PPPPPPathak DR, Whittemore AS. Combined effects of body size, parity, and menstrual events on breast cancer incidence in

seven countries. Am J Epidemiol 1992;135:153-68.

Peel DJ, Ziogas A, Fox EA, Gildea M, Laham B, Clements E, Kolodner RD, Anton-Culver H. Characterization of hereditarynonpolyposis colorectal cancer families from a population-based series of cases. J Natl Cancer Inst 2000;92:1517-22.

Perkins CI, Allen ME, Wright WE, Takahashi E, Stoodt G, Cohen R. Breast Cancer in California: Stage at Diagnosis andMedi-Cal Status. Sacramento: California Department of Health Services, Cancer Surveillance Section, 2000.

Perkins CI, Cohen R, Morris CR, Allen M, Kwong SL, Schlag RD, Wright WE. Cancer in California: 1988-1995. Sacramento:California Department of Health Services, Cancer Surveillance Section, 1998.

Perkins CI, Cohen R, Young JL, Schlag RD, Wright WE. Cancer in California: Detailed site and Histology, 1990-1994.Sacramento: California Department of Health Services, Cancer Surveillance Section, 1997.

Perkins CI, Hoegh HJ, Wright WE, Young JL. Cancer Incidence and Mortality by Race/Ethnicity in California, 1988-1990. Sacramento: California Department of Health Services, Cancer Surveillance Section, 1993.

Perkins CI, Kwong SL, Morris CR, Cohen R, Allen M, Schlag RD, W.E. W. Cancer in California, 2001. Sacramento: Depart-ment of Health Services, Cancer Surveillance Section, 2000.

Perkins CI, Kwong SL, Morris CR, Wright WE. Trends in female breast cancer mortality in California, 1973-1994. JRegistry Management 1996;23:164-67.

Perkins CI, Morris CR, Wright WE. Cancer Incidence and Mortality in California by Race/Ethnicity, 1988-1993. Sacramento:California Department of Health Services, Cancer Surveillance Section, 1996.

Perkins CI, Morris CR, Wright WE, Young JL. Cancer Incidence and Mortality in California by Detailed Race/Ethnicity,1988-1992. Sacramento: California Department of Health Services, Cancer Surveillance Section, 1995.

Perkins CI, Wright WE, Allen M, Samuels SJ, Romano PS. Breast cancer stage at diagnosis in relation to duration ofmedicaid enrollment. Med Care 2001;39:1224-33.

Perkins CI, Wright WE, Schlag RD. Cancer Incidence and Mortality in California by Race/Ethnicity, 1988-1994. Sacramento:California Department of Health Services, Cancer Surveillance Section, 1997.

Peters FM, Preston-Martin S, Yu MC. Brain tumors in children and occupational exposure of parents. Science1981;213:235-7.

Peters JM, Garabrant DH, Wright WE, Bernstein L, Mack TM. Uses of a cancer registry in the assessment of occupationalcancer risks. Natl Cancer Inst Monogr 1985;69:157-61.

Peters JM, Preston-Martin S. Childhood tumors and parental occupational exposures. Teratog Carcinog Mutagen1984;4:137-48.

Peters JM, Preston-Martin S, London SJ, Bowman JD, Buckley JD, Thomas DC. Processed meats and risk of childhoodleukemia (California, USA). Cancer Causes Control 1994;5:195-202.

Peters JM, Wright WE, Garabrant DH. Occupational epidemiology: detection of cancer in the workplace. West J Med1982;137:555-9.

Peters RK, Bear MB, Thomas D. Barriers to screening for cancer of the cervix. Prev Med 1989;18:133-46.



PPPPPPeters RK, Chao A, Mack TM, Thomas D, Bernstein L, Henderson BE. Increased frequency of adenocarcinoma of the uterine

cervix in young women in Los Angeles County. J Natl Cancer Inst 1985;76:423-8.

Peters RK, Garabrant DH, Yu MC, Mack TM. A case-control study of occupational and dietary factors in colorectalcancer in young men by subsite. Cancer Res 1989;49:5459-68.

Peters RK, Henderson BE. Trends in cervical cancer rates in Norway [letter]. J Natl Cancer Inst 1988;80:288-9.

Peters RK, Mack T, Garabrant DH, Homa DM, Pike MC. Calcium and colon cancer in Los Angeles County. In: Lipkin M,Newmark HL, Kelloff G, eds. Calcium, Vitamin D and Prevention of Colon Cancer. Boston: CRC Press, 1991:113-20.

Peters RK, Mack TM. Patterns of anal carcinoma by gender and marital status in Los Angeles County. Br J Cancer1983;48:629-36.

Peters RK, Mack TM, Bernstein L. Parallels in the epidemiology of selected anogenital carcinomas. J Natl CancerInst 1984;72:609-15.

Peters RK, Pike MC, Chang WW, Mack TM. Reproductive factors and colon cancers. Br J Cancer 1990;61:741-8.

Peters RK, Pike MC, Garabrant D, Mack TM. Diet and colon cancer in Los Angeles County, California. Cancer CausesControl 1992;3:457-73.

Peters RK, Thomas D, Hagan DG, Mack TM, Henderson BE. Risk factors for invasive cervical cancer among Latinasand non-Latinas in Los Angeles County. J Natl Cancer Inst 1986;77:1063-77.

Peters RK, Thomas D, Skultin G, Henderson BE. Invasive squamous cell carcinoma of the cervix after recent negativecytologic test results—a distinct subgroup? Am J Obstet Gynecol 1988;158:926-35.

Peto J, Henderson BE, Pike MC. Trends in mesothelioma incidence in the United States and the forecast epidemicdue to asbestos exposure during World War II. In: Peto R, Schneiderman M, eds. Banbury Report 9: Quantificationof Occupational Cancer, 1981:51-69.

Petrakis NL, Lowenstein JM, Wiencke JK, Lee MM, Wrensch MR, King EB, Hilton JF, Miike R. Gross cystic disease fluidprotein in nipple aspirates of breast fluid of Asian and non-Asian women [published erratum appears in CancerEpidemiol Biomarkers Prev 1994 Jun;3(4):369]. Cancer Epidemiol Biomarkers Prev 1993;2:573-9.

Pike MC, Bernstein L, Peters RK. Re: “Dietary fat and postmenopausal breast cancer.” J Natl Cancer Inst 1992;84:1666-7.

Pike MC, Henderson BE, Casagrande JT, Rosario I, Gray G. Oral contraceptive use and early abortion as risk factorsfor breast cancer in young women. Br J Cancer 1981;43:72-76.

Pike MC, Henderson BE, Krailo M, Duke A, Roy S. Breast cancer and oral contraceptives: Reply to critics. Lancet1983:1414.

Pike MC, Peters RK, Bernstein L. Re: “Total energy intake: Implications for epidemiologic analyses.” Am J Epidemiol1993;137:811-2.

Pike MC, Peters RK, Cozen W, Probst-Hensch NM, Felix JC, Wan PC, Mack TM. Estrogen-progestin replacementtherapy and endometrial cancer. J Natl Cancer Inst 1997;89:1110-6.

Pike MC, Ross RK. Breast cancer. Br Medical Bull 1984;40:351-4.

Pike MC, Ross RK. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer. Steroids2000;65:659-64.



PPPPPPike MC, Ross RK. RESPONSE: re: Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen

plus progestin. J Natl Cancer Inst 2000;92:1951-2.

Plaxe SC, Saltzstein SL. Impact of ethnicity on the incidence of high-risk endometrial carcinoma. Gynecol Oncol1997;65:8-12.

Plummer SJ, Anton-Culver H, Webster L, Noble B, Liao S, Kennedy A, Belinson J, Casey G. Detection of BRCA1 mutationsby the protein truncation test. Hum Mol Genet 1995;4:1989-91.

Plummer SJ, Santibanez-Koref M, Kurosaki T, Liao S, Noble B, Fain PR, Anton-Culver H, Casey G. A germline 2.35 kbdeletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumenisyndrome family. Oncogene 1994;9:3273-80.

Pogoda JM, Preston-Martin S. Pesticide exposure and development of brain tumors in children in Los AngelesCounty. Environ Health Perspect 1998;105:1214-20.

Pogoda JM, Preston-Martin S. Solar radiation, lip protection, and lip cancer risk in Los Angeles County women(California, United States). Cancer Causes Control 1996;7:458-63.

Pogoda JM, Preston-Martin S, Paoff KJ, Lijinsky W. Survey of residual nitrite levels in cured meats in the UnitedStates and Canada, 1970-1991. In Press.

Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, Eley JW, Stephenson RA, Harlan LC. Healthoutcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer OutcomesStudy. J Natl Cancer Inst 2000;92:1582-92.

Prehn AW, Leung R, Davis MM, Brown SR, Glaser S, West DW. Cancer Incidence in the Santa Clara Region, 1988-1994.Union City: Northern California Cancer Center, 1997.

Prehn AW, Satriano ER, Leung R, Davis MM, Brown SR, Glaser S, West D. Cancer Incidence in the San Francisco BayArea, 1988-1994. Union City: Northern California Cancer Center, 1997.

Prehn AW, Topol B, Lin S, Clarke C, Davis MM, Glaser S, West D. Cancer Incidence in the San Francisco Bay Area, 1988-1995. Union City: Northern California Cancer Center, 1998.

Prehn AW, Topol B, Lin S, Clarke C, Davis MM, Glaser S, West D. Cancer Incidence in the Santa Clara Region, 1988-1995. Union City: Northern California Cancer Center, 1998.

Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A, Slamon DJ,Phillips RN, Ross JS, Wolman SR, Flom KJ. HER-2/neu gene amplification characterized by fluorescence in situhybridization: Poor prognosis in node-negative breast carcinomas. J Clin Oncol 1997;15:2894-904.

Preston-Martin S. A case-control study of brain tumors in men in Los Angeles County: investigaion of N-nitrosocompound exposures. IARC Sci Publ 1990;105:221-7.

Preston-Martin S. A case-control study of intracranial meningiomas in women. Am J Epidemiol 1978;108:233-4.

Preston-Martin S. Central Nervous Tumors, Epidemiology. In: Aminoff MJ, Daroff RB, eds. Encylopedia of the NeurologicalSciences. San Diego: Academic Press, In Press.

Preston-Martin S. Combined modality therapy of central nervous system tumors-Chapter 1. Berlin; New York: Springer,2000.

Preston-Martin S. Descriptive epidemiology of primary tumors of the brain, cranial nerves and cranial meninges inLos Angeles County. Neuroepidemiology 1989;8:283-95.



PPPPPPreston-Martin S. Descriptive epidemiology of primary tumors of the spinal cord and spinal meninges in Los Angeles

County, 1972-1985. Neuroepidemiology 1990;9:106-11.

Preston-Martin S. Epidemiology, Chapter 1. In: Berger M, Wilson C, eds. The Gliomas. Cambridge, MA: W.B. SaundersCo., 1998:824.

Preston-Martin S. Epidemiology of primary CNS neoplasms. Neurol Clin 1996;14:273-90.

Preston-Martin S. N-nitroso compounds as a cause of human cancer. IARC Sci Publ 1987;84:477-84.

Preston-Martin S. Prior x-ray therapy for acne related to tumors of the parotid gland. Arch Dermatol 1989;125:921-4.

Preston-Martin S, Bernstein L, Pike MC, Maldonado AA, Henderson BE. Thyroid cancer among young women re-lated to prior thyroid disease and pregnancy history. Br J Cancer 1987;55:191-5.

Preston-Martin S, Garabrant D. Occupational risks for meningiomas [letter]. J Occup Med 1988;30:14, 16, 18.

Preston-Martin S, Gurney JG, Pogoda JM, Holly EA, Mueller BA. Brain tumor risk in children in relation to use ofelectric blankets and water bed heaters. Results from the United States West Coast Childhood Brain TumorStudy. Am J Epidemiol 1996;143:1116-22.

Preston-Martin S, Henderson BE. Esthesioneuroblastoma [letter]. CA Cancer J Clin 1984;34:356.

Preston-Martin S, Henderson BE. N-nitroso compounds and human intracranial tumours. IARC Sci Publ 1984;57:887-94.

Preston-Martin S, Henderson BE, Bernstein L. Medical and dental x-rays as risk factors for recently diagnosed tumors of thehead. Natl Cancer Inst Monogr 1985;69:175-9.

Preston-Martin S, Henderson BE, Peters JM. Descriptive epidemiology of central nervous system neoplasms in LosAngeles County. Ann NY Acad Sci 1982;381:202-8.

Preston-Martin S, Henderson BE, Pike MC. Descriptive epidemiology of cancers of the upper respiratory tract inLos Angeles. Cancer 1982;49:2201-7.

Preston-Martin S, Henderson BE, Yu MC. The epidemiology of intracranial meningiomas in Los Angeles County.Neuroepidemiology 1984;2:164-78.

Preston-Martin S, Mack W. Gliomas and meningiomas in men in Los Angeles County: investigation of exposures toN-nitroso compounds. IARC Sci Publ 1991;105:197-203.

Preston-Martin S, Mack W. Neoplasms of the nervous system. In: Schottenfeld D, Fraumeni Jr. JF, eds. Cancer Epide-miology and Prevention, 2nd Edition. New York: Oxford University Press, 1996:1231-81.

Preston-Martin S, Mack W, Henderson BE. Risk factors for gliomas and meningiomas in males in Los Angeles County.Cancer Res 1989;49:6137-43.

Preston-Martin S, Menck HR. The epidemiology of thyroid cancer in Los Los Angeles County. West J Med1979;131:369-72.

Preston-Martin S, Monroe K, Lee PJ, Bernstein L, Kelsey J, Henderson S, Forrester D, Henderson B. Spinal meningiomas inwomen in Los Angeles County: investigation of an etiological hypothesis. Cancer Epidemiol Biomarkers Prev1995;4:333-9.



P-RP-RP-RP-RP-RPreston-Martin S, Navidi W, Thomas D, Lee PJ, Bowman J, Pogoda J. Los Angeles study of residential magnetic fields and

childhood brain tumors [see comments]. Am J Epidemiol 1996;143:105-19.

Preston-Martin S, Peters JM. Prior employment as a welder associated with the development of chronic myeloidleukaemia. Br J Cancer 1988;58:105-8.

Preston-Martin S, Peters JM, Yu MC, Garabrant DH, Bowman JD. Myelogenous leukemia and electric blanket use.Bioelectromagnetics 1988;9:207-13.

Preston-Martin S, Pike MC, Ross RK, Henderson BE. Epidemiologic evidence for the increased cell proliferationmodel of carcinogenesis. Prog Clin Biol Res 1991;369:21-34.

Preston-Martin S, Pike MC, Ross RK, Henderson BE. Epidemiologic evidence for the increased cell proliferationmodel of carcinogenesis. Environ Health Perspect 1993;101 Suppl 5:137-8.

Preston-Martin S, Pogoda JM, Mueller BA, Holly EA, Lijinsky W, Davis RL. Maternal consumption of cured meats andvitamins in relation to pediatric brain tumors. Cancer Epidemiol Biomarkers Prev 1996;5:599-605.

Preston-Martin S, Pogoda JM, Mueller BA, Lubin F, Modan B, Holly EA, Filippini G, Cordier S, Peris-Bonet R, Choi W,Little J, Arslan A. Results from an international case-control study of childhood brain tumors: the role of prenatalvitamin supplementation. Environ Health Perspect 1998;106 Suppl 3:887-92.

Preston-Martin S, Thomas DC, Henderson BE. Medical x-rays and adult-onset myelogenous leukemia in Los Angeles. 100Jahre Roentgen: Medizinische Gesellscheft fur Strahlerschutz e. V . 1997.

Preston-Martin S, Thomas DC, White SC, Cohen D. Prior exposure to medical and dental x-rays related to tumors ofthe parotid gland. J Natl Cancer Inst 1988;80:943-9.

Preston-Martin S, Thomas DC, Wright WE, Henderson BE. Noise trauma in the aetiology of acoustic neuromas inmen in Los Angeles County, 1978-1985. Br J Cancer 1989;59:783-6.

Preston-Martin S, Thomas DC, Yu MC, Henderson BE. Diagnostic radiography as a risk factor for chronic myeloidand monocytic leukaemia (CML). Br J Cancer 1989;59:639-44.

Preston-Martin S, White SC. Brain and salivary gland tumors related to prior dental radiography: implications forcurrent practice. J Am Dent Assoc 1990;120:151-8.

Preston-Martin S, Yu MC, Benton B, Henderson BE. N-Nitroso compounds and childhood brain tumors: a case-control study. Cancer Res 1982;42:5240-5.

Preston-Martin S, Yu MC, Henderson BE, Roberts C. Risk factors for meningiomas in men in Los Angeles County. JNatl Cancer Inst 1983;70:863-6.

Ragland KE, Selvin S, Merrill DW. Black-white differences in stage-specific cancer survival: analysis of seven selected sites.Am J Epidemiol 1991;133:672-82.

Re A, Taylor TH, DiSaia PJ, Anton-Culver H. Risk for breast and colorectal cancers subsequent to cancer of theendometrium in a population-based case series. Gynecol Oncol 1997;66:255-7.

Reichardt JK, Makridakis N, Henderson BE, Yu MC, Pike MC, Ross RK. Genetic variability of the human SRD5A2 gene:implications for prostate cancer risk. Cancer Res 1995;55:3973-5.

Renneker M. An inner city cancer prevention clinic. Design, methods, and early results. Cancer 1991;67:1802-7.



RRRRRReynolds P, Boyd PT, Blacklow RS, et al. The relationship between social ties and survival among black and white breast

cancer patients. National Cancer Institute Black/White Cancer Survival Study Group. Cancer Epidemiol Biom Prev1994;3:253-9.

Reynolds P, Elkin E, Layefsky M, Lee G. Cancer in California School Employees, 1988-1992. Am J Ind Med 1999;36:271-278.

Reynolds P, Saunders LD, Layefsky ME, Lemp GF. The spectrum of acquired immunodeficiency syndrome (AIDS)-associatedmalignancies in San Francisco, 1980-1987. Am J Epidemiol 1993;137:19-30.

Richardson B, Hulka B, David-Peck J, Hughes C, van den Berg BJ, Christianson R, Calvin J. Levels of maternal serumalpha-fetoprotein in pregnant women and subsequent breast cancer risk. Am J Epidemiol 1998;148:719-727.

Richardson JL, Langholz B, Bernstein L, Burciaga C, Danley K, Ross RK. Stage and delay in breast cancer diagnosis byrace, socioeconomic status, age and year. Br J Cancer 1992;65:922-6.

Robbins AS, Whittemore AS, Thom DH. Differences in socioeconomic status and survival among white and blackmen with prostate cancer. Am J Epidemiol 2000;151:409-16.

Romano PS, Bloom J, Syme SL. Smoking, social support, and hassles in an urban African-American community. AmJ Public Health 1991;81:1415-22.

Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, Harris BS, III , Hoffman DA, McConahey WM, Maxon HR,Preston-Martin S, Warshauer ME, Wong FL, Boice JD, Jr. Cancer mortality following treatment for adult hyperthyroidism.Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 1998;280:347-55.

Rosenthal DL, Acosta D, Peters RK. Computer-assisted rescreening of clinically important false negative cervicalsmears using the PAPNET Testing System. Acta Cytol 1996;40:120-6.

Ross R, Dworsky R, Nichols P, Paganini-Hill A, Wright W, Koss M, Lukes R, Henderson B. Asbestos exposure andlymphomas of the gastrointestinal tract and oral cavity. Lancet 1982;2:1118-20.

Ross R, Dworsky R, Paganini-Hill A, Boone J, Nichols P, Mack T. The occurrence of multiple lymphoreticular andhematological malignancies in the same households. Br J Cancer 1983;47:853-6.

Ross R, Dworsky R, Paganini-Hill A, Levine A, Mack T. Non-Hodgkin’s lymphomas in never married men in Los Ange-les. Br J Cancer 1985;52:785-7.

Ross RK. Epidemiology of prostate cancer: Prospects for prevention. Accomplishments in Cancer Research 1992 GeneralMotors Cancer Research Foundation: J.P. Lippincott, 1992:219-228.

Ross RK, Bernstein L, Garabrant D, Henderson BE. Avoidable nondietary risk factors for cancer. Am Fam Physician1988;38:153-60.

Ross RK, Bernstein L, Hartnett NM, Boone JR. Cancer patterns among Vietnamese immigrants in Los Angeles County.Br J Cancer 1991;64:185-6.

Ross RK, Casagrande JT, Dworsky RL, Levine A, Mack T. Kaposi’s sarcoma in Los Angeles, California. J Natl Cancer Inst1985;75:1011-5.

Ross RK, Dworsky R, Paganini-Hill A, Nichols P. The epidemiology of lymphomas. In: Pattengale P, Lukes R, Taylor C, eds.Lymphoproliferative Diseases: Pathogenesis, Diagnosis, Therapy. Boston: Martinez-Nijhoff Publishers, 1985:55-71.

Ross RK, Hartnett N, Bernstein L, Henderson BE. A portrait of incidence and mortality, 1972-1987. Kenneth Norris Jr.Comprehensive Cancer Center 1991.



R-SR-SR-SR-SR-SRoss RK, Hartnett NM, Bernstein L, Henderson BE. Epidemiology of adenocarcinomas of the small intestine: is bile

a small bowel carcinogen? Br J Cancer 1991;63:143-5.

Ross RK, Henderson BE. Epidemiology of Hodgkin’s and non-Hodgkin’s lymphomas. In: Aoki K, Tominaga S, Hirayama T, HirotaY, eds. Proceedings of the First UICC Conference on Cancer Prevention in Developing Countries. Nagoya, Japan:University of Nagoya Press, 1982:515-517.

Ross RK, Jones PA, Yu MC. Bladder cancer epidemiology and pathogenesis. Semin Oncol 1996;23:536-45.

Ross RK, McCurtis JW, Henderson BE, Menck HR, Mack TM, Martin SP. Descriptive epidemiology of testicular andprostatic cancer in Los Angeles. Br J Cancer 1979;39:284-92.

Ross RK, Paganini-Hill A, Henderson BE. The etiology of prostate cancer: what does the epidemiology suggest?Prostate 1983;4:333-44.

Ross RK, Paganini-Hill A, Henderson BE. Epidemiology of bladder cancer. In: Skinner DG, ed. Urological Cancer:Grune & Stratton, Inc., 1983:113-33.

Ross RK, Paganini-Hill A, Henderson BE. Epidemiology of prostate cancer. In: Skinner DG, ed. Urological Cancer:Grune & Stratton, Inc., 1983:1-19.

Ross RK, Paganini-Hill A, Henderson BE. Epidemiology of prostatic cancer. In: Skinner D, Lieskovsky G, eds. Diagnosisand Management of Genitourinary Cancer. Philadelphia: W.B. Saunders & Co., 1988:40-45.

Ross RK, Paganini-Hill A, Henderson BE. Epidemiology of bladder cancer. In: Skinner DG, Liewskovsky G, eds. Diag-nosis and Management of Genitourinary Cancer. Philadelphia: W.B. Saunders & Co., 1988:23-31.

Ross RK, Paganini-Hill A, Krailo MD, Gerkins VR, Henderson BE, Pike MC. Effects of reserpine on prolactin levels andincidence of breast cancer in postmenopausal women. Cancer Res 1984;44:3106-8.

Ross RK, Paganini-Hill A, Landolph J, Gerkins V, Henderson BE. Analgesics, cigarette smoking, and other risk factorsfor cancer of the renal pelvis and ureter. Cancer Res 1989;49:1045-8.

Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: estrogenversus estrogen plus progestin. J Natl Cancer Inst 2000;92:328-32.

Ross RK, Pike MC. RESPONSE: re: Effect of hormone replacement therapy on breast cancer risk: Estrogen versusestrogen plus progestin. J Natl Cancer Inst 2000;92:1100A-101.

Ross RK, Schottenfeld D. Prostate cancer. In: Schottenfeld D, Fraumeni J, eds. Cancer Epidemiology and Prevention,2nd Edition. New York: Oxford University Press, 1996:1022-39.

Ross RK, Yuan JM, Yu MC. Recent progress in understanding the epidemiology and etiology of bladder cancer. In:Golematis BC, Dimopoulos KA, eds. Tumors of the Pelvis. New York: Wiley-Liss, Inc., In Press.

Ruder AM, Ward EM, Brown DP. Cancer mortality in female and male dry-cleaning workers. J Occup Med 1994;36:867-74.

Saltzstein SL. An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ:Analysis of 11,436 cases from the California Cancer Registry. Anat Pathol 1996;1:193-203.

Saltzstein SL. Breast cancer is being detected earlier. San Diego Physician 1992;79:11.

Saltzstein SL. The association of ethnicity and the incidence of mammary carcinoma in situ in women: 11,436 casesfrom the California Cancer Registry. Cancer Detect Prev 1997;21:361-9.



SSSSSSaltzstein SL, Behling C, Baergen R. Features of cancer in nonagenarians and centenarians. J Am Geriatr Soc

1998;46:994-8.

Saltzstein SL, Behling C, Savides T. The relation of age, race and gender to the subsite location of colorectal carcinoma.Cancer 1998;82.

Satriano E, Darbinian J, Leung R, Glaser S, West D. Cancer Incidence in the San Francisco Bay Area, 1988-1993. Union City:Northern California Cancer Center, 1996.

Satriano E, Darbinian J, Leung R, Glaser S, West D. Cancer Incidence in the Santa Clara Region, 1988-1993. UnionCity: Northern California Cancer Center, 1996.

Schlag RD, Harris D, Kwong S. Ovarian Cancer in California, 2001. Sacramento: California Department of Health Services,Cancer Surveillance Section, 2001.

Schmid HP, Stamey TA, McNeal JE, Freiha FS, Redwine EA, Whittemore AS. [Effect of the natural history on managementof adenocarcinoma of the prostate]. Urologe A 1994;33:144-8.

Schroen AT, Cress RD. Use of surgical procedures and adjuvant therapy in rectal cancer treatment: a population-basedstudy. Ann Surg 2001;234:641-51.

Seiffert JE. Editorial - Special Focus: Central Cancer Registries. J of Registry Management 1998;25:5.

Selby JV. Explaining recent declines in colorectal cancer incidence: was it the sigmoidoscope? [In Process Citation]. AmJ Med 2000;109:332-4.

Selby JV, Friedman GD. Epidemiologic evidence of an association between body iron stores and risk of cancer. IntJ Cancer 1988;41:677-82.

Selby JV, Friedman GD, Collen MF. Sigmoidoscopy and mortality from colorectal cancer: the Kaiser PermanenteMultiphasic Evaluation Study. J Clin Epidemiol 1988;41:427-34.

Selby JV, Friedman GD, Fireman BH. Screening prescription drugs for possible carcinogenicity: eleven to fifteenyears of follow-up. Cancer Res 1989;49:5736-47.

Selvin S, Merrill D, Schulman J, Sacks S, Bedell L, Wong L. Transformations of maps to investigate clusters of disease.Soc Sci Med 1988;26:215-21.

Selvin S, Schulman J, Merrill DW. Distance and risk measures for the analysis of spatial data: a study of childhoodcancers. Soc Sci Med 1992;34:769-77.

Semenza JC, Ziogas A, Largent J, Peel D, Anton-Culver H. Gene-environment interactions in renal cell carcinoma.Am J Epidemiol 2001;153:851-9.

Shibata A, Mack TM, Paganini-Hill A, Ross RK, Henderson BE. A prospective study of pancreatic cancer in the elderly.Int J Cancer 1994;58:46-9.

Shibata A, Whittemore AS, Imai K, Kolonel LN, Wu AH, John EM, Stamey TA, Paffenbarger RS. Serum levels of prostate-specific antigen among Japanese-American and native Japanese men. J Natl Cancer Inst 1997;89:1716-20.

Shibata D, Weiss LM, Hernandez AM, Nathwani BN, Bernstein L, Levine AM. Epstein-Barr virus-associated non-Hodgkin’slymphoma in patients infected with the human immunodeficiency virus. Blood 1993;81:2102-9.



Shimizu H, Mack TM, Ross RK, Henderson BE. Cancer of the gastrointestinal tract among Japanese and white immigrants inLos Angeles County. J Natl Cancer Inst 1987;78:223-8.

Shimizu H, Preston-Martin S, Casagrande JT, Ross RK, Henderson BE, Pike MC. Epidemiological characteristics of adenocar-cinoma of the lung in Los Angeles County. Natl Cancer Inst Monogr 1982;62:161-4.

Shimizu H, Ross RK, Bernstein L. Possible underestimation of the incidence rate of prostate cancer in Japan. Jpn JCancer Res 1991;82:483-5.

Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast amongJapanese and white immigrants in Los Angeles County. Br J Cancer 1991;63:963-6.

Shimizu H, Wu AH, Koo LC, Gao YT, Kolonel LN. Lung cancer in women living in the Pacific Basin area. Natl Cancer InstMonogr 1985;69:197-201.

Silverman S, Jr. Gorsky M. Epidemiologic and demographic update in oral cancer: California and national data -1973 to 1985. J Am Dental Assoc 1990;120:495-9.

Simons AJ, Ker R, Groshen S, Gee C, Anthone GJ, Ortega AE, Vukasin P, Ross RK, Beart RW, Jr. Variations in treatmentof rectal cancer: the influence of hospital type and caseload. Dis Colon Rectum 1997;40:641-6.

Simpson CL, Garabrandt DH, Fryzek J, Homa DM, Peters RK. Wood dust exposure and colon cancer. J Occup EnvironHealth In Press.

Slattery ML, Benson J, Curtin K, Ma KN, Schaeffer D, Potter JD. Carotenoids and colon cancer. Am J Clin Nutr2000;71:575-82.

Slattery ML, Edwards SL, Palmer L, Curtin K, Morse J, Anderson K, Samowitz W. Use of archival tissue in epidemio-logic studies: collection procedures and assessment of potential sources of bias. Mutat Res 2000;432:7-14.

Slattery ML, Potter JD, Ma KN, Caan BJ, Leppert M, Samowitz W. Western diet, family history of colorectal cancer,NAT2, GSTM-1 and risk of colon cancer. Cancer Causes Control 2000;11:1-8.

Slebos RJ, Hoppin JA, Tolbert PE, Holly EA, Brock JW, Zhang RH, Bracci PM, Foley J, Stockton P, McGregor LM, FlakeGP, Taylor JA. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environ-mental exposures in a population-based study. Cancer Epidemiol Biomarkers Prev 2000;9:1223-32.

Slovak ML, Weiss LM, Nathwani BN, Bernstein L, Levine AM. Cytogenetic studies of composite lymphomas: mono-cytoid B-cell lymphoma and other B-cell non-Hodgkin’s lymphomas. Hum Pathol 1993;24:1086-94.

Snipes KP, Morris CR, Wright WE. Stage at diagnosis of female breast cancer in California, 1988-1992. J RegistryManagement 1996;23:158-63.

Snipes KP, Perkins CI, Wright WE, Young JL. Cancer Incidence and Mortality by Race/Ethnicity in California, 1988-1991. Sacramento: California Department of Health Services, Cancer Surveillance Section, 1994.

Spirtas R, Beebe GW, Connelly RR, Wright WE, Peters JM, Sherwin RP, Henderson BE, Stark A, Kovasznay BM, DaviesJN, et al. Recent trends in mesothelioma incidence in the United States. Am J Ind Med 1986;9:397-407.

Spirtas R, Heineman EF, Bernstein L, Beebe GW, Keehn RJ, Stark A, Harlow BL, Benichou J. Malignant mesothelioma:attributable risk of asbestos exposure. Occup Environ Med 1994;51:804-11.

Spruck CH, III, Rideout WM, III , Olumi AF, Ohneseit PF, Yang AS, Tsai YC, Nichols PW, Horn T, Hermann GG, Steven K, et al. Distinctpattern of p53 mutations in bladder cancer: relationship to tobacco usage. Cancer Res 1993;53:1162-6.

SSSSS



Stalsberg H, Thomas DB, Rosenblatt KA, Jimenez LM, McTiernan A, Stemhagen A, Thompson WD, Curnen MG, Satariano W,Austin DF, et al. Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 UnitedStates men. Cancer Causes Control 1993;4:143-51.

Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP. Localized prostate cancer. Relationship of tumorvolume to clinical significance for treatment of prostate cancer. Cancer 1993;71:933-8.

Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, Albertsen PC, Harlan LC, Potosky AL. Urinaryand sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate CancerOutcomes Study. JAMA 2000;283:354-60.

Stewart SL, Swallen KC, Glaser SL, Horn-Ross PL, West DW. Comparison of methods for classifying Hispanic ethnicityin a population-based cancer registry. Am J Epidemiol 1999;149:1063-71.

Swallen KC, Glaser SL, Stewart SL, West DW, Jenkins CN, McPhee SJ. Accuracy of racial classification of Vietnamesepatients in a population-based cancer registry. Ethn Dis 1998;8:218-27.

Swallen KC, West DW, Stewart SL, Glaser SL, Horn-Ross PL. Predictors of misclassification of Hispanic ethnicity in apopulation-based cancer registry. Ann Epidemiol 1997;7:200-6.

Swanson GM, Ragheb NE, Lin CS, Hankey BF, Miller B, Horn-Ross P, White E, Liff JM, Harlan LC, McWhorter WP, et al.Breast cancer among black and white women in the 1980s. Changing patterns in the United States by race, age,and extent of disease [see comments]. Cancer 1993;72:788-98.

Takasugi M, Terasaki PI, Henderson B, Mickey MR, Menck H, Thompson RW. HL-A antigens in solid tumors. CancerRes 1973;33:648-50.

Taylor TH, Anton-Culver H. Let’s leave the date out of the name of the standard population. J Natl Cancer Inst2000;92:1269-70.

Theuer CP. Asian gastric cancer patients at a Southern California comprehensive cancer center are diagnosedwith less advanced disease and have superior stage-stratified survival. Am Surg 2000;66:821-6.

Theuer CP, Anton-Culver H. Important prognostic factor in patients with gastric cancer. West J Med 1998;169:254.

Theuer CP, Kurosaki T, Taylor TH, Anton-Culver H. Unique features of gastric carcinoma in the young: a population-based analysis. Cancer 1998;83:25-33.

Theuer CP, Kurosaki T, Ziogas A, Butler J, Anton-Culver H. Asian patients with gastric carcinoma in the United Statesexhibit unique clinical features and superior overall and cancer specific survival rates. Cancer 2000;89:1883-92.

Theuer CP, Nastanski F, Butler JA, Anton-Culver H. Signet-ring cell histology is associated with unique clinical fea-tures but does not affect gastric-cancer survival: a population-based multivariate analysis of more than 3,000cases. Am Surgeon 1999;65:915-21.

Theuer CP, Taylor TH, Anton-Culver H. Different racial/ethnic groups may require different screening guidelines. NEngl J Med 2000;343:1652.

Theuer CP, Wagner JL, Taylor TH, Brewster WR, Tran D, McLaren CE, Anton-Culver H. Racial and ethnic colorectal cancerpatterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology2001;120:848-56.

SSSSS-----TTTTT



Thomas DB, Kolonel LN, Ross RK, Thompson DJ. Proposal for a collaborative epidemiology study of prostate cancer in thePacific Basin. Natl Cancer Inst Monogr 1982;62:151-5.

Thomas DC, Preston-Martin S. Risk of leukemia caused by diagnostic x-rays. Health Phys 1992;63:576-8.

Travis LB, Curtis RE, Hankey BF, Fraumeni JF, Jr. Second cancers in patients with chronic lymphocytic leukemia. J Natl CancerInst 1992;84:1422-7.

Travis LB, Gonzalez CL, Hankey BF, Jaffe ES. Hodgkin’s disease following non-Hodgkin’s lymphoma. Cancer1992;69:2337-42.

Tu IP, Balise RR, Whittemore AS. Detection of disease genes by use of family data. II. Application to nuclear families.Am J Hum Genet 2000;66:1341-50.

Ursin G, Aragaki CC, Paganini-Hill A, Siemiatycki J, Thompson WD, Haile RW. Oral contraceptives and premeno-pausal bilateral breast cancer: A case-control study. Epidemiology 1992;3:414-9.

Ursin G, Bernstein L, Pike MC. Breast cancer. Cancer Surv 1994;20:241-64.

Ursin G, Henderson BE, Haile RW, Pike MC, Zhou N, Diep A, Bernstein L. Does oral contraceptive use increase therisk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women? Cancer Res1997;57:3678-81.

Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC. A pilot study of urinary estrogenmetabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer. EnvironHealth Perspect 1997;105 Suppl 3:601-5.

Ursin G, Paganini-Hill A, Siemiatycki J, Thompson WD, Haile RW. Early adult body weight, body mass index, andpremenopausal bilateral breast cancer: data from a case-control study. Breast Cancer Res Treat 1995;33:75-82.

Ursin G, Pike MC, Preston-Martin S, d’Ablaing III G, Peters RK. Sexual, reproductive, and other risk factors for adenocarcinoma ofthe cervix: results from a population-based case-control study (California, United States) [see comments]. Cancer CausesControl 1996;7:391-401.

Vatten LJ, Ursin G, Ross RK, Stanczyk FZ, Lobo RA, Harvei S, Jellum E. Androgens in serum and the risk of prostatecancer: a nested case-control study from the Janus serum bank in Norway. Cancer Epidemiol Biomarkers Prev1997;6:967-9.

Waldman FM, DeVries S, Chew KL, Moore II DH, Kerlikowske K, Ljung BM. Chromosomal alterations in ductal carcinomasin situ and their in situ recurrences. J Natl Cancer Inst 2000;92:313-20.

Waldman FM, Hwang ES, Etzell J, Eng C, DeVries S, Bennington J, Thor A. Genomic alterations in tubular breastcarcinomas. Hum Pathol 2001;32:222-6.

Walker A. Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors inBreast Cancer. Contraception 1996;54:1S-106S.

Walker A, Ross RK, Pike MC, Henderson BE. A possible rising incidence of malignant germ cell tumors in youngwomen. Br J Cancer 1984;49:669-72.

Walker AH, Ross RK, Haile RWC, Henderson BE. Hormonal factors and risk of ovarian germ cell cancer in youngwomen. Br J Cancer 1988;57:418-22.

TTTTT-----WWWWW



Walton L, Silverman SJ, Costa CR. Epidemiology and Demographic Update in Oral Cancer: California 1973-1990. CA DentalAssoc J 1991;19:17-22.

Weinberg DM, Ross RK, Mack TM, Paganini-Hill A, Henderson BE. Bladder cancer etiology. A different perspective. Cancer1983;51:675-80.

Whittemore AS. Colorectal cancer incidence among Chinese in North America and the People’s Republic of China:variation with sex, age and anatomical site. Int J Epidemiol 1989;18:563-8.

Whittemore AS. Fertility drugs and risk of ovarian cancer. Hum Reprod 1993;8:999-1000.

Whittemore AS. Personal characteristics relating to risk of invasive epithelial ovarian cancer in older women in theUnited States. Cancer 1993;71:558-65.

Whittemore AS, Harris R, Itnyre J, Halpern J. Characteristics relating to ovarian cancer risk: Collaborative analysis of12 US case-control studies. I. Methods. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1175-83.

Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 UScase-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group.Am J Epidemiol 1992;136:1184-203.

Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 UScase-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. AmJ Epidemiol 1992;136:1212-20.

Whittemore AS, Holly EA, Lee IM, Abel EA, Adams RM, Nickoloff BJ, Bley L, Peters JM, Gibney C. Mycosis fungoidesin relation to environmental exposures and immune response: a case-control study. J Natl Cancer Inst1989;81:1560-7.

Whittemore AS, Keller JB, Betensky R. Low-grade, latent prostate cancer volume: predictor of clinical cancer inci-dence? [see comments]. J Natl Cancer Inst 1991;83:1231-5.

Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, Burch JD, Hankin J, Dreon DM, West DW, et al.Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the UnitedStates and Canada [see comments]. J Natl Cancer Inst 1995;87:652-61.

Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh CZ, Stamey T. Family history andprostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 1995;141:732-40.

Whittemore AS, Wu ML, Paffenbarger RS, Jr. Sarles DL, Kampert JB, Grosser S, Jung DL, Ballon S, Hendrickson M.Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder,tobacco, alcohol, and coffee. Am J Epidemiol 1988;128:1228-40.

Whittemore AS, Wu ML, Paffenbarger RS, Jr. Sarles DL, Kampert JB, Grosser S, Jung DL, Ballon S, Hendrickson M,Mohle-Boetani J. Epithelial ovarian cancer and the ability to conceive. Cancer Res 1989;49:4047-52.

Whittemore AS, Wu-Williams AH, Lee M, Zheng S, Gallagher RP, Jiao DA, Zhou L, Wang XH, Chen K, Jung D, et al. Diet, physicalactivity, and colorectal cancer among Chinese in North America and China. J Natl Cancer Inst 1990;82:915-26.

Whittemore AS, Zheng S, Wu A, Wu ML, Fingar T, Jiao DA, Ling CD, Bao JL, Henderson BE, Paffenbarger RS, Jr. Colorectalcancer in Chinese and Chinese-Americans. Natl Cancer Inst Monogr 1985;69:43-6.

Wiencke JK, Wrensch MR, Miike R, Zuo Z, Kelsey KT. Population-based study of glutathione S-transferase mu genedeletion in adult glioma cases and controls. Carcinogenesis 1997;18:1431-3.

WWWWW



Wilkinson T. Features of cancer in nonagenarians and centenarians (Letter to the Editor). J Am Geriatr Soc 1999;47.

Winn DM, Blot WJ, McLaughlin JK, Austin DF, Greenberg RS, Preston-Martin S, Schoenberg JB, Fraumeni JF, Jr. Mouthwashuse and oral conditions in the risk of oral and pharyngeal cancer. Cancer Res 1991;51:3044-7.

Witte JS, Ursin G, Siemiatycki J, Thompson WD, Paganini-Hill A, Haile RW. Diet and premenopausal bilateral breast cancer: Acase-control study. Breast Cancer Res Treat 1997;42:243-51.

Wrensch M, Bondy ML, Wiencke J, Yost M. Environmental risk factors for primary malignant brain tumors: a review.J Neurooncol 1993;17:47-64.

Wrensch M, Lee M, Miike R, Newman B, Barger G, Davis R, Wiencke J, Neuhaus J. Familial and personal medicalhistory of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol1997;145:581-93.

Wrensch M, Miike R, Lee M, Neuhaus J. Are prior head injuries or diagnostic X-rays associated with glioma inadults? The effects of control selection bias. Neuroepidemiology 2000;19:234-44.

Wrensch M, Petrakis NL, King EB, Lee MM, Miike R. Breast cancer risk associated with abnormal cytology in nippleaspirates of breast fluid and prior history of breast biopsy. Am J Epidemiol 1993;137:829-33.

Wrensch M, Weinberg A, Wiencke J, Masters H, Miike R, Barger G, Lee M. Does prior infection with varicella-zostervirus influence risk of adult glioma? Am J Epidemiol 1997;145:594-7.

Wrensch M, Yost M, Miike R, Lee G, Touchstone J. Adult glioma in relation to residential power frequency electro-magnetic field exposures in the San Francisco Bay area. Epidemiology 1999;10:523-7.

Wrensch MR, Petrakis NL. Nipple aspirate cytology in high-risk breast cancer identification. Contemporary Oncol-ogy 1994;4:37-45.

Wrensch MR, Petrakis NL, King EB, Miike R, Mason L, Chew KL, Lee MM, Ernster VL, Hilton JF, Schweitzer R, et al.Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol1992;135:130-41.

Wright WE, Bernstein L, Peters JM, Garabrant DH, Mack TM. Adenocarcinoma of the stomach and exposure tooccupational dust. Am J Epidemiol 1988;128:64-73.

Wright WE, Peters JM, Mack TM. Leukaemia in workers exposed to electrical and magnetic fields [letter]. Lancet1982;2:1160-1.

Wright WE, Peters JM, Mack TM. Organic chemicals and malignant melanoma. Am J Ind Med 1983;4:577-81.

Wright WE, Sherwin RP, Dickson EA, Bernstein L, Fromm JB, Henderson BE. Malignant mesothelioma: incidence,asbestos exposure, and reclassification of histopathology. Br J Ind Med 1984;41:39-45.

Wu AH. Exposure misclassification bias in studies of environmental tobacco smoke and lung cancer. Environ HealthPerspect 1999;107 Suppl 6:873-7.

Wu AH. Soy and risk of hormone-related and other cancer. New York: Kluwer Academic/Plenum Publishers, 2000.

Wu AH, Bernstein L. Breast Cancer among Asian Americans and Pacific Islanders. As Am Pac Island J Health1998;6:327-43.

WWWWW



Wu AH, Fontham ET, Reynolds P, Greenberg RS, Buffler P, Liff J, Boyd P, Correa P. Family history of cancer and risk of lungcancer among lifetime nonsmoking women in the United States [see comments]. Am J Epidemiol 1996;143:535-42.

Wu AH, Fontham ET, Reynolds P, Greenberg RS, Buffler P, Liff J, Boyd P, Henderson BE, Correa P. Previous lung disease andrisk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 1995;141:1023-32.

Wu AH, Henderson BE. Alcohol and tobacco use: risk factors for colorectal adenoma and carcinoma? [editorial; comment].J Natl Cancer Inst 1995;87:239-40.

Wu AH, Henderson BE, Pike MC, Yu MC. Smoking and other risk factors for lung cancer in women. J Natl Cancer Inst1985;74:747-51.

Wu AH, Henderson BE, Thomas D, Mack TM. Secular trends in histologic types of lung cancer. J Natl Cancer Inst1986;77:53-6.

Wu AH, Pike MC. Phytoestrogen content in foods and their role in decreasing cancer risk. Handbook of antioxidants,biochemical, nutritional, and clinical aspects, 2nd edition: Marcel Dekker, Inc., In Press.

Wu AH, Pike MC, Stram DO. Meta-analysis: Dietary fat intake, serum estrogen levels, and the risk of breast cancer.J of Natl Cancer Inst 1999;91.

Wu AH, Whittemore AS, Kolonel LN, John EM, Gallagher RP, West DW, Hankin J, Teh CZ, Dreon DM, Paffenbarger RS, Jr.Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white,and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev 1995;4:735-41.

Wu AH, Whittemore AS, Kolonel LN, Stanczyk FZ, John EM, Gallagher RP, West DW. Lifestyle determinants of 5 alpha-reductase metabolites in older African-American, white, and Asian-American men. Cancer Epidemiol Biomarkers Prev2001;10:533-8.

Wu AH, Yu MC, Mack TM. Smoking, alcohol use, dietary factors and risk of small intestinal adenocarcinoma. Int JCancer 1997;70:512-7.

Wu AH, Yu MC, Thomas DC, Pike MC, Henderson BE. Personal and family history of lung disease as risk factors foradenocarcinoma of the lung. Cancer Res 1988;48:7279-84.

Wu AH, Ziegler RG, Horn-Ross PL, Nomura AM, West DW, Kolonel LN, Rosenthal JF, Hoover RN, Pike MC. Tofu and riskof breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 1996;5:901-6.

Wu AH, Ziegler RG, Nomura AM, West DW, Kolonel LN, Horn-Ross PL, Hoover RN, Pike MC. Soy intake and risk ofbreast cancer in Asians and Asian Americans. Am J Clin Nutr 1998;68:1437S-43S.

Wu AH, Ziegler RG, Pike MC, Nomura AMY, West DW, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hoover RN. Menstrualand reproductive factors and risk of breast cancer in Asian-Americans. Br J Cancer 1996;73:680-6.

Wu ML, Whittemore AS, Jung DL. Errors in reported dietary intakes. II. Long-term recall. Am J Epidemiol1988;128:1137-45.

Wu ML, Whittemore AS, Paffenbarger Jr. RS, Sarles DL, Kampert JB, Grosser S, Jung DL, Ballon S, Hendrickson M,Mohle-Boetani J. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproduc-tive and menstrual events and oral contraceptive use. Am J Epidemiol 1988;128:1216-27.

Wu-Williams AH, Fontham ET, Correa P, et al. Previous lung disease and risk of lung cancer among lifetime nonsmokingwomen in the United States. Am J Epidemiol 1995;141:1023-32.

WWWWW



Wu-Williams AH, Lee M, Whittemore AS, Gallagher RP, Jiao DA, Zheng S, Zhou L, Wang XH, Chen K, Jung D, et al.Reproductive factors and colorectal cancer risk among Chinese females. Cancer Res 1991;51:2307-11.

Wu-Williams AH, Samet JM. Cigarette smoking and lung cancer. In: Samet JM, ed. Lung Biology in Health andDisease: Marcel Dekker, Inc., 1994.

Wu-Williams AH, Yu MC, Mack TM. Life-style, workplace, and stomach cancer by subsite in young men of Los AngelesCounty. Cancer Res 1990;50:2569-76.

Xu J. Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancerfamilies from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet 2000;66:945-57.

Xue W, Irvine RA, Yu MC, Ross RK, Coetzee GA, Ingles SA. Susceptibility to prostate cancer: interaction betweengenotypes at the androgen receptor and prostate-specific antigen loci. Cancer Res 2000;60:839-41.

Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California fordifferent race/ethnic groups. Cancer Causes Control 2001;12:703-11.

Yost K, Schlag RD. Colorectal Cancer in California, 2001. Sacramento: California Department of Health Services, CancerSurveillance Section, February 2002.

Young JL, Snipes KP, Perkins CI, Wright WE. Prostate Cancer: The Relationship among Incidence, Treatment andStaging. J of Registry Management 1995;22:21-5.

Yu MC, Garabrant DH, Peters JM, Mack TM. Tobacco, alcohol, diet, occupation, and carcinoma of the esophagus.Cancer Res 1988;48:3843-8.

Yu MC, Ho JH, Ross RK, Henderson BE. Nasopharyngeal carcinoma in Chinese—salted fish or inhaled smoke? PrevMed 1981;10:15-24.

Yu MC, Mack T, Hanisch R, Peters RL, Henderson BE, Pike MC. Hepatitis, alcohol consumption, cigarette smoking,and hepatocellular carcinoma in Los Angeles. Cancer Res 1983;43:6077-9.

Yu MC, Mack TM, Hanisch R, Cicioni C, Henderson BE. Cigarette smoking, obesity, diuretic use, and coffee consumption asrisk factors for renal cell carcinoma. J Natl Cancer Inst 1986;77:351-6.

Yu MC, Ross RK. Epidemiology of bladder cancer. In: Petrovich Z, Baert L, Brady L, eds. Carcinoma of the Bladder:Innovations in Management. Berlin; Heidelberg: Springer-Verlag, 1998:1-13.

Yu MC, Ross RK. Risk factors in head and neck cancer. New Engl J Med 1982;307:54-5.

Yu MC, Ross RK, Chan KK, Henderson BE, Skipper PL, Tannenbaum SR, Coetzee GA. Glutathione S-transferase M1genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers.Cancer Epidemiol Biomarkers Prev 1995;4:861-4.

Yu MC, Skipper PL, Taghizadeh K, Tannenbaum SR, Chan KK, Henderson BE, Ross RK. Acetylator phenotype,aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Ange-les, California. J Natl Cancer Inst 1994;86:712-6.

Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE. Prevalence of hepatitis B and C viral markersin black and white patients with hepatocellular carcinoma in the United States [see comments]. J Natl CancerInst 1990;82:1038-41.

Yu MC, Tong MJ, Govindarajan S, Henderson BE. Nonviral risk factors for hepatocellular carcinoma in a low-risk population,the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-6.

WWWWW-----YYYYY



Yu MC, Yuan JM, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 2000;14:703-9.

Yu MC, Yuan JM, Ross RK, Govindarajan H. Presence of antibodies to the hepatitis B surface antigen is associatedwith an excess risk for hepatoceullar carcinoma among non-Asians in Los Angeles County, California. Hepatology1997;25:226-8.

Yu MC, Yuan JM, Ross RK, Govindarajan S. Presence of antibodies to the hepatitis B surface antigen is associated with anexcess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California [published erratumappears in Hepatology 1997 May;25(5):1298]. Hepatology 1997;25:226-8.

Yuan A, Yu CJ, Chen WJ, Lin FY, Kuo SH, Luh KT, Yang PC. Correlation of total VEGF mRNA and protein expression withhistologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Int JCancer 2000;89:475-83.

Yuan JM, Castelao JE, Gago-Dominguez M, Ross RK, Yu MC. Hypertension, obesity and their medications in relationto renal cell carcinoma. Br J Cancer 1998;77:1508-13.

Yuan JM, Castelao JE, Gago-Dominguez M, Yu MC, Ross RK. Tobacco use in relation to renal cell carcinoma. CancerEpidemiol Biomarkers Prev 1998;7:429-33.

Yuan JM, Gago-Dominguez M, Castelao JE, Hankin JH, Ross RK, Yu MC. Cruciferous vegetables in relation to renalcell carcinoma. Int J Cancer 1998;77:211-6.

Yuan JM, Wang XL, Xiang YB, Gao YT, Ross RK, Yu MC. Active and passive cigarette smoking in relation to nasopharyngealcarcinoma in Shanghai, China. Int J Cancer In Press.

Yuan JM, Wang XL, Xiang YB, Gao YT, Ross RK, Yu MC. Non-dietary risk factors for nasopharyngeal carcinoma inShanghai, China. Int J Cancer 2000;85:364-9.

Yuan JM, Wang XL, Xiang YB, Gao YT, Ross RK, Yu MC. Preserved foods in relation to risk of nasopharyngeal carci-noma in Shanghai, China. Int J Cancer 2000;85:358-63.

Ziegler RG, Hoover RN, Nomura AM, West DW, Wu AH, Pike MC, Lake AJ, Horn-Ross PL, Kolonel LN, Siiteri PK, FraumeniJF, Jr. Relative weight, weight change, height, and breast cancer risk in Asian- American women. J Natl CancerInst 1996;88:650-60.

Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL,Rosenthal JF, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst1993;85:1819-27.

Ziogas A, Gildea M, Cohen P, Bringman D, Taylor TH, Seminara D, Barker D, Casey G, Haile R, Liao SY, Thomas D, NobleB, Kurosaki T, Anton-Culver H. Cancer risk estimates for family members of a population-based family registry forbreast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 2000;9:103-11.

Zippin C, Lum D. Study of completeness of the surveillance, epidemiology and end results (SEER) program caseascertainment by hospital size and casefinding source. Health Rep 1993;5:87-90.

YYYYY-----ZZZZZ

CCCCCALALALALALIFIFIFIFIFOOOOORRRRRNIANIANIANIANIA C C C C CANANANANANCECECECECERRRRR R R R R REEEEEGIGIGIGIGISSSSSTTTTTRRRRRYYYYY P P P P PUUUUUBBBBBLLLLLIIIIICCCCCAAAAATTTTTIIIIIOOOOONNNNNSSSSS

OOOOOCTOBERCTOBERCTOBERCTOBERCTOBER 2003 2003 2003 2003 2003

Documents

CALIFORNIA CANCER REGISTRYccr.ca.gov/pdf/Reports/CCRPub2003.pdf · 6 california cancer registry publications, 2003 state of california, department of health services october 2003